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Abstract 
 
 
Chapter 1 describes an efficient multi-step synthesis of an endotopic but sterically un-
hindered biisoquinoline decorated with long alkyl groups for better solubility. This chelate is 
ideally suited for macrocycle formation around transition metal ions and therefore a valuable 
new building block for topological chemistry. 
Sokolov’s concept to use an octahedral metal template for the syntheses of macrocycles and 
molecular knots is discussed in Chapter 2. The concept was successfully realised for the 
synthesis of a macrocyclic, hexadentate ligand that incorporates three bipyridine units. One-
to-one complexes with this ligand and zinc(II), iron(II) and ruthenium(II) were prepared and a 
crystal structure of the latter was obtained. 
Three novel oligonuclear, macrocyclic ruthenium(II) complexes are presented in Chapter 3. 
The complexes are mononuclear, dinuclear and trinuclear and were prepared from bidentate, 
tetradentate or hexadentate macrocyclic ligands, respectively. The compounds were 
extensively characterised and their physical properties have been investigated. 
Chapter 4 describes the diversification of ligand families into neocuproin (suited for 
coordination to copper(I)), ferroin (suited for coordination to iron(II)) and heteroditopic 
structure type. Proof-of-principle conversion into palladium(II) and copper(I) complexes were 
prepared and their structures are discussed. 
The synthesis of a symmetric bipyridine ligand which possesses pyrene domains is shown in 
Chapter 5. Homoleptic and heteroleptic iron(II) and ruthenium(II) complexes with this ligand 
are presented and their solid state structures and photophysical properties are examined. 
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1 A Biisoquinoline Chelate 
 
 
Biological motors[1] are proteins (for example, myosins, kinesins and dyneins) and are 
important in biological processes including muscle contraction, intracellular transport and 
signal transduction. The ATP synthase[2, 3] is an enzyme that is another genuine example for a 
molecular motor able to synthesise adenosine triphosphate (ATP) from adenosine 
diphosphate (ADP) using energy usually in the form of protons moving down an 
electrochemical gradient. ATP is the common immediate energy source of cells. 
Nature has had roughly 4.5 billion years time to develop molecular machines whereas 
mankind has only been working for several decades on synthetic molecular machines. 
Clearly, the natural molecular machines are superior in terms of complexity and functionality 
to their artificial analogues. 
Synthetic molecular motors are often based on catenanes or rotaxanes in which motion can 
be triggered and controlled at will; hence act as molecular machines or at least like their 
prototypes. 
 
 
1.1 Introduction 
Interlocked molecules are built from two or more modules that are mechanically linked 
together. Figure 1.1-1 illustrates a [2]catenanea and a [2]rotaxane − two of the simplest and 
most common compounds that are intertwined. The name catenane is derived from the Latin 
word catena which means “chain”. The interlocked rings cannot be separated without 
breaking a covalent bond. A [2]rotaxane is comprised of a linear, dumbbell-shaped fragment 
that is threaded through a cyclic component. Bulky groups (stoppers) trap the two components 
such that they are not free to separate unless a covalent bond is broken. 
                                                 
a
 The number in brackets designates the number of components. 
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  [2]catenane      [2]rotaxane 
Figure 1.1-1. Schematic representation of a [2]catenane and a [2]rotaxane. 
 
R. M. Willstädter discussed the possibility of interlocked rings in a talk in Zürich almost a 
century ago.[4] He could not conjecture that his early “visionary” speculations would become 
true and that today’s chemists are not only able to synthesise catenanes in high yields but also 
geometrical structures of much higher topological complexity. In 1960, Wasserman published 
for the first time the synthesis of a catenane by a statistical threading approach.[5] The 
intramolecular acyloin condensation of a diester to form a macrocycle in the presence of a 
large alkane ring should deliver a statistical amount of a catenated species supposing that 
during the reaction some molecules of the diester have been threaded in the ring. With this 
very intuitive, though not efficient, method, only one percent of the species with interlocked 
rings could be isolated after extensive chromatographic purification (see Scheme 1.1-1).   
 
 
Scheme 1.1-1. Wasserman’s statistical synthesis[5] via intramolecular acyloin condensation in the 
presence of a cyclic alkane yielded approximately one percent of the catenane. 
 
The directed synthesis of catenanes has been performed by Schill et al. and published in 
1971.[6, 7] 
With the appearance of various templated approaches in the 1980’s, the research area of 
topologically unusual but doubtlessly beautiful molecules and their applications literally 
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exploded. Since 1983, a copper-metal template strategy introduced by Sauvage et al.[8, 9] that 
allowed catenanes, rotaxanes and knots to be obtained in reasonable to excellent yields. 
Figure 1.1-2 shows the first example of an extremely short and convenient synthetic route to a 
catenane, that is based on a generalized template effect around a metal ion.[10] In the first step 
the complex 2+ is formed quantitatively with ligand 1 and Cu(MeCN)4+. This very stable, 
deep red complex was reacted further under high dilution conditions with a diiodo chain, 
derived from pentaethylene glycol, in the presence of Cs2CO3 affording 3+ in 27% yield. 
 
 1     2+     3+ 
Figure 1.1-2. Synthesis of a catenand (metalated catenane) around a copper(I) ion in 27% yield. 
Adapted from reference.[10]  
 
 
In 2006, Beer et al.[11] reported the synthesis of a [2]catenane that was templated by a chloride 
anion (see Figure 1.1-3). Equimolar solutions of 4a (chloride salt) and 4b (hexafluoro-
phosphate salt) were mixed and subjected to a ring closing metathesis (RCM) affording the 
catenane in 78% yield. Interestingly, analogous RCM reactions with pure 4a or 4b gave 
significantly lower yields, 34% and 16% respectively. The lower yield of catenane is 
explained by a favoured formation of a macrocycle in case of the pure chloride and the lack of 
anion templation from chloride in case of the pure hexafluorophosphate salt. However, 
catenane formation in the latter shows that pi-pi stacking and pyridinium CH···O hydrogen 
bonds participate in the formation process. 
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  4a: X = Cl 
  4b: X = PF6 
Figure 1.1-3. a) Structure of the catenane precursor; b) Crystal structure of the [2]catenane with a 
chloride ion in the binding cavity. Other counterions, hydrogen atoms and solvent molecules have 
been omitted for clarity. Adapted from reference.[11] 
 
In order to achieve good yields, the building blocks have to be pre-organised. Such pre-
organisation has been very successfully demonstrated in many syntheses with the interactions 
including coordination to a metal ion,[9, 10, 12] hydrophobic effects[13], hydrogen bond 
formation,[14, 15] charge-transfer interactions[16, 17] and covalent bond formation.[18] In 
particular, Stoddart and his group have worked on the synthesis of interlocked systems based 
on secondary dialkylammonium salts and crown ethers[19, 20] and on systems based on pi-
electron-rich/pi-electron-deficient aromatic systems.[16] Hunter[21], Vögtle[22, 23] and Leigh[24] 
worked on catenane systems with hydrogen-bonds as templates, and cyclodextrin systems 
have been presented by Harada, Wenz and Ogino.[13, 25, 26] Furthermore, one can also find 
rotaxanes based on crown ether frameworks reported by Gibson.[27]  
All these molecules display interesting physical properties such as photoinduced intra-
molecular electron transfer,[28] electrochemically triggered molecular motion and photo-
chemical dethreading processes. This leads us to multicomponent systems which can act as 
molecular machines, molecular devices or molecular computers.[29-33]  
One appealing example for a molecular machine is the hydrogen-bonded molecular shuttle[31] 
developed by Leigh’s group (see Scheme 1.1-2). A benzylic amide macrocycle is 
mechanically locked onto a thread bearing two potential H-bonding stations. In the ground 
state the ring is predominantly bound around the succinamide site (green). After irradiation 
and photoreduction of the naphtalamide site (red), the reduced naphtalamide (blue) is now the 
stronger H-bond acceptor, and the equilibrium shifts to the second station. After charge 
recombination, the macrocycle shuttles back to its original position. This process is reversible 
and has properties that are characteristic of an energy-driven piston. 
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Scheme 1.1-2. A photoresponsive, H-bond-assembled, molecular shuttle.From reference.[31] 
 
Another example from Sauvage and co-workers[34, 35] of a molecular machine that is based on 
redox processes of the Cu(II)/Cu(I) couple is depicted in Figure 1.1-4. The rotaxane 5+ 
consists of dumbbell-shaped axis incorporating one bipyridine binding side and a ring that has 
a bidentate phenanthroline moiety and a tridentate terpyridine moiety. Copper(I) prefers to 
form tetrahedral complexes with coordination number four and copper(II) preferentially forms 
5-coordinate species. The interconversion between these two states is performed electro-
chemically. The complex undergoes an electrochemically driven pirouetting motion of the 
ring around the axis that occurs on the millisecond timescale. This system exhibits enhanced 
rate constants compared to a similar system from the same group.[36] The rate of motion 
depends strongly on the oxidation state of the metal centre. In addition, the metal centre 
which is as accessible as possible has the most rate increasing effects. Hence, ligands which 
have little steric hinderance are chosen. Sterically non-hindering endocyclic ligands of the 
biisochinoline family[37-44] have been developed in the Sauvage group for this and other 
purposes. A [2]rotaxane with a ring incorporating the biisoquinoline showed indeed 
remarkably faster motion than the analogous [2]rotaxane with a phenanthroline moiety.[40] 
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N
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O
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      5+        52+ 
Figure 1.1-4. Electrochemically induced motion of the ring in rotaxane 5n+. The bidentate chelate (red) 
and the tridentate fragment (green) are alternatively coordinated to the copper centre. Adapted from 
reference.[35] 
 
The 2,9-diphenylphenanthroline is a sterically more demanding ligand compared to the 
corresponding biisoquinoline system (see Scheme 1.1-3). The distances between the carbon 
atoms in the phenyl rings that are linked to the ligand moiety are 700 pm and 1100 pm[41], 
respectively. The complexed metal centre will be remote from any organic group of the 
biisoquinoline ligand. 
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Scheme 1.1-3. Pronounced steric hindrance will occur once the dpp-fragment is coordinated to a 
metal (left). Substituted biisoquinoline fragments allow endocyclic and sterically non-hindered 
coordination (right). 
 
The homoleptic iron(II)-complex of ligand 6 illustrates the endotopic but sterically non-
hindering fashion of coordination (see Figure 1.1-5).[38, 41] 
 
 
 
  6       [Fe(6)3]2+ 
Figure 1.1-5. Reagents and conditions: a) Fe(BF4)2, CH2Cl2. The crystallographic structure of the 
cation [Fe(6)3]2+ is shown on the right. Counterions, solvent molecules and hydrogen atoms have been 
omitted for clarity. Adapted from references.[38, 41] 
 
 
1 A BIISOQUINOLINE CHELATE 
8 
 
1.2 Aims and Overview 
 
Ligands of the biisoquinoline family[37-44] are ideally suited for macrocycle formation around 
transition metal ions and are promising novel building blocks for topologically unusual 
molecules. They feature two crucial properties that seem to be contradictory:  
(i) they coordinate in an unhindered or only very slightly hindered fashion since they 
have no substituents in α position.  
(ii) the binding site is inevitably arranged towards the endo part of the crescent shaped 
ligand that will lead unambiguously to an endocylic coordination if the chelate is 
subsequently included in a ring.  
 
This chapter describes the synthesis of the novel biisoquinoline ligand 7 (see Scheme 1.2-1). 
Alkyl chains render this ligand soluble. Ethylene glycol chains bearing terminal alkene 
functionalities ready to undergo olefin metathesis and macrocycle formation are attached at 
the termini of the aromatic system. 
 
    7 
Scheme 1.2-1. Biisoquinoline ligand 7. Note the terminal alkene function ready for RCM and long alkyl 
side chains that help to solubilise the ligand. 
 
Grubbs’ catalysed ring closing metathesis (RCM) has proven to be very efficient in such 
cyclisation reactions and, furthermore, features very mild reaction conditions.[45, 46] 
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This sterically unhindered endotopic ligand 7 paves the way to molecules with unusual 
chemical topologies. The synthesis of a cyclic [3]catenane has never been reported to date. 
One possible route to this compound using ligands of the biisoquinoline family and an 
octahedral transition metal as templating agent is outlined in Figure 1.2-1. 
 
Figure 1.2-1. Synthetic strategy towards a cyclic [3]catenane. 
 
The synthesis of a [3]catenane has been attempted using this strategy and the outcome and 
insights are discussed in this chapter. 
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1.3 Results and Discussion 
 
 
The retrosynthetic route towards biisoquinoline 7 is shown below. Ligand 7 is accessible via a 
homocoupling of the corresponding substituted (e. g. X = OTf) isoquinoline J. The phenolic 
functions can be deprotected in refluxing pyridinium chloride, and a double Williamson ether 
synthesis using a glycolic chain with a terminal olefinic function will yield our target 
molecule 7. With the help of typical coupling reactions like the Stille (Y = SnR3) or Suzuki 
(Y = BOR3) reaction between the brominated part L and the biphenyl M, compound J can be 
prepared. The reaction yielding isoquinoline L, functionalized at the 3 and 8 positions, can be 
carried out following an existing literature procedure.[47] 2,2-Diethoxyacetyl chloride (O) 
condensed with 2-bromobenzylamine (N) results in amide K which can be cyclised in a 
Pomeranz-Fritsch reaction to yield L. The biphenyl M can be made via a statistical Suzuki 
coupling of building blocks P and Q, which are prepared with relative ease or can be 
purchased commercially. 
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N
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Scheme 1.3-1. Proposed synthetic route to ligand 7. 
 
It has been shown that the solubility of rigid and other very poorly soluble species can be 
greatly enhanced by attaching flexible side chains.[48] 
The 1,4-di-n-hexylbenzene was obtained by a method analogous to the literature 
procedure.[49] Thus, n-hexylmagnesium bromide was coupled with 1,4-dichlorobenzene (8) 
using nickel-catalysis to give the respective product in almost quantitative yield (98%). In the 
next step, 1,4-di-n-hexylbenzene was brominated as a neat liquid under rigorous exclusion of 
light. The crude product could easily be isolated and was recrystallized from ethanol. 
Analytically pure 9, made in excellent yield (82%), showed bromination exclusively at C-1 
and C-4 (see Scheme 1.3-2). 
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Scheme 1.3-2. Preparation of the biphenyl part of the ligand. Reagents and conditions: a) n-
C6H13MgBr, [(dppp)Cl2Ni], Et2O, reflux (98%); b) Br2 (2.1 eq), I2 (0.01 eq), RT (82%); c) 4-
methoxyphenylboronic acid, [Pd(PPh3)4] (2 mol%), Na2CO3, toluene/EtOH/H2O (80:15:5, v/v, 79%); 
d) n-BuLi, THF, –78 °C then B(OMe) 3, THF, –78 °C → RT then H+/H2O (80%-quant). dppp = 1,3-
bis(diphenylphosphino)propane. 
 
The statistical Suzuki coupling between the dibromo compound 9 and 4-methoxy-
phenylboronic acid turned out to be very successful. In the presence of a catalytic amount of 
[Pd(PPh3)4], with sodium carbonate as a base in a solvent mixture of toluene, ethanol and 
water, product 10 was synthesised in 79% yield. The Suzuki coupling is considered as “green 
chemistry” because water or mixtures of water and organic solvents are used. Boronic acids 
are harmless unlike the carcinogenic stannane compounds used in Stille couplings.[50] The 
boronic acid 11 was formed in 80% to quantitative yield depending on the quality of n-
butyllithium solution used. The crude product was sufficiently pure to be used without further 
purification. 
 
Sodium diethoxyacetate 12 was activated with thionyl chloride and subsequently condensed 
with 2-bromobenzylamine 13 in 72% yield. The amide 14 can be cyclised in concentrated 
sulfuric acid and forms 8-bromoisoquinoline-3-ol (15) in a so-called Pomeranz-Fritsch 
reaction.[41] For the coupling reaction between the isoquinoline part and the biphenyl part, the 
phenolic function needs to be protected as shown by preliminary experiments. The TIPS-
protecting group (triisopropylsilyl) was introduced using TIPSCl in the presence of imidazole 
in DMF (see Scheme 1.3-3). 
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Scheme 1.3-3. Preparation of the isoquinoline part of the ligand. Reagents and conditions: a) SOCl2, 
Et2O, reflux then pyridine/toluene, reflux (72%); c) H2SO4, RT (30-40%); d) TIPSCl, imidazole, DMF, 
RT (82%). TIPSCl = triisopropylsilyl chloride. 
 
Although the TIPS-protecting group can be removed under basic aqueous conditions, the 
Suzuki-coupling between the brominated isoquinoline 16 and the boronic acid 11 was 
performed in excellent yield (65% over three steps from 16 to 19). During the reaction, the 
coupled product was partially deprotected. It was preferable not to isolate the TIPS-protected 
coupling product, so for simplicity the deprotection was completed with TBAF in THF. The 
crude phenol 18 was filtered to remove less polar side products and was directly converted to 
the triflate 19, which could be readily purified by chromatography since the product is the 
least polar component and there is a large difference between the retention factors of the 
product and the impurities (see Scheme 1.3-4). 
 
Scheme 1.3-4. Coupling between the isoquinoline part and the biphenyl part and subsequent 
reactions: Reagents and conditions: a) [Pd(PPh3)4] (4 mol%), Ba(OH)2, DME/H2O (5:1, v/v); b) TBAF, 
THF, RT; c) Tf2O, Et3N, CH2Cl2 (65%; 3 steps). TBAF = tetra-n-butylammonium fluoride. 
 
Ligand 20 was obtained in 74% yield by a palladium-catalyzed homocoupling reaction 
between two molecules of 19 with triflate functionalities using elemental zinc as the electron 
source. The use of high triflate concentrations (> 1 mM) was of pivotal importance for 
favouring bimolecular homocoupling over undesired triflate/hydrogen exchange. 
Furthermore, the use of dry N,N'-dimethylformamide was imperative.[51]  
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Scheme 1.3-5. Homocoupling and subsequent reactions: a) [PdCl2dppf], Zn, KI, DMF (74%); 
b) pyridinium chloride, reflux (92%); c) 3-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)prop-1-ene (28), 
Cs2CO3, DMF (74%). dppf = 1,1'-bis(diphenylphosphino)ferrocene. 
 
The dimethoxy compound 20 was deprotected in refluxing pyridinium chloride to give 21 in 
92% yield, which was converted via a double Williamson ether synthesis to ligand 7 in 74% 
yield (Scheme 1.3-5). 
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Scheme 1.3-6. Synthesis of the homoleptic iron(II) complex 22. Reagents and conditions: a) Fe(BF4)2 
· 6 H2O, reflux, CH2Cl2, MeOH. 
 
The iron(II) complex [Fe(7)3](BF4)2 (22) was obtained in very good yield (93%) by mixing 
Fe(BF4)2 · 6H2O (1.5 eq, in methanol) and ligand 7 (3 eq, in CH2Cl2). The reaction mixture 
was heated at reflux overnight and purified via column chromatography to remove traces of 
free ligand and excess iron tetrafluoroborate. The ESI-MS spectra exhibited one peak for the 
222+ cation at m/z = 1938.2 (calc. 1938.2). The measured isotopic pattern matches the 
calculated pattern. 
 
After complexation, complex 22 was subjected to intramolecular threefold RCM with Grubbs 
catalyst 1st generation. The 1H-NMR showed the disappearance of the two typical multiplets 
for terminal alkenes at δ 5.9 ppm and δ 5.2 ppm and the appearance of one new singlet at δ 
5.88 ppm that can be assigned to the protons of the closed double bonds in complex 23. 
Reduction of the double bonds was carried out with molecular hydrogen in the presence of 
palladium on charcoal. The singlet at δ 5.88 ppm vanished in the 1H-NMR spectrum. The 
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removal of the metal was assumed to be beneficial for the purification process. All attempts to 
remove the iron(II) ion in a reductive manner failed (H2O2/KOH). Refluxing complex 242+ in 
1,2-dichloroethane in the presence of an excess of phen (1,10-phenanthroline) (10 eq) resulted 
in the formation of the more stable [Fe(phen)3]2+complex and yielded free ligand 25 (see 
Scheme 1.3-7). 
 
Scheme 1.3-7. Synthesis of 25. Reagents and conditions: a) Grubbs 1st generation catalyst, CH2Cl2 
(80-90%); b) H2, Pd/C, CH2Cl2 (90%); c) 1,10-phenanthroline (10 eq), DCE, chromatography. DCE = 
1,2-dichloroethane. 
 
A MALDI-TOF-MS spectrum of 25 was measured. The suspected [3]catenane 25 has a 
calculated mass of m/z = 3742.4. A peak at m/z = 3741.1 (isomer with one unreacted double 
bond plus one proton) and at m/z = 3802.9 (25 + Mg2+ + Cl-) with matching isotopic pattern 
were observed. 
 
 
Pleasingly, the 1H NMR spectrum of 25 looked very similar to the spectrum of the ligand 7 
before RCM. Signals a-e (see Figure 1.3-1) are much broader in the proposed [3]catenane, 
which may be due to dynamic processes such as hindered rotation of one ring around the 
others or partial protonation of nitrogen atoms. Already in the spectrum of ligand 7 signals a-e 
are much broader than signals h-i, which are sharp in both cases. The signals of the terminal 
alkene functionality are no longer present in 25.  
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Figure 1.3-1. 1H NMR spectra in CDCl3 at 400 MHz of a) ligand 7 and b) proposed [3]catenane 25. 
The solvent residual signal is marked with an asterisk (*). For labelling see Scheme 1.2-1. 
 
No X-ray structure of 25 was obtained, and therefore its structure remains therefore 
unconfirmed. 
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1.4 Summary  
 
In summary, an efficient multi-step synthesis of an endotopic biisoquinoline ligand has been 
developed. This chelate is ideally suited for macrocycle formation around transition metal 
ions and is thus a valuable new building block for topological chemistry. In contrast to the 
vast majority of previously reported endotopic diimine ligands, this 8,8’-diaryl-3,3’-biiso-
quinoline is sterically unhindered.  
Long alkyl chains attached to extended aromatic systems have the advantage of rendering 
these molecules more soluble and to facilitate their manipulation. Otherwise, the synthetic 
effort is usually considerably higher and the chances to obtain crystals suitable for X-ray 
analysis that might be necessary for unambiguous structure determination are smaller due to 
an increased number of degrees of freedom. 
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2 Macrocyclic Tris(bipyridine) − A Metal Templated 
Synthesis for Trivial Knots  
 
 
 
It is probably surprising that “simple” objects from daily life like knots can become subject to 
advanced scientific investigation. Mathematics developed knot theory more than a century 
ago[52] and insight into these systems is today of great use for physicists, chemists and 
molecular biologists working on fields that deal with this kind of topology. Chemists 
synthesised molecular knots, at first for the synthetic challenge, emphasizing the viability and 
potential of their synthetic methods and tools, and secondly for possible future applications. 
The demand for novel devices on the molecular scale with various properties in 
nanotechnology and information technology is clearly a motivation in addition to purely 
fundamental viewpoints. Obviously, chirality is an essential property in many areas of 
chemistry, and the chirality arising from knots stems from their topology and not from the 
classical stereogenic units (points, axes, helices and planes). This makes them especially 
interesting for asymmetric induction, for instance in asymmetric catalysis. 
 
 
2.1 Introduction 
The discovery of natural knotted forms of DNA[53-55] and proteins[56-60] verifies the captivating 
beauty of nature that is able to produce such highly complex three dimensional structures. But 
the unusual geometry also has an impact on the biological properties. For example, the 
activity for the transport of iron(III) ions is remarkably higher in the knotted form of 
lactoferrin (see Figure 2.1-1a) than for its linear analogue.[56] Enhanced chirality and rigidity 
due to the knotted topology seem to play a critical role in the antiviral activities of proteins 
circulin A and B, and make them promising anti-HIV drugs.[61, 62] With the development of 
elaborate techniques like electron microscopy, it is today possible to give an unambiguous 
topological characterisation of catenated and knotted DNA. Figure 2.1-1b shows exquisite 
electron micrographs of knotted DNA.[53] 
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Figure 2.1-1. a) Schematic representation of lactoferrin,[56] a naturally occurring knotted protein. 
b) Electron micrographs of trefoil DNA molecules.[53] 
 
These findings initiated a new field of research that has been named “Biological 
Topology”.[55] Besides the fascinating naturally occurring knotted and catenated DNA, 
Seeman and co-workers accomplished and reported the synthesis of artificial single-stranded 
DNA knots and many intriguing topologies have been produced.[63-69] 
 
In knot theory[52], the simplest knot of all is the unknotted circle, which is called the unknot or 
the trivial knot. The next simplest knot is a trefoil knot, its topological structure and its three 
topological isomers are depicted in Figure 2.1-2. One is the planar cycle (III) whose graph 
contains no crossings in contrast to the two trefoil knots. In chemical topology[4, 70] the 
molecule or the molecular assembly is schematically represented on paper as a graph. The two 
non-planar knots (I, II) are enantiomers and topologically chiral. Their chirality can be 
evidenced by rationalising that their image and their mirror image are non-superposable. 
 
a) b)
 
Figure 2.1-2. a) Computed structure of a trefoil knot (MAPLE 10); b) Schematic representations of the 
two enantiomers of the trefoil knot (I,II) and its planar isomer the cycle (III). 
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After the isolation of the first [2]catenane by Wasserman[5] in 1960, a lively discussion about 
the synthesis of a molecular knot emerged in the chemical literature. Scientists suggested 
using a Möbius strip as a precursor[4, 71], a covalent template[72, 73] or metal coordination.[74, 75] 
Sokolov[74] proposed an octahedral tris(chelate) template. This chapter describes the 
realisation of his design with the help of recent achievements in modern chemistry – at least 
for the synthesis of a trivial knot. None of these early designs could be realised to date. 
Reviews by Walba[76] and Sauvage and Dietrich-Buchecker[77] describe the ideas and 
prospects of these early attemps in more detail. A more recent review from Vögtle and co-
workers[61] gives a very good background on molecular knots and their assemblies and 
provides an overview on molecular knots that have been prepared in the laboratory. 
 
The first successful synthesis of a molecular knot was reported 20 years ago by Sauvage and 
co-workers.[78] They conceived a seminal method taking advantage of the template effect of a 
transition metal and the particular geometry of helical dinuclear complexes (see Figure 2.1-3).  
 
 
Figure 2.1-3. Strategy used to make a trefoil knot.[78] a) Two bis(chelate) molecular strands are 
coordinated to a transition metal forming a helical complex; b) The ends of the double stranded helix 
are cyclised leading to the knotted structure. 
 
Two bis-chelating molecular threads were coordinated to two copper(I) metal centres to form 
a helical dinuclear complex. The helical geometry is a prerequisite, and the stability of the 
copper complex is of utmost importance. The knot was formed after linking the ends with 
oligoethyleneglycol chains. Variation of length and rigidity in the bridge that links the 
chelating units and the chains used during cyclisation led to a variety of knots and 
improvement in yield.[79, 80] The best yield of this topologically non-trivial molecule (35% 
over seven steps from commercially available starting materials) was achieved by 
employment of the highly efficient ring-closing metathesis (RCM) methodology[79] (see 
Scheme 2.1-1, compound 29). The knots obtained by the concept of helical copper(I)-
phenanthroline complexes were characterised by X-ray structure analysis[81] and the 
resolution into its enantiomers was also successful.[82] Furthermore, two knotted moieties 
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were fused to a composite knot whose isomeric composition involves a meso form and a pair 
of enantiomers.[83] 
 
                     292+        306+ 
 
Scheme 2.1-1. Molecular trefoil knots that have been synthesised from a helical precursor. The 
dicopper complex 292+ was prepared in very good yields.[79] The cation 306+ was synthesised in very 
poor yield but does not need an external template.[84] 
 
The synthesis of the trefoil knot 30 in extremely low yields was reported by Stoddart and co-
workers in 1997.[84] Their design logic relied on the formation of a double stranded 
supramolecular complex between pi-electron rich and pi-electron deficient strands by pi-
donor/pi-acceptor interactions. Irreversible covalent bond formation connecting the termini of 
the precursers afforded both a trefoil knot and a macrocycle. The compounds could be 
purified by high performance liquid chromatography (HPLC) and were characterised by 
means of liquid secondary-ion mass spectrometry (LSIMS). 
After the successful employment of a transition metal and pi-donor/pi-acceptor interactions, 
another templating mode was introduced by Vögtle and co-workers[85] in 2000 for the 
synthesis of trefoil knots. An intramolecular hydrogen-bonding pattern of oligoamides and the 
folding of the loop provided conditions in which a one-pot procedure afforded the desired 
molecules in reasonable yields. Their concept is especially intriguing due to the simplicity of 
the synthesis, unique possibilities of further derivatization and that the assembly of the amide-
knots has much in common with the formation of tertiary structural motifs found in natural 
proteins.[86] A huge variety of derivatized knots has been prepared, including dendrimers, 
rotaxanes with knots acting as stopper groups, and other assemblies that link knots in linear, 
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triangular or cyclic fashions.[61] Chiral resolution of the latter knot assemblies into their 
isomers could be performed in some cases by HPLC with a chiral stationary phase. 
More recently, a trefoil knot was made from amino acids and steroids as building blocks.[87] 
The unexpected knotted geometry was observed in cyclic oligoamides that were built from 
alternating sequences of aminodeoxycholanic acid and a natural amino acid. The authors state 
that the knot was prepared only as one diastereoisomer due to asymmetric induction from 
chiral optically pure building blocks. The topology must have been preorganized prior to the 
final ring-closure because an amide bond is formed irreversibly. The chain of backbone atoms 
is depicted in Figure 2.1-4b displaying the knot topology. 
 
Figure 2.1-4. Two examples for molecular knots: a) Reversible folding of a tris(chelate) oligomer 
around zinc(II) into an open knot[88]; b) Chain of backbone atoms illustrating the non-trivial topology of 
a knot that was prepared from amino acids and steroids.[87] 
 
A linear tris(bipyridine) oligomer that folded around an octahedral zinc(II) metal centre 
forming an open knot was reported by Hunter and co-workers.[88] The folding process was 
found to be fully reversible. Addition of chloride quantitatively yields the free oligomer and 
addition of silver ions (which precipitate as AgCl) refolds it (see Figure 2.1-4a). 
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2.2 Aims and Overview 
The Russian chemist Sokolov suggested a very interesting approach towards a molecular 
trefoil knot in his review from 1973.[74] Three bidentate ligands coordinated in a suitable 
fashion around an octahedral transition metal used as a matrix might, after connection of their 
ends, lead to a molecular knot. The ends have to be connected two by two in an appropriate 
way. Clearly, there are many possibilities that lead to different compounds with a low 
probability for the desired knot. 
Scheme 2.2-1 illustrates a possible realisation of Sokolov’s application of an octahedral 
tris(chelate) template for the synthesis of a trefoil knot using olefin metathesis. Extended 
bipyridine ligands bear chains that allow a certain degree of flexibility and have terminal 
alkene functionalities. Olefin metathesis can be performed under very mild conditions 
(ambient temperature, neutral pH, compatibility with various functional groups), is a 
reversible reaction and the products are usually formed in high yields. Assuming that 
intermolecular reactions can be excluded by using high dilution conditions and that the chains 
have a length too short to allow reaction of two double bonds stemming from the same ligand 
and just long enough to react with the right end, then there are only two possible outcomes 
from such a threefold ring closing metathesis after complete conversion: a knot and a cycle. 
 
 
Scheme 2.2-1. Synthetic pathway that will lead to a knotted and/or a cyclic molecule after ring closing 
metathesis (RCM), hydrogenation and demetalation. 
 
The reaction sequence was successfully performed yielding the macrocyclic molecule 31. No 
knotted species was found. 
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Compound 31 is a large macrocycle with a ring size of 96 atoms. If the hexadentate cyclic 
ligand is coordinated to an octahedral transition metal, there is the possibility for two 
geometrical isomers (see Scheme 2.2-1b). One has only facial linkages whereas the other has 
two meridional linkages and four facial linkages. Searle investigated isomers of cobalt(II) 
complexes with the cyclic hexaazacyclen ligand and proposed to describe the isomers as fac 
and mer, respectively.[89] No IUPAC-nomenclature for this type of isomerism is known and 
the proposed nomenclature from Searle was used for novel complexes in this chapter. Others 
have suggested a presumably more accurate but also more intricate nomenclature.[90, 91] 
 
 
                         31 
Scheme 2.2-1. a) Novel hexadentate and macrocyclic ligand 31 with ring and atom labelling for NMR 
spectroscopic assignments; b) Two possible geometrical isomers of complexes with ligand 31 and an 
octahedral transition metal; c) Novel zinc(II), iron(II) and ruthenium(II)-complexes with 31. 
 
One-to-one complexes of ligand 31 with zinc(II), iron(II) and ruthenium(II) have been 
prepared and will be presented in this chapter. A crystal structure of the “mer” isomer of the 
latter was obtained and the influence of the reduced symmetry on the spectroscopic properties 
is described. 
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2.3 Synthesis 
The preparation of extended bipyridine ligands bearing chains with terminal alkene 
functionalities, their assembly around an octahedral transition metal and the metal templated 
synthesis of macrocyclic ligand 31 and complexes of the type [M(31)]2+ (M = Zn2+, Fe2+, 
Ru2+) are described below.  
The synthesis of 5,5'-dibromo-2,2'-bipyridine (32) can be realised via two synthetic pathways: 
a palladium(0)-catalysed Stille reaction or the direct reaction of protonated 2,2'-bipyridine 
with molecular bromine under very harsh conditions (see Scheme 2.3-1). Ziessel and 
Romero[92] reported for the latter synthesis a yield of 42%. However, in our hands, 
considerably smaller yields were obtained and other groups also share this experience.[93, 94] 
The 2,2'-bipyridine was protonated with hydrobromic acid and the precipitate dried under 
vacuum. The salt and bromine were then heated to 180 °C in a sealed tube for 72 hours. The 
reaction is difficult to monitor and degradation and the formation of side-products is expected. 
Ligand 32 was isolated in 21% yield after column chromatography.  
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Scheme 2.3-1. Reagents and conditions for compound 32. Path 1: a) n-Bu6Sn2 (0.5 eq), [Pd(PPh3)4] 
(2 mol%), toluene, reflux, 3 d, 79%. Path 2: b) HBr, 99%; c) Br2 (2 eq), 180 °C, 3 d, 21%.  
 
A more efficient method was reported by Michel[94] and co-workers in 2002 using 50 mol% 
of hexa-n-butylstannane and a catalytic amount of palladium(0). First, approximately half of 
the 2,5'-dibromopyridine are transformed to 2-tributylstannylpyridine in situ taking advantage 
of the different reactivity of the two bromine substituents. Secondly, the Stille cross coupling 
reaction is performed in the presence of [Pd(PPh3)4] yielding ligand 32 in very good yield.  
Boronic acid 33 is commercially available but can also be prepared easily on a large scale. 
Lithiation of 3-bromoanisole followed by treatment with trimethylborate led to a boronic 
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ester. The ester was hydrolysed in an aqueous hydrochloric acid solution yielding 33. The 
product can be conveniently purified via extraction. 
 
 
        33 (83 %) 
 
Scheme 2.3-2. Reagents and conditions: a) n-BuLi (1.1 eq), −78 °C, THF, 2 h; b) B(OMe) 3 (1.1 eq), 
−78 °C → r.t.; c) H+/H2O, 83% (over three steps). 
 
The bis(methoxy) compound 34 was prepared according to a procedure published by 
Constable and co-workers.[95] The ligand 34 was synthesised by Suzuki coupling of 5,5'-
dibromo-2,2'-bipyridine (32) with 3-methoxyphenylboronic acid (33) in biphasic conditions in 
the presence of [Pd(PPh3)4] and was isolated after column chromatography in 90% yield as a 
white crystalline solid (see Scheme 2.3-3). 
 
Scheme 2.3-3. Reagents and conditions: a) 3-methoxyphenylboronic acid (33, 2.5 eq), [Pd(PPh3)4] 
(4.5 mol%), Na2CO3 (5 eq), toluene/H2O, reflux, 20 h, 90%; b) pyridinium chloride, reflux, 4 h, 98%. 
 
Deprotection of 34 is conveniently achieved by heating the compound in refluxing pyridinium 
chloride at 210 °C and the bis(phenol) derivative 35 was obtained in almost quantitative yield 
despite the harsh reaction conditions. 
 
A modular approach appeared to be advantageous for designing ligands that can assemble 
around a single octahedral metal centre into a trefoil knot after a ring closing reaction on 
terminal alkene functionalities. The outcome of the ring closing reaction will most likely also 
depend on the length of the chains that are attached to the bis(phenol) ligand 35. Thus, a 
series of chains with varying lengths bearing terminal alkene functionalities and a bromo 
group to function as leaving group have been prepared (see Scheme 2.3-4). Commercially 
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available diols were reacted with allyl bromide leading to mono-allyl compounds 36, 37 or 26 
in moderate yields. The latter were transformed to the corresponding mesylates 38, 39 and 27 
which can then be converted to the bromo-derivatives 40, 41 and 28 in very good yields. 
Mesylate is expected to be a poorer leaving group than bromide. Little synthetic effort was 
required to prepare the bromo-derivatives since they can be prepared in large-scale and are 
easily purified. It was assumed that it would be beneficial to have a good leaving group for 
the subsequent Williamson ether synthesis and therefore to synthesise the bromo-compounds 
instead of using the mesylates. 
 
 
 
 
 
        36 (35%): n = 1    38 (95%): n = 1    40 (53%): n = 1 
        37 (42%): n = 2    39 (96%): n = 2    41 (66%): n = 2 
        26 (37%): n = 3    27 (35%): n = 3    28 (92%): n = 3 
 
Scheme 2.3-4. Reagents and conditions: a) KOH (1 eq), allyl bromide (0.5 eq), 80 °C, 2 h; b) Mesyl 
chloride (1.6 eq), NEt3 (20 eq), CH2Cl2, −78 °C → r.t.; c) LiBr (5 eq), acetone, reflux, 12 h.  
 
The Williamson ether synthesis was developed by Alexander Williamson in the 1850s.[96] It is 
the most common synthetic method to prepare symmetric or asymmetric ethers. Ligands 42, 
43 and 44 were prepared in the presence of caesium carbonate and the corresponding bromo-
compounds in very good yields (see Scheme 2.3-5). Instead of caesium carbonate the cheaper 
potassium carbonate was also employed successfully with a negligible drop in yields. A wide 
range of solvents was tested (acetone, acetonitrile, tetrahydrofuran) but only DMF and heating 
to 120 °C over several days showed satisfying conversions probably due to the poor solubility 
of bis(phenol) 35.  
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Scheme 2.3-5. Reagents and conditions: a) Cs2CO3 (4 eq), 40 or 41 or 28 (2.2 eq), DMF, 120 °C, 4 d. 
 
Iron(II) is a d6 metal and has a preference for octahedral geometry (imposed by crystal field 
stabilisation energy) with chelating bipyridine ligands. 
Scheme 2.3-6 shows the synthesis of the homoleptic iron(II) complex 45 with ligand 34. 
 
 
 
 
  34        45 (35%) 
Scheme 2.3-6. Reagents and conditions: a) [FeCl2] · 4 H2O, CH3CN/H2O, reflux, 16 h; b) NH4PF6. 
 
Iron(II) complexes of 42, 43 and 44 were prepared in excellent yields by treatment of the 
ligand with the required iron salt [Fe(BF4)2]· 6 H2O in acetonitrile. The typically deep-red 
colour emerged instantaneously. Full conversion was surprisingly only achieved after heating 
the reaction mixture for several days at reflux. The formation of complexes of the [Fe(bpy)3]2+ 
motif usually happens within minutes and no thermal excitation is needed. The iron salt was 
used in excess and the products were purified via extraction or filtration. 
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Scheme 2.3-7. Reagents and conditions: a) [Fe(BF4)2]· 6 H2O, CH3CN, reflux, 3 d. 
 
Ruthenium(II) also has the d6 electronic configuration and the complexes formed with 
chelating polypyridyl-ligands display an octahedral geometry. The formation requires thermal 
excitation. In a microwave reactor, the reaction mixtures can be heated beyond the boiling 
point of the solvent and shorter reaction times compared to reactions under conventional 
conditions are mainly due to thermal effects but solubility issues may also play an important 
role.  
Ruthenium(II) complexes 49 and 50 could be obtained in excellent yields and 51 was 
synthesised in good yield. Their synthesis is depicted in Scheme 2.3-8. The ruthenium(II) 
complexes with the ligands 34 and 44 were prepared by heating a mixture of the 
corresponding ligand and 0.33 equivalents of [Ru(DMSO)4Cl2] in a microwave reactor to 
140 °C in ethanol for 25 min or 1 h, respectively. The synthesis of complex 50 with the very 
poorly soluble ligand 35 was not successful under these reaction conditions. It was necessary 
to heat the reaction mixture in ethylene glycol to 230 °C in a microwave reactor in order to 
achieve complete conversion. The counterion was exchanged for all the ruthenium(II) 
complexes by adding an aqueous solution of ammonium hexafluorophosphate to the reaction 
mixture and the precipitates were collected. Pure compounds 49 and 50 could be obtained 
after a simple filtration over aluminium oxide. Complex 51 needed to be purified via column 
chromatography. 
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Scheme 2.3-8. Reagents and conditions: a) for 49: 34, [Ru(DMSO)4Cl2], µW, EtOH, 140 °C, 1h; for 50: 
35, [Ru(DMSO)4Cl2], µW, ethylene glycol, 230 °C, 30 min; for 51: 44, [Ru(DMSO)2Cl2], µW, EtOH, 
140 °C, 25 min; b) all compounds: NH 4PF6. 
 
If a ring closing metathesis (RCM) is carried out on e.g. iron complex 46 (see Scheme 2.3-9) 
the formation of a trefoil knot is possible. This issue was already discussed in chapter 2.2. For 
a proof-of-principle, ruthenium(II) complex 51 was subjected to a RCM reaction. The 
formation of three new double bonds could be confirmed via NMR- and ESI-MS techniques 
but it was soon apparent that several isomers had been formed and an efficient purification 
method was needed. Chromatography is usually easier to perform on an organic molecule 
than on a complex, and so it was decided to use the labile iron complexes rather than the very 
stable ruthenium(II) complexes. Iron can be removed with various methods, but for 
ruthenium, no demetalation procedure is known for complexes presented in this chapter. 
The RCM was tried on the three iron(II) complexes 46, 47 and 48. They all possess six oligo 
ethylene glycol chains with terminal alkene functionalities and differ in their chain lengths. In 
the presence of Hoyveda-Grubbs catalyst 2nd generation (53, see Scheme 2.3-11) the 
complexes (1 mM) were stirred for 30 days in dichloromethane. The complex with the 
medium length chain 47 was successfully converted to the intermediate complex 54. The 
reaction could easily be monitored via ESI-MS (see Figure 2.4-7). The 1H-NMR spectrum 
clearly showed the disappearance of the terminal olefin protons at δ 5.2 ppm and δ 5.8 ppm 
and the appearance of two new sets of signals at δ 5.9 ppm and δ 5.7 ppm for the newly 
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formed double bond (cis- and trans-isomers). Scheme 2.3-9 illustrates the reaction and only 
one of the isomers of 54 is shown. Each double bond can be oriented in a cis- or trans- 
configuration and there are other optical and geometrical isomers. The complex is drawn such 
that a macrocycle was formed. It was shown later that the cyclic molecule was the main 
product and no proof for the other isomer, the trefoil knot, was found. 
Even though the threefold olefin metathesis was performed successfully on 48, its chains 
seem to be too long because not only was the desired reaction between two double bonds of 
different ligands observed, but the unwanted metathesis between two double bonds stemming 
from the same ligand was also possible. Attempts to purify the organic products after 
hydrogenation and demetalation did not succeed. 
Molecular models confirmed that the compound with the short chains 46 should be able to 
assemble into a knot or a macrocycle. The RCM showed almost full conversion of precursor 
to product but only the smaller [2+2]-macrocycle 55 (see Scheme 2.3-11) could be identified 
after hydrogenation and demetalation.  
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Scheme 2.3-9. Reagents and conditions: a) Hoyveda-Grubbs catalyst 2nd generation (20 mol%), 
CH2Cl2, r.t., 30 d. Only one isomer is shown. 
 
There are two complementary synthetic paths to the hexadentate, macrocyclic ligand 31 (see 
Scheme 2.3-10). First, the three double bonds in the iron complex 54 can be hydrogenated in 
the presence of palladium on charcoal in an ethanol-dichloromethane mixture. In the second 
step the iron can be removed with the disodium salt of ethylenediaminetetraacetic acid 
(H2Na2Edta) in the presence of sodium carbonate in a water-acetonitrile mixture. The order of 
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the steps can also be reversed. Ligand 31 was obtained in 26% yield over three steps (from 47 
to 31). The hydrogenation and the removal of the metal probably occur in an almost 
quantitative manner. If the threefold RCM is counted as three synthetic steps then the average 
yield for each of the five steps is 76%. 
 
O
O
Fe
N
N
O
N
N
ON
N
O
O
2
2 BF4
Z
Z
Z
O
n
O
nO n
O
n
54: n = 2, -Z- = 56: n = 2, -Z- =
O
O
Fe
N
N
O
N
N
ON
N
O
O
2
2 BF4
Z
Z
Z
N
OO
N
O O
3
2 2
N
OO
N
O O
3
2 2
57 31
a)
a)
b) b)
 
Scheme 2.3-10. Reagents and conditions: a) H2 (1 atm), Pd/C (25 mol%), CH2Cl2/EtOH (1:1), 12 h; 
b) H2Na2EDTA (5 eq), Na2CO3 (10 eq), CH3CN, 50 °C, 3 h, 26% (over three steps). 
 
Attempts to remove the iron with cyanide, or with mixtures of hydrogen peroxide and sodium 
hydroxide, caused decomposition of the ligand. The stability constant for [Fe(terpy)2]2+ is 
several orders of magnitudes higher than that for [Fe(bpy)3]2+. Iron could also be removed 
with an excess of a terpyridine ligand. The disadvantage is that the terpyridine ligand has to 
be removed chromatographically, too. The method using H2Na2Edta/Na2CO3 proved to be 
superior. 
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    55       53 
Scheme 2.3-11. Tetradentate macrocycle 55 and Hoyveda-Grubbs catalyst 2nd generation. 
 
Iron complex 56 was obtained as an intermediate on the synthetic path towards macrocyclic 
hexadentate compound 31 (see Scheme 2.3-10). It can also be obtained by reacting pure 31 
with one equivalent of an iron salt (see Scheme 2.3-12) and could be unambiguously 
identified by ESI-MS (see Figure 2.4-9b). The 1H-NMR spectrum exhibited many signals and 
broad peaks assumed to be due to the possible formation of different geometrical isomers 
causing the loss of symmetry. Traces of paramagnetic iron(III) might also have contributed of 
the complex nature of the spectrum. A separation of the isomers was not attempted because 
the iron complex is kinetically labile and the complexes will most likely return to their initial 
equilibrium, once separated. 
 
    31       56 (quant.) 
Scheme 2.3-12. Reagents and conditions: a) [Fe(BF4)2] · 6 H2O (1 eq), CH3CN, reflux, 4 d. 
 
Clear ESI-MS evidence (see Figure 2.4-9a) was also found for the zinc [1+1]-complex 58. 
The 1H-NMR spectrum showed typically shifted signals with the expected relative integrals. 
 
       58 (99%) 
Scheme 2.3-13. Reagents and conditions: a) [Zn(ClO4)] · 6 H2O (1 eq), CH2Cl2/CH3CN, r.t., 16 h. 
 
In contrast to iron(II) and zinc(II), ruthenium(II) usually forms kinetically inert complexes 
with polypyridyl ligands. Ruthenium(II) complex 59 was obtained in moderate yield by 
heating 31 and [Ru(DMSO)4Cl2] in a microwave reactor in ethanol. Ion exchange and 
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chromatography yielded the pure [1+1]-complex 59. The molecule was characterised via one 
and two-dimensional NMR techniques (see Figure 2.4-6), ESI-MS (see Figure 2.4-9c), X-ray 
crystallography (see Figure 2.4-1) and elemental analysis. 
 
 
         59 (19%) 
Scheme 2.3-14. Reagents and conditions: a) [Ru(DMSO)4Cl2] (1 eq), EtOH, µW, 1 h; b) NH4PF6. 
 
Other kinetic products including oligo and polymeric structures can also be envisaged if one 
ruthenium metal centre is bound to more than one ligand. That is presumably one reason for 
the moderate yield. 
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2.4 Characterisation 
Ruthenium complex 59 was synthesised as described above and was analyzed via NMR-
spectroscopy, ESI mass spectrometry, elemental analysis and single crystal X-ray 
crystallography. The latter could answer the crucial question as to whether the complexed 
ligand is in the form of a cycle or a knot.  
 
 
Figure 2.4-1. a) Molecular structure of the cation [Ru(31)]2+ (592+) depicted as capped stick 
representation; b) Space-filling representation of  592+. The ligand 31 is macrocyclic and hexadentate. 
Solvent molecules, counterions and hydrogen atoms have been omitted for clarity. 
 
Despite the structure’s poor quality, connectivity and the overall geometry were clearly 
established (see Figure 2.4-1).[97] The organic molecule is macrocyclic and not knotted. The 
molecular skeleton is made up of a single 96-membered molecular chain that is assembled 
around the octahedral ruthenium core such that the bipyridine units can coordinate to the 
metal. The cation has effective C1 symmetry and is therefore chiral. It contains only one 
trivial symmetry operation: the identity. Furthermore, careful analyses revealed that the 
molecules that crystallized have “mer”-configuration. It should be pointed out that from 
solution studies the “mer/fac”-ratio was deduced to be 2:1 (see later). The bond angles and 
lengths appeared to be in the expected range. Ruthenium – nitrogen bond distances vary from 
206.4(9) pm to 215.6(9) pm. 
Single crystals suitable for X-ray crystallography were obtained for the homoleptic complexes 
45 and 49. Their molecular composition differs only in the central metal that is iron(II) and 
ruthenium(II), respectively. Their molecular structures are shown in Figure 2.4-2. 
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Figure 2.4-2. Molecular structures depicted as capped stick representations as they were found in 
single crystals of homoleptic iron and ruthenium complex cations: a) [Fe(34)3]2+ (452+); b) [Ru(34)3]2+ 
(492+). Solvent molecules, counterions and hydrogen atoms have been omitted for clarity. 
 
The ionic radius of low spin iron(II) in octahedral complexes is with 61 pm[98] smaller than the 
ionic radius of ruthenium(II). That is also mirrored in the nitrogen-metal bond length in the 
solid state of complexes 45 and 49. The values are listed in Table 2.4-1 and the average N-Fe 
bond length was calculated as 196.3(7) pm and the average N-Ru bond length was found to be 
roughly 5% longer with 206.5(1) pm. 
 
Table  2.4-1. Bond lengths between nitrogen atoms and central metal atoms that were found in crystal 
structures of [Fe(34)3]2+ and [Ru(34)3]2+. 
 N1-X/pm N2-X/pm N3-X/pm N4-X/pm N5-X/pm N6-X/pm N-X/pm[a] 
X = Fe(II) 196.2(2) 196.3(2) 196.7(3) 195.3(2) 197.4(2) 196.2(2) 196.3(7) 
X = Ru(II) 206.4(3) 206.6(3) 206.4(3) 206.6(3) 206.4(4) 206.6(4) 206.5(1) 
[a]average bond length with standard deviation in brackets.  
 
Single crystals of protonated ligand 34 suitable for X-ray analysis were found as a minor by-
product while setting up crystallisation trials for the iron complex 45. The unit cell contains 
the protonated ligand, one hexafluorophosphate anion and one water molecule that is 
hydrogen bonded to H1 (203 pm). The bond distance between H1 and N1 is 85.0 pm and H1 
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and N2 are separated by 226 pm through space. Carbon-carbon bond lengths were found in 
the range of 137.5(4) pm (C13-C14) and 148.3(4) pm (C9-C21) and all bond angles appeared 
to be in the expected range. The bipyridine unit containing N1 and N2 is essentially planar, 
with an angle between the least-square planes of the two pyridine rings of 3.7(1)°. The 
conformation of the protonated ligand with respect to the nitrogen atoms is cis. The angle 
between the least-square planes from the aromatic rings containing N2 and C22 is 38.6(1)° 
and for the two planes containing N1 and C15 an angle of 27.1(1)° was measured. 
 
Figure 2.4-3. The molecular structure of [34H]+ with atom labelling of selected atoms. Ellipsoids are 
drawn at the 50% probability level and protons are shown as small spheres of arbitrary radii. The 
hydrogen bond between H1 and O3 is show as a green line. Hydrogen atoms have been omitted for 
clarity (except for H1-H3). 
 
All ligands and complexes have been extensively studied via NMR spectroscopy. Most of the 
signals could be assigned. One example is presented in Figure 2.4-4: The 1H-NMR and the 
13C-NMR spectrum of the macrocyclic ligand 31 that incorporates three bipyridine units. All 
1H and 13C-NMR signals could be assigned with two dimensional NMR techniques (COSY, 
HMBC, HMQC, and NOESY). The symmetry of the molecule is reflected in the spectra and 
there are 13 distinguishable 1H-NMR resonances and 17 peaks in the 13C-NMR spectrum. The 
connectivity between the atoms was established by NMR spectroscopy, the molecular size 
was determined by ESI-MS and the molecular composition was determined by elemental 
analysis. The remaining question whether a knot or a macrocycle was formed could be 
answered with the help of crystal structure analysis (Figure 2.4-1). The chemical shifts are 
very similar and the relative peak positions are the same compared to the ligands bearing one 
bipyridine moiety (e.g. 34, 42).  
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Figure 2.4-4. NMR-spectra of hexadentate, macrocyclic ligand 31 in CD2Cl2: a) 1H-NMR with 
assignments; b) 13C-NMR with assignments. The insets show zooms in parts of the spectrum of 
interest. The solvent residual signal is marked with an asterisk (*). Labelling is given in Figure 2.2-1a. 
 
Correlation spectroscopy in NMR is very useful in elucidating structural data that are not 
satisfactorily represented in a one dimensional spectrum. The most common is a COSY 
experiment whose spectrum displays diagonal peaks and cross peaks that result from a 
phenomenon called magnetisation transfer. If a cross peak appears in the spectrum between 
two resonances then the two atoms are spin-spin coupled over chemical bonds. The COSY 
spectrum for the aromatic and the aliphatic region of compound 31 is illustrated in Figure 2.4-
5. For instance, a cross peak between the aromatic protons A3/A4 and A4/A6 was observed. 
That means that these atoms are magnetically coupled. Proton A3 couples over three bonds to 
A4 with J = 8.3 Hz and A4 and A6 (separated by four bonds) have a coupling constant of J ≈ 
2 Hz. The absolute value of the coupling constant can be compared to the intensity of the 
cross peak. 
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Figure 2.4-5. COSY spectra of 31 recorded in CD2Cl2 at 298 K and 500 MHz: a) Aromatic region 
displaying the typical coupling pattern; b) Aliphatic region showing coupling between protons. 
 
In the aliphatic region (Figure 2.4-5b) a cross peak between protons E5 and D is detected 
indicating that they are adjacent to each other. 
The 1H-NMR spectra of the ruthenium complexes 59 and 49 are compared in Figure 2.4-6. 
The complex 49 with three bis(methoxyphenyl)-bipyridine (34) ligands has a high symmetry. 
This symmetry is lost if the ligands are connected to one cyclic hexadentate ligand like in 59. 
Furthermore, two geometrical isomers are expected depending on how the connections were 
made. From the spectrum the ratio of the two isomers was found to be 2:1. Integration gives 
the expected values. The assignments for the aromatic protons in 59 were made by analysing 
COSY-NMR, peak position and shape compared to 49, integrations and HMQC cross peaks 
of expected 13C correlations. 
2.4 CHARACTERISATION 
41 
δ/ppm
6.16.56.97.37.78.18.58.9
A3 A4
A6
B5 B6
B4
B2
*
A3
A4 A6
B5
B2+B4+B6
 
Figure 2.4-6. 1H-NMR spectra at 298 K and 500 MHz of ruthenium complexes [Ru(31)](PF6)2 (59) 
(TOP) and [Ru(34)3](PF6)2 (49) (BOTTOM). The asterisk (*) marks the solvent residual signal. 
 
ESI-MS was a very versatile and valuable tool in following the ring closing metathesis 
(RCM) and characterizing metal complexes. The doubly charged cation of iron complex 47 
with m/z = 923.3 was easily detected. Threefold RCM resulted in a loss of three ethene 
molecules and gave rise to a single peak of m/z = 881.1: the double charged cation 542+. 
Hydrogenation of three double bonds brought about a mass peak of three atomic mass units 
higher (562+). The mass spectra are shown in Figure 2.4-7. 
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Figure 2.4-7. a) Iron(II) complex [Fe(43)3]2+ (472+) before threefold olefin metathesis; b) Iron(II) 
complex [Fe(57)]2+ (542+) after olefin metathesis; c) Iron(II) complex [Fe(31)]2+ (562+) after 
hydrogenation. 
 
 
Only charged species can be analysed via ESI-MS. Complexes usually lose one or more 
counterions if present and the cations are detected in the positive mode. For neutral 
molecules, the ions observed are created by the addition of a proton, another cation such as a 
sodium ion, or the removal of a proton (e.g. phenols, carboxylic acids). 
The highest mass peak in the ESI mass spectrum of the neutral, hexadentate macrocyclic 
ligand 57 and 31 were observed as [M+Na]+. The measured isotopic patterns matched the 
calculated patterns (see Figure 2.4-8). 
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Figure 2.4-8. ESI-MS spectra of hexadentate, macrocyclic ligands: a) [57+Na]+ with three double 
bonds; b) [31+Na]+ after saturation of double bonds. The insets show the measured and calculated 
isotopic patterns. 
 
Figure 2.4-9 displays the ESI-MS mass spectra of the zinc(II), iron(II), and ruthenium(II) 
complexes with macrocyclic ligand 31. As already observed, the doubly charged cations were 
much more likely to be detected than singly charged species coming from the parent 
complexes.  
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Figure 2.4-9. ESI-MS spectra of mononuclear complexes of macrocyclic 31: a) [Zn(31)]2+ (582+); b) 
[Fe(31)]2+ (562+); c) [Ru(31)]2+ (592+). 
2.5 SUMMARY AND OUTLOOK 
45 
 
2.5 Summary and Outlook 
Sokolov’s concept[74] to use an octahedral metal core as template for the synthesis of a 
macrocycle (trivial knot) was for the first time successfully employed.  
Three novel extended bipyridine ligands with chains having terminal alkene groups were 
prepared for this purpose. The chelating ligands were wrapped around iron(II) or ruthenium(II) 
and a threefold ring-closing metathesis (RCM) was performed that linked the termini two by 
two. In the case of iron complex 47 the RCM followed by hydrogenation and demetalation led 
to the isolation of a unique, macrocyclic, hexadentate ligand 31 that incorporates three 
bipyridine units. One-to-one complexes with this ligand and zinc(II), iron(II) and 
ruthenium(II) were synthesised and a crystal structure of the latter was obtained.  
The use of a single octahedral metal centre to control the assembly of ligand threads into a 
macrocycle was accomplished, it is apparent that changes in the ligand architecture that will 
fulfil geometrical prerequisites might lead to the preparation of a trefoil knot. 
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3 Oligonuclear Ruthenium(II) Complexes with 
Macrocyclic Ligands 
 
This chapter will deal with complexes that are formed between ruthenium (a rare transition 
metal of the platinum group from the periodic table) and several organic ligands. One of the 
ligands is a macrocycle: a ring architecture of more than nine atoms that usually enables 
molecules to achieve a certain degree of pre-organisation but no rigidity. Not only chemists 
but everybody encounters macrocycles each day in an unavoidable way since they occur in 
many natural products. The active site in haemoglobin −a protein in our blood that 
transports oxygen− contains a macrocyclic moiety (the porphyrin). Other examples are 
vancomycin (an antibiotic) or chlorophyll (a photosynthetic pigment in plants). On the other 
hand, ruthenium is widely used in alloys, as a versatile catalyst, in mixed-metal oxides for 
cathodic protection and in dye sensitized solar cells that are potentially cheaper to produce 
than conventional silicon based solar cells.[99, 100] The combination of both, ruthenium, being 
the central atom in its oxidation state two, and ligands that have donor atoms that can bind or 
form coordinate bonds is a complex. The metal is considered as a Lewis acid (electron pair 
acceptor) and the ligands are Lewis bases (electron pair donors).  
3.1 Introduction  
The prototype for ruthenium(II) polypyridyl complexes is [Ru(bpy)3]2+ which has become one 
of the most investigated compounds in the past 40 years due to its particularly interesting 
combination of chemical stability, redox properties, excited state reactivity, luminescence 
emission and excited state lifetimes. Ruthenium(II) possesses a d6 system and the bipyridine 
ligands coordinated to it have σ-donor orbitals localized on the nitrogen atoms and pi donor 
and pi* acceptor orbitals localized on aromatic rings. A simplified orbital diagram showing the 
possible transitions during irradiation is depicted in Figure 3.1-1a. Transition of an electron 
from a metal piM orbital to the ligand piL orbitals leads to a metal to ligand charge transfer 
(MLCT) excited state − the transition with the lowest energy. Promotion of an electron from 
piM to σM* orbitals and from piL to piL* orbitals give rise to metal centred (MC) and ligand 
centred (LC) excited states, respectively. If a photon is absorbed from the singlet ground state 
(1GS), the 1MCLT or higher singlet states are populated followed by an intersystem crossing 
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to the 3MCLT state (with ΦISC = 1). The system can return to the ground state either by 
emission (with Φemission = 0.06) or radiationless decay. Schematic potential energy curves are 
represented in Figure 3.1-1b. 
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Figure 3.1-1. a) Simplified molecular orbital diagram for ruthenium(II) polypyridine complexes that 
show the three types of electronic transitions occurring at low energies. b) Schematic representation 
for the relative positions of 3MC and 3MLCT excited states that are found in [Ru(bpy)3]2+ and transitions 
that take place. Adapted from references.[101-103] 
 
The area of research for this compound and its derivatives exploded in the 1970’s with the 
awareness that it might be used to split water into molecular hydrogen and oxygen using 
sunlight.[104, 105] The chemistry of ruthenium polypyridyl complexes has been reviewed 
extensively[101, 106] covering initial findings, applications and possible future uses. Polynuclear 
complexes[107] of this type and photochemical, photophysical and redox data[102] have also 
been reviewed in detail. 
Fossil energy carriers such as oil and gas are limited on Earth. It thus became a major 
challenge to convert solar energy to electric energy via solar cells. In the early 1990’s, Grätzel 
and co-workers developed photovoltaic cells based on the principle of sensitization of wide-
bandgap mesoporus semiconductors like nanocrystalline TiO2 surfaces that are modified with 
monolayers of ruthenium complexes.[108, 109] Dye-sensitized photoelectrochemical solar cells 
are a promising alternative to conventional junction based photovoltaic devices. Molecular 
sensitization is one of two general approaches that have been developed in order to use 
sunlight. The other approach doping is found in conventional photovoltaic devices. The 
operating principle of a dye-sensitized solar cell is depicted in Scheme 3.1-1b. A photoanode 
and a counter electrode are facing each other and the gap is filled with an electrolyte. The 
sensitizer (S) is converted to its excited state (S*) by light and is able to inject an electron into 
the conduction band (CB) of the semiconductor. The sensitizer in its one-electron oxidized 
form (S+) is rapidly reduced by I--ions in solution. Photoinjected electrons flow in the circuit 
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and can perform electric work. They are also available at the counter electrode for the 
reduction of the electron mediator acceptor I3-. The system is then back at its initial point, 
ready for another catalytic cycle. 
 
 
          60 
Scheme 3.1-1. a) Simplified operation principle of a dye sensitized solar cell. b) [Ru(dcbpy)2(NCS)2] 
(dcbpy = 4,4'-carboxylbipyridine), also known as “red dye”. 
 
Sensitizers usually have functional groups such as –COOH, -PO(OH)2 or -B(OH)2 to ensure 
stable adsorption onto the semiconductor substrate. Ruthenium complexes such as 60 (“red 
dye”) are typically used but recently also copper complexes showed promising results.[110] 
Several review articles describe past and recent progress in this area that often combines 
nanotechnology, material science, interfacial electron transfer and supramolecular 
photochemistry in a very multidisciplinary way.[100, 111] 
Ruthenium polypyridyl complexes were also utilised to mimic the photosystem II.[112] 
Artificial light harvesting antenna systems[113-115] can be constructed from mixed ruthenium-
manganese complexes that are able to store photoinduced holes. The natural excited 
chlorophyll donor in the photosystem II can extract up to four electrons in a consecutive 
manner from the so-called manganese cluster. Oxygen can be produced from the four-times 
oxidized manganese cluster recycling the initial state that can undergo another photoinduced 
cycle.[112] 
Topological objects can be built using the specific geometry imposed by the ligand and the 
octahedral metal core of the ruthenium(II). The thermodynamic and kinetic stability of the 
resulting complexes is in general beneficial. Rack-type complexes are linearly arranged 
species and grid-type complexes are arranged species in a plane.[116, 117] Ruthenium 
polypyridyl complexes have been examined photochemically and the emission in a rack could 
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be moved to the near-IR[118] or was totally quenched in a tetranuclear mixed ruthenium-iron 
grid.[119] These classes of compounds are usually constructed with terpyridine ligands but also 
pyrimidine-containing complexes have been reported.[120]  
Dendrimers are repeatedly branched molecules and those containing ruthenium(II) have been 
studied and the results have been reviewed.[121-123] In one example the three chromophoric 
units, namely [Ru(bpy)3]2+, naphthyl and 1,3-dimethoxybenzene were combined and 
properties of a light-harvesting antenna system and a possible frequency converter were 
investigated.[124] The [Ru(tpy)2]2+ motif was utilized to construct multinuclear arrangements 
and recently for a dye sensitized photoelectrochemical cell.[125] The heteronuclear complex 61 
illustrates an approach to build up polypyridylruthenium systems relying upon coordination to 
a tetracarboxylato metal dimer.[126] Compound 62 is the first trinuclear ruthenium polypyridyl 
complex which was characterised by X-ray diffraction and was reported along with evidence 
of stereospecific complexation during its formation.[127] There are a few examples of 
metallomacrocyclic multinuclear ruthenium complexes[128-131] such as 63[132] whose extraction 
properties for alkali metal picrates have been investigated. 
 
 61          62      63 
 
Scheme 3.1-2. Examples of multinuclear ruthenium(II) complexes. The mixed rhodium(II)-ruthenium(II) 
complex 61, the trinuclear complex 62 and the metallomacrocyclic complex 63. Charges are omitted 
for simplicity. 
 
Metallomacrocycles can also be prepared with non-linear ditopic bis(terperidine) ligands.[133, 
134]
 Preorganisation and design of the ligand allow the control of dimensionality and 
nuclearity up to a certain degree. These complexes all have in common that the macrocycle is 
formed by coordinative bonds − they are metallomacrocycles. In these cases, kinetic or 
thermodynamic factors favour the formation of a cycle with precise size over linear, 
oligomeric or polymeric species. It has been shown that with labile metal ions 
metallopolymers or metallocycles are formed depending on the reaction conditions.[135]  
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3.2 Aims and Overview 
 
Is it possible to start with a macrocyclic ligand bearing multitopic binding sides and to 
coordinate several kinetically inert metals like ruthenium(II) to it? Multinuclear complexes 
displaying this particular kind of topology have not been reported yet, neither with ruthenium 
or other transition metals. This was one motivation to synthesise oligonuclear, macrocyclic 
complexes 64 (one metal centre), 65 (two metal centres) and 66 (three metal centres) along 
with their particularly appealing photophysical properties. Their molecular structures are 
represented in Scheme 3.2-1 together with [Ru(34)(bpy)2](PF6)2 (67) which can be regarded 
as a reference compound displaying the properties of one complex subunit. The synthesis, 
characterisation, crystal structures of 67, 64 and 65, photophysical properties and the ability 
of 64 to act as a sodium receptor will be discussed in this chapter. 
 
 
 
         64: m = 1, n = 3    67 
   65: m = 2, n = 1 
   66: m = 3, n = 2 
    
Scheme 3.2-1. Novel multinuclear complexes 64, 65, 66 and mononuclear reference complex 67. 
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3.3 Synthesis 
 
The synthesis of the open form ligands 34, 42 and 43 is described in Chapter 2. 
Ruthenium(II)-complexes of the type [RuL(bpy)2]2+ are available with relative ease in very 
good yields and short reaction times thanks to the employment of microwave technology. In a 
typical reaction, one equivalent of the ligand and a small excess of cis-[Ru(bpy)2Cl2][136] were 
heated in a microwave reactor in ethanol at 120 °C for 30 minutes. The reaction mixture was 
added to an aqueous solution containing an excess of ammonium hexafluorophosphate, the 
precipitate was collected and washed with water and diethyl ether (see Scheme 3.3-1). The 
crude products exhibited clean NMR spectra, but correct micro analysis necessitated a 
filtration over aluminium oxide.  
 
 
Scheme 3.3-1. Reagents and conditions: a) cis-[Ru(bpy)2Cl2] (1.01 eq), EtOH, 120 °C, microwave; b) 
NH4PF6. 
 
These mononuclear complexes can be made in high yields and are purified via filtration. In 
particular, no chromatography is needed. Once familiar with them, the synthetic protocol was 
used in similar reactions on multitopic macrocyclic ligands. Complex [Ru(34)(bpy)2](PF6)2 
(67) will serve later as a reference compound, being used to help to interpret NMR spectra, 
photophysical properties, electrochemical properties and stereochemical considerations of the 
more intricate multinuclear ruthenium(II) complexes. The molecule 69 which has two 
terminal double bonds on the ethylene glycol chain is the starting material for the smallest 
macrocyclic ruthenium(II) complex presented in this chapter. 
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   70   71   53 
Scheme 3.3-2. Grubbs’ catalyst 1st generation 70, Grubbs’ catalyst 2nd generation 71 and Hoyveda-
Grubbs’ catalyst 2nd generation 53. Cy = cyclohexyl, Mes = 2,4,6-trimethylphenyl. 
 
Ring closing metathesis (RCM) has been established as an efficient tool to synthesise 
macrocyclic molecules via intramolecular formation of a carbon-carbon double bond.[137-140] 
As a first test, we tried the RCM in the presence of Grubbs’ catalysts 70 of the first generation 
and 71 of the second generation. The reactions turned out to be very slow at room temperature 
and the purification of the product was demanding as a result of decomposition from the 
parent catalyst complexes. The diene 69 was then subjected to the air-stable and more reactive 
Hoyveda-Grubbs’ catalyst of the second generation 53[141-143] (see Scheme 3.3-2). After 
hydrogenation with molecular hydrogen catalysed by palladium on charcoal, the desired 
macrocyclic complex 64 was obtained (see Scheme 3.3-3). The crystal structure revealed that 
one sodium cation coordinated to the ethylene glycol chain. This behaviour will be discussed 
in more detail in chapter 3.5. 
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Scheme 3.3-3. Reagents and conditions: a) Hoyveda-Grubbs’ catalyst 2nd generation (20 mol%), 
CH2Cl2, r.t.; b) H2 (1 atm), Pd/C (11 mol%), EtOH/CH2Cl2 (1:1). 
  
The RCM reaction cannot be performed on the free ligand. The ligand is not innocent and 
binds to the catalyst which is then blocked and “poisoned” for further conversion. The 
[Ru(bpy)2]2+ moiety can, in this respect, be regarded as a protecting group even if its cleavage 
is not possible.  
This example shows that it is possible to make a macrocyclic complex by carrying out the 
olefin metathesis on the complex. It is also feasible to synthesise first the macrocyclic ligand 
and then coordinate a transition metal to it. 
Chapter 2 described how the macrocyclic ligands, 55 and 31, with two and three bpy units are 
prepared. Our goal was to convert them into oligonuclear ruthenium(II) complexes. If the 
synthetic protocol for ligands bearing one bpy unit is adapted with a different stoichiometry, 
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the formation of 65 and 66 can be expected. The desired compounds were synthesised in good 
to very good yields (see Scheme 3.3-4).  
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65: m = 2, n = 1 
     66: m = 3, n = 2 
 
Scheme 3.3-4. Reagents and conditions: a) cis-[Ru(bpy)2Cl2] (2.01 eq for 65, 3.01 eq for 66), EtOH, 
120 °C, microwave; b) NH 4PF6. 
 
The dinuclear compound [Ru2(55)(bpy)4](PF6)4 (65) was obtained pure as the homochiral 
∆∆/ΛΛ-form after chromatography on aluminium oxide. The other diastereoisomer namely 
the heterochiral Λ∆-isomer could not be identified unambiguously and is not considered here. 
This explains the lower yield (46% compared to the usual 90%). Unfortunately, we were not 
able to separate the two diastereoisomers (∆∆∆/ΛΛΛ and ∆∆Λ/ΛΛ∆) arising from the 
trinuclear complex 66. Both complexes were comprehensively characterised by NMR and 
mass spectrometry. The purity of 66 and 65 was confirmed by microanalysis.  
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3.4 Characterisation and Crystal Structures 
 
The molecular structures for 67, 64, 65 and a general labelling scheme are shown in 
Figure 3.4-1 and structural parameters are found in Table 3.4-1. As expected, the ligands 
coordinate in a propeller-like arrangement around the central metal atoms and the complexes 
are chiral. Only one of the two enantiomers present in the crystal is shown. All complexes 
exhibit distorted octahedral geometry with bond distances varying from 205.2(3) pm to 
207.0(4) pm around the ruthenium(II) centres. Despite distortions, the Ru-N bond distances 
are similar to those in the molecular structure of [Ru(bpy)3]2+ which was solved using X-ray 
crystallography in 1979 by Rillema.[144] The Ru-N bond length (205.6 pm) in the D3 
symmetric [Ru(bpy)3][PF6]2 complex is to some extent shorter than in Ru(NH3)62+ 
(210.4 pm).[145] This indicates a notable backbonding between the t2g-orbitals of the metal 
core and the pi*-orbitals of the ligand.  
The dihedral angles describing the twist between the two aromatic rings A und B in 
[Ru(34)(bpy)2](PF6)2 (67), 64 and 65 are different on the two sides of the bis(methoxy-
phenyl)bipyridine moiety and vary between 11.2(2)° (in 64) and 42.3(2)° (in 67). Distortions 
from the ideal octahedral geometry can also be evaluated by the angles of coordinating atoms 
(not discussed here) and ascertained by angles of least square-planes calculated from the 
aromatic rings around the coordination environment. The values span from 1.0(3)° to 9.8(2)° 
(see Table 3.4-1). 
For comparison, [Ru(bpy)3]2+ displays a dihedral angle based on the twist about the pyridine 
rings in bipyridine of 9.97°.[146] 
 
 
 
Table 3.4-1. Angles between least-square planes of aromatic rings. Values are given in [°]. 
least-square 
planes of 
aromatic rings 
[Ru(bpy)3]2+ 67 64 65 
AA' n.a. 7.8(2) 2.9(2), 5.0(2) 7.3(2), 10.1(2) 
CC' 9.97[a] 2.8(2), 9.8(2) 1.9(2), 5.5(2), 
5.7(2), 7.9(2) 
1.0(3), 2.8(3), 
6.5(3), 6.8(3) 
AB, A'B' n.a. 34.1(2), 42.3(2) 11.2(2), 24.1(5), 
31.0(3), 31.2(2) 
21.5(3), 24.9(2), 
32.0(2), 32.3(3) 
[a]
 from reference[146] 
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Figure 3.4-1. Molecular structures of a) 672+, b) 642+ (two molecules per unit cell, one has a sodium 
cation coordinated to its ether chain) and c) 654+, depicted as stick representations as they were found 
in the single crystal. Hydrogen atoms, solvent molecules and counterions have been omitted for 
clarity. The colour coding is: ruthenium = violet, nitrogen = blue, carbon = black and oxygen = red. A 
general labelling mode is presented in d). 
 
Figure 3.4-2. Molecular structures of the coordination environment of the sodium cation in 64 with 
ellipsoids plotted at 20% probability level. The colour coding is: carbon = black, oxygen = red, 
phosphorus = orange, fluorine = yellow, sodium = violet. 
a) b) 
c) d) 
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Table 3.4-2. Crystal structure data collection information. 
 
67·CH3CN 64 (squeeze) 65·C2H2Cl2·2.5C4H8O2 
    
Empirical formula C45H39N7O2P2F12Ru C58H62Na0.5N6O8P2.5F15Ru C112H116Cl2N12O13P4F24Ru2 
Formula weight [g 
mol-1] 
1112.85 1446.13 2691.12 
Temperature [K] 446 173 123 
Wavelength [Å] 0.71073 0.71073 0.71073 
Crystal system Triclinic Triclinic Triclinic 
Space group P-1 P-1 P-1 
Unit cell dimensions 
[Å, °] 
a = 12.44(3)  
b = 13.75(3) 
c = 14.219(3) 
α = 76.49(3)  
β = 74.54(3)  
γ = 83.29(3) 
a = 15.154(3)  
b = 17.614(4) 
c = 126.892(5) 
α = 86.54(3)  
β = 82.28(3)  
γ = 84.31(3) 
a = 14.1156(13) 
b = 20.075(2) 
c = 23.409(2) 
α = 77.354(5) 
β = 73.193(5) 
γ = 85.179(11) 
Volume [Å3] 2278.23 7070, 6194.7(11) 
Z 2 4 2 
Absorption coefficient 
[mm-1] 0.512 0.372 0.437 
F(000) 1118 2952 2748 
Crystal size [mm] 0.30 x 0.27 x 0.07 0.45 x 0.28 x 0.16 0.05 x 0.13 x 0.29 
Reflections collected 8048 89634 48405 
Independent 
reflections 
7300 21321 18510 
Goodness-of-fit on F2 
(all data) 1.096 1.054 1.0375 
Final R indices R1 = 0.0572,  
ωR2 = 0.1435 
R1 = 0.0658,  
ωR2 = 0.1683 
R1 = 0.0679,  
ωR2 = 0.0723 
R indices (all data) R1 = 0.0629,  
ωR2 = 0.1493 
R1 = 0.0763,  
ωR2 = 0.1755 
R1 = 0.1455,  
ωR2 = 0.1851 
 
Interestingly, the complex 64 crystallizes in two forms per unit cell: the complex and the 
complex which has one sodium cation coordinated to its ether chain. In this macrocyclic 
complex, the chain goes around the side that is occupied by the bipyridine ligands. In the unit 
cell, the two metal cores are separated by 1.40 nm and the bond length between the oxygen 
atoms and the sodium cation are 230.4(5) pm, 268.6(4) pm and 261.8(5) pm.  
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There are five more short contacts to the sodium cation from the fluorine atoms of two 
hexafluorophosphate counterions (242.9(5) pm, 247.3(5) pm, 248.8(5) pm, 250.7(6) pm and 
253.2(6) pm, see Figure 3.4-1c and Figure 3.4.2). That results in a coordination number of 
eight for the singly charged alkali metal. The closest distances between a carbon atom in the 
chain and a carbon atom in bipyridine ligand are found between E7 and C5 with 380 pm.  
Chiral dinuclear macrocyclic complex 65 was synthesised as a racemate and turned out to be 
homochiral, therefore the stereochemical descriptors for the two enantiomers are ∆∆ and ΛΛ, 
respectively. Both enantiomers are found in the unit cell. The two ruthenium metal atoms are 
separated by 1.00 nm. The closest distance between the two complex entities is found 
between carbon atoms A3 and C4 with ≈ 360 pm. In the solid state, the same couple on the 
other side of the complex is separated by ≈ 440 pm, therefore the two complex entities are not 
completely symmetric in the crystal structure.  
 
Figure 3.4-3. Packing in solid state structures of a) 67 and b) 65. Hydrogen atoms, solvent molecules 
and counterions have been omitted for clarity. 
 
The analysis of short contacts reveals a close proximity of a methoxyphenyl ring (B) to a 
pyridine ring (A) of an adjacent molecule in the solid state packing. The distance between the 
centroid of the aromatic B-ring and the carbon atom A3 was calculated as 341 pm (see Figure 
3.4-3). 
No particular packing effects were observed for the complexes 64 and 65.  
 
The ruthenium(II) complexes were studied extensively via NMR spectroscopy. All proton and 
carbon nuclei could be assigned with the help of two dimensional COSY, HMBC, HMQC, 
NOESY and DEPT experiments (for all data see Experimental part). For a labelling scheme 
see Figure 3.4-1d. The protons of the free ligand 5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine 
(34) are shifted distinctively in the ruthenium(II) complexes. The A6-proton in α-position to 
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the nitrogen is the only signal that is shifted to a higher field from δ 8.9 ppm to δ 7.8 ppm in 
the complex. The protons A4, B2, and B6 exhibit resonances at lower field (∆δ ≈ 0.3 ppm) 
and the other signals are hardly affected. By analysing the molecular structure of 
[Ru(34)(bpy)2](PF6)2 (67), it is apparent that the symmetric bipyridine now has two different 
moieties in the complex. By considering, for example, the neighbouring proton to the N-atom 
(C6 and C'6), one can see that the C6-proton points towards the aromatic A-ring from ligand 
34 and the C'6-proton points towards the aromatic C-ring from the other bipyridine. 
Therefore, the two bipyridine units are diastereotopic and chemically non-equivalent.  
Figure 3.4-4 shows the proton spectra of the aromatic region of the mononuclear compound 
[Ru(34)(bpy)2](PF6)2 (67) (top) and the dinuclear compound 65 (bottom). The dinuclear 
compound 65 seems to be composed of two sets of signals that can in particular be observed 
for protons A3, C6 and A4. Furthermore, protons A3 and A4 are shifted to lower frequencies 
by about ∆δ = 0.2 ppm and ∆δ = 0.1 ppm, respectively. The reason may be a stronger 
shielding due to the close proximity of the second complex entity (for visualisation compare 
crystal structure Figure 3.4-1c).  
6.76.97.17.37.57.77.98.18.38.58.7
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Figure 3.4-4. 1H-NMR spectra in d3-acetonitrile of a) dinuclear complex 65 and b) mononuclear 
reference complex 67. 
 
The mononuclear, macrocyclic compound 64 exhibits downfield shifted nucleus B6 
(∆δ = 0.27 ppm) and upfield shifted nucleus B2 (∆δ ≈ 0.2 ppm) compared to 67. A different 
dihedral angle between the aromatic rings A and B, and therefore different degrees of 
shielding or deshielding, rationalizes this outcome. The trinuclear macrocyclic complex 66 
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and 67 have very similar chemical shifts. The molecular complex moieties are separated far 
enough from each other in space by the ethylene glycol chain to not influence each other (see 
Table 3.4-3).  
 
Table 3.4-3. 1H NMR spectroscopic shift data (500 MHz and 600 MHz, 298 K, CD3CN) for the 
aromatic region. 
proton 67 64 65 66 
3 8.58 8.56 8.41 8.55 
4 8.33 8.35 8.19 − 8.14 8.29 A 
6 7.80 7.82 7.81 − 7.75 7.79 
2 6.92 6.75 − 6.70 6.91 6.99 − 6.90 
4 7.00 6.96 6.98 6.99 − 6.90 
5 7.36 7.38 7.32 7.30 
B 
6 7.00 7.27 6.91 6.99 − 6.90 
 
The 3J coupling constant for aromatic protons is observed between 7.9 Hz and 8.6 Hz except 
for the protons in α -positions to the nitrogen atoms (A6, C6 and C'6) with 3J ≈ 5.5 Hz.  
In the aliphatic region, the signals for the methylene protons adjacent to an oxygen atom (E) 
are found between δ 4.1 ppm and δ 3.3 ppm and the signals for methylene protons that are 
neighboured by other methylene groups (D) are found at ≈ δ 1.6 ppm. An unusual feature was 
observed for the E7 proton from mononuclear macrocyclic complex 64. Its resonance is at 
very high field (δ 2.3 ppm). This might stem from an anisotropy effect. In the solid state (see 
crystal structure Figure 3.4-1b) the chain reaches around the side of the complex which is 
occupied by the bipyridine ligands. If we assume the structure to be similar in solution then 
the protons might lie in the zone where the magnetic field B0 is reduced (shielding is 
increased above and below the ring) by the ring current of the electrons from the aromatic 
bipyridine. This is opposite to the effect that causes aromatic protons outside the ring (e.g. in 
benzene) to be shifted to low fields.[147] 
The 13C spectrum ranges in the aromatic region from δ 161 ppm (B3) to δ 113 ppm (B2). The 
nuclei from the methylene groups adjacent to an oxygen atom (E) are usually found between 
δ 68 ppm and δ 72 ppm and the nuclei from the methylene group neighboured by other groups 
(D) appear around δ 27 ppm. Again, the nucleus E7 in 64 exhibits an unusual upfield shifted 
signal at δ 35 ppm. 
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Electrospray ionisation (ESI) was the technique applied to produce ions for mass 
spectrometry (MS). It is a very mild method that is very useful for complexes and 
macromolecules because the ionisation energy is low enough that usually no fragmentation is 
observed (except for the fragmentation of a salt into cations and anions as in the case of 
complexes presented in this chapter). In 2002, the development of ESI-MS was rewarded with 
the Nobel Prize in Chemistry to John Bennet Fenn.[148] 
All compounds presented in this chapter could be studied via ESI-MS and showed correct 
spectra with expected masses. One typical example is illustrated in Figure 3.4-5. The 
trinuclear ruthenium(II) complex 66 deconvolutes into its +6, +5, +4, +3, +2 and +1 (not 
shown) cations which are detected in the positive mode of the mass spectrometer. The 
isotopic pattern can the examined by recording a zoom scan on these cations. 
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Figure 3.4-5. ESI-MS spectrum of trinuclear complex 66 showing its deconvolution in +2, +3, +4, +5 
and +6 charged cations. 
 
The measured isotopic pattern can be compared to a simulated pattern. The line spacing 
reflects the ratio mass over charge (m/z) of the fragment in question, that will for example 
lead to a difference of  1/5 atomic mass units between two adjacent isotopes for a +5 charged 
cation (see Figure 3.4-6). 
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Figure 3.4-6. a) Measured isotopic pattern of +6, +5 and +4 charged cations from 66. The m/z ratio is 
also reflected in the line spacing. b) Simulated isotopic pattern of the same cations. 
 
Infrared spectra and melting points have been determined for all compounds and the data is 
documented the Experimental part of this thesis. 
For compounds 67, 68, 69, 65 and 66 correct micro analysis could be obtained. 
a) 
b) 
3 OLIGONUCLEAR RU(II) COMPLEXES WITH MACROCYCLIC LIGANDS 
64 
 
3.5 Photophysical Properties and Redox Potentials 
 
Absorption spectroscopy is an easy method to get some cursory information about the 
electronic structure and electronic transitions that take place in a molecular species. 
The absorption spectra of macrocyclic complexes 64, 65 and 66 are shown in Figure 3.5-1. 
The band around 290 nm is probably a spin-allowed LC pi → pi* transition. The two bands at 
240 nm and 460 nm can be assigned to spin-allowed MLCT d → pi* transitions. The 
shoulders at 320 nm and 355 nm might be MC transitions. Assignments have been made by 
referring to the properties of [Ru(bpy)3]2+, the prototype of ruthenium(II) polypyridine 
complexes[101], which has an MLCT band at λmax = 452 nm (ε = 14600 M-1 cm-1). 
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Figure 3.5-1. Absorption spectra of complexes 64 (black, solid line), 65 (blue, dotted line) and 66 (red, 
dashed line). 
 
It is noteworthy to mention that the extinction coefficients are almost increased by a factor of 
two for the dinuclear compound 65 and by a factor of three for the trinuclear compound 66 
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compared to the mononuclear compound 64. These molecules contain one, two or three 
chromophoric groups, respectively. 
 
In 1959 Paris and Brandt[149] first reported the luminescence of [Ru(bpy)3]2+ whose intensity, 
lifetime and energy position are more or less temperature dependent. At room temperature the 
maximum lies at 615 nm (τ ≈ 1 µs) in acetonitrile.  The ruthenium(II) compounds introduced 
in this chapter exhibit an emission at ≈ 620 nm except for 64 which has its emission band at 
lower energy (641 nm). 
 
 
 
 
 
Table 3.5-1. Absorption data (10-5 M in dichloromethane) and emission data (10-4 M in dichloro-
methane or acetonitrile) of ruthenium complexes.  
 Absorption Emission 
 
λmax [nm] ε [M-1 cm-1] 
λexc = 355 nm 
λmax [nm] 
 
67 
457 
318 (shoulder) 
289 
15 000 
46 500 
85 900 
616 
    
64 
457 
354 (shoulder) 
321 (shoulder) 
290 
14 700 
39 200 
45 700 
86 800 
641 
    
65 
457 
316 (shoulder) 
290 
19 700 
61 800 
114 300 
617 
    
66 
457 
355 (shoulder)  
318 (shoulder)  
290 
31 200 
77 000 
100100 
181000 
621 
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The redox properties of the ruthenium(II) complexes have been investigated by means of  
cyclic voltammetry (CV). One typical example is shown in Figure 3.5-2 for the cyclic 
voltammogram of 64 in degassed acetonitrile.  
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Figure 3.5-2. Cyclic voltammogram of 64 (1 mM) in degassed acetonitrile containing 0.1 M 
[NnBu4]PF6, v = 100 mV s-1. 
 
Usually, the oxidation of ruthenium(II) in the complexes introduced in this chapter happens 
between 900 – 930 mV and there are four reduction processes which are reversible for the 
mononuclear complexes 67 and 64, but not for the multinuclear complexes 65 and 66. The 
potentials have been measured versus Ferrocene0/Ferrocenium+ (Fc/Fc+). The cyclic 
voltammogram of [Ru(bpy)3]2+ in degassed acetonitrile was measured for comparison and 
exhibits one oxidation process (890 mV) and four reduction processes (-1.73V, -1.93V, -
2.17V), all are monoelectronic and reversible.[150] Many references are found in the literature 
for [Ru(bpy)3]2+ and oxidation of ruthenium(II) to ruthenium(III) is usually reported at 
1260 mV versus the NHE (Normal Hydrogen Electrode) in acetonitrile or water.[151-154] 
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Table 3.5-2. Redox potentials measured for complexes 64-67 in argon-purged solutions of acetonitrile. 
E1/2 values are given for reversible processes from the cyclovotammetry and are peak potentials for 
irreversible processes from square wave.  
                               Potential [V] versus Fc/Fc+ 
 oxidation reduction 
 
[Ru(bpy)3]2+ 0.890 -1.73, -1.93, -2.17 
67 0.903 -1.60,-1.87, -2.10, -2.41 
64 0.904 -1.60[a], -1.92, -2.12, -2.41 
65 0.919 -1.48[a], -1.60[a], -1.85[a], -2.15[a], -2.44[a] 
66 0.927[b] -1.57[a], -1.97[a], -2.21[a], -2.42[a] 
[a] irreversible process, peak potential from square wave. [b] reversible process, peak potential from 
square wave.  
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3.6 NMR Enantiodifferentiation of Chiral Ruthenium(II) Complexes 
 
 
Chirality in coordination compounds will occur when chelating ligands are bonded to an 
octahedral core. If the mirror image of a molecule and the original molecule are non-super-
posable then the molecule is optically active (chiral).[98] Another more general definition says 
that any object that does not have any symmetry elements of the second kind (mirror plane, 
centre of inversion, rotation reflection axis) will be chiral.[155] A demonstrative example is the 
cation [Ru(bpy)3]2+ which is optically active and can appear in the form of the ∆- and Λ-
enantiomer.  
 
 
Figure 3.6-1. Optical isomers of the coordination complex [Ru(bpy)3]2+. The ∆-isomer and the Λ-
isomer are non-superposable and they are mirror images of each other. 
 
In an achiral environment, [Ru(bpy)3]2+ will be formed as a racemate (equal quantities of ∆- 
and Λ-enantiomers). 
Pentavalent hexacoordinated phosphorus of octahedral geometry allows the formation of 
chiral phosphate anions if three identical bidentate ligands are coordinated. In 1997, Lacour 
and co-workers reported the synthesis and resolution of the configurationally stable 
TRISPHAT-anion (tris(tetrachlorobenzenediolato)phosphate(V)-ion)[156] (see Figure 3.6-2). 
The non-substituted tris(benzenediolato)phosphate(V) anion is readily synthesised as an 
ammonium salt from catechol, PCl5 and an amine but it is unfortunately configurationally 
labile and its enantioenriched form undergoes fast epimerisation in solution.[157, 158] However, 
the use of catechols substituted with electron-withdrawing groups as in the case of 
TRISPHAT, prevents the epimerisation due to steric hindrance and electronic effects. 
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Figure 3.6-2. Hexacoordinated phosphate anion TRISPHAT (tris(tetrachlorobenzenediolato)-
phosphate(V)). The ∆-enantiomer is shown. 
 
Both enantiomers of the TRISPHAT anion can be obtained on a multigram scale through a 
reported resolution procedure[159] and one isomer is also commercially available. It has found 
many applications as a NMR chiral shift reagent[160-164], as a resolving auxiliary[165-168], as an 
asymmetry-inducing agent[169-172] and solubilising reagent[173, 174] for organic, organometallic, 
metallo-organic and polymeric substances. 
The advantage of an NMR spectroscopic investigation via chiral shift reagents over chiro-
optical methods is that there is no need for parameters which characterise the pure 
enantiomers.[175] In the case of a racemic ruthenium(II) complex, one has to replace the achiral 
counterions (e.g. PF6-) by enantiopure optically active counterions (e.g. ∆-TRISPHAT). The 
racemic mixture of enantiomers will be converted to a mixture of diastereoisomers. 
Since we prepared cyclic complexes with one, two and three chiral centres, the study of their 
chirality appeared to be interesting. 
For a first test, the racemic ruthenium(II) complex 67 as its hexafluorophosphate salt was 
dissolved in dichloromethane, two equivalents of ∆-TRISPHAT were added and the reaction 
mixture was extracted with water. Figure 3.6-3 shows the 1H NMR spectrum of the complex 
with the achiral hexafluorophosphate counterion (top) and the spectrum of the complex with 
the enantiopure ∆-TRISPHAT counterion (bottom). The signals for protons A3, C3+C'3 and 
B5 clearly split into two sets of signals in roughly equal intensities. This can be explained by 
the formation of the two diastereoisomers [∆-67][∆-TRISPHAT] and [Λ-67][∆-TRISPHAT] 
that have different chemical shifts. 
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Figure 3.6-3. 1H NMR spectra of a) rac-67 as its hexafluorophosphate salt; b) rac-67 with 
approximately two equivalents of [Et4N][∆-TRISPHAT]. Both spectra are recorded at 500 MHz in 
CD2Cl2 at 25 °C. 
 
The trinuclear complex 66 has three stereogenic metal centres, and for each there is the 
possibility of Λ- or ∆-configuration. Two racemic diastereoisomers which are distinguishable 
in an achiral environment are possible: the homochiral ΛΛΛ/∆∆∆-stereoisomer-pair and the 
heterochiral ΛΛ∆/∆∆Λ-stereoisomer-pair. The situation is depicted in Scheme 3.6-1. Any 
compound with n-stereocentres will give rise to 2n isomers.[176] Statistically, there are eight 
isomers (23 = 8) expected for the complex 66. The heterochiral forms ΛΛ∆/∆∆Λ are triple 
degenerated because a rotation of ±120° around the axis in the plane of paper will convert one 
isomer into one of the others (e.g. ΛΛ∆ = Λ∆Λ = ∆ΛΛ). In summary, there are two isomers 
from the homochiral form and two threefold degenerate isomers from the heterochiral form. 
Therefore, the ratio between these two diastereoismeric pairs is expected to be 2:6. 
a) 
b) 
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Scheme 3.6-1. The four possible isomers of complex 66. 
 
Figure 3.6-4 shows the 1H-NMR spectra of the trinuclear complex as the hexafluorophosphate 
salt (top) and with ∆-TRISPHAT as counterion (bottom).   
 
6.16.56.97.37.78.18.58.9
δ/ppm
A3
A4
C6
A6+C‘6
B5
C5+C‘5 B2+B4+B6
C3+C‘3
C4+C‘4
 
Figure 3.6-4. 1H NMR spectra of a) rac-66 as hexafluorophosphate salt; b) rac-66 with approximately 
six equivalents of [Et4N][∆-TRISPHAT]. Both spectra are recorded at 500 MHz in CD2Cl2 at 25 °C. 
 
The spectrum of the trinuclear complex 66 exhibits a similar pattern to that of the 
mononuclear complex 67. Chemical shifts and coupling patterns are comparable. It seems to 
a) 
b) 
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be composed of a major component and a minor component in a 5:1 ratio. Once the 
counterion is replaced by enantiopure ∆-TRISPHAT, the proton spectrum appears to be more 
complex. Four different species are assumed to be distinguishable: ([ΛΛΛ-66][∆-
TRISPHAT], [∆∆∆-66][∆-TRISPHAT], [ΛΛ∆-66][∆-TRISPHAT] and  [∆∆Λ-66][∆-
TRISPHAT]). They will occur in different ratios. From the spectrum one cannot tell 
unambiguously how many compounds are present but there are more than two. 
The dinuclear ruthenium(II) complex 65 has three isomers: The chiral ∆∆-form and ΛΛ-form 
and the achiral ∆Λ-form. The latter is a meso-compound.[177] The crucial property is that it 
contains an inversion centre that makes it achiral despite the fact that it possesses two 
asymmetric metal cores.[98] Furthermore, the molecule and its mirror image are identical.[178] 
The situation is depicted in Scheme 3.6-2. Only the homochiral form of the complex could be 
isolated, no treatment with TRISPHAT has been done to date. 
diastereoisomers 
Λ Λ
Λ ∆
∆ ∆
î
inversion centre
∆ Λ≡
 
Scheme 3.6-2. The three possible isomers of complex 65. 
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3.7 Determination of Coordinated Sodium in 64 via Atomic Absorption 
Spectroscopy 
 
Atomic absorption spectroscopy (AAS) and atomic emission spectroscopy (AES) are widely 
used in micro analyses[179] and elements such as sodium, potassium, lithium and calcium, for 
example in biological liquids and tissues, are easily detected.  
Most of the sodium atoms are in the ground state at room temperature.[180] The valence 
electron occupies the 3s-orbital. Thermal excitation (heat of the flame) can cause a transition 
from the ground state to a higher energy level. As the transition back to a ground state occurs 
energy is emitted in form of a photon with the characteristic energy between the two energy 
levels. In the case of sodium, the transition from the 3p to the 3s-orbital can be detected at 
589.0 nm and 589.6 nm. These wavelengths are also responsible for the typical yellow colour 
of sodium salts in a flame. The detection limit for sodium is lower in the case of flame atomic 
emission spectroscopy (0.1 ng/mL) than for atomic absorption spectroscopy (20 ng/mL).[180, 
181]
 That is the reason why the AES (atomic emission spectroscopy) is usually preferred for 
this element over AAS (atomic absorption spectroscopy).  
 
Table 3.7-1. Standards with known concentration of sodium and calculated concentration of the 
sample. 
solution 
Concentration 
[µM] 
absorption 
a. u. 
Relative 
SD [%] 
standard 1 2.0 0.0223 1.5 
standard 2 3.0 0.034 1.3 
standard 3 4.0 0.0481 0.54 
standard 4 6.0 0.065 0.49 
standard 5 10.0 0.1144 1.9 
sample 4.46 0.0507 1.8 
 
A calibration curve was obtained after measurement of three standard solutions containing 
exactly known concentrations (see Table 3.6-1 and Figure 3.6-1). For all measurements, the 
typical yellow colour of the flame was observed which indicated the presence of sodium. 
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Figure 3.7-1. Linear calibration plot for standard solution and sample. 
 
The sodium concentration was found to be 4.5 µM in the sample solution. Deduced from the 
weighed complex, the concentration compound 64 in the sample was 12.9 µM. Therefore, 
roughly (35±10)% of the molecules had a sodium cation coordinated to the ether chain in 
solution. This value is comparable to the results found in the crystal structure with 50% of the 
molecules containing sodium. The relative error was estimated from the standard error 
coming from the linear regression and the unknown nature of one third of the counterions 
(chloride was assumed). 
A few more comments have to be made. The main question is how the sodium came to be in 
the complex if during its synthesis no sodium in the form of salts or any other form has been 
used. One explanation is that the aluminium oxide used for chromatography usually contains 
up to one gram sodium per kilogram. Another way to rationalize the appearance of the sodium 
is that the counterion hexafluorophosphate might decompose to fluoride and its conjugate 
acid, hydrofluoric acid, which is well known for its ability to dissolve glass. Common 
laboratory glassware such as borosilicate contains, for example, around 4% sodium oxide. 
Trials to synthesise 64 without any extra coordinating sodium were unsuccessful. Either it 
was impossible to purify the compound solely over ultrapure silica gel or sodium, which is 
difficult to exclude completely, found its way to the molecule. 
No matrix effects were considered, especially those coming from the ruthenium complex 
might interfere with the analyte. This can be avoided by utilizing the Standard Addition 
Method or the Internal Standard Method.[180] Those methods have not been applied because of 
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the more demanding employment and only the nature of the coordinated species and the 
approximate amount of analyte were of interest. 
3 OLIGONUCLEAR RU(II) COMPLEXES WITH MACROCYCLIC LIGANDS 
76 
 
3.8 Summary and Outlook 
Three novel oligonuclear, macrocyclic ruthenium(II) complexes have been presented in this 
chapter. In contrast to well-known metallomacrocycles, the cycle is not formed by co-
ordinative bonds but by covalent bonds. The complexes consist of bipyridine ligands and one 
ligand that is either a bidentate, tetradentate or hexadentate macrocycle leading to mono-
nuclear (64), dinuclear (65) or trinuclear (66) complexes, respectively. The macrocyclic 
complex can be synthesised in two ways: reaction of a multitopic macrocyclic ligand with cis-
[Ru(bpy)2Cl2] or direct ring-closing metathesis (RCM). The compounds could be 
comprehensively characterised and single crystals suitable for X-ray crystallography analysis 
were obtained for 67, 64 and 65. Cyclic voltammetry, absorption and emission spectroscopy 
revealed that the particular macrocyclic topology of these compounds hardly influence their 
physical properties. Molecules with more than one octahedral metal centre and bidentate 
ligands lead to a mixture of isomers. Diastereoisomers can often be separated chromato-
graphically. It will be very interesting to synthesise these multinuclear complexes in an 
enantioselective synthesis providing only one of the possible diastereoisomers. Enantiopure 
∆-[Ru(bpy)2(py)2]2+ can be prepared by a known procedure[182] and could be used instead of 
racemic cis-[Ru(bpy)2Cl2] during the synthesis. The resulting complexes will be homochiral 
and optically pure.[183] 
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4 Diversification of Ligand Families 
 
The crystal field theory[98] is a good model to describe colour, magnetism and other 
properties of transition metal complexes. The theory which was introduced by the physicists 
Bethe and van Vleck[184] in the 1930s considers ligands to be negative point charges that 
surround a positively charged metal ion. In octahedral complexes, the negative charges are 
located on the six vertices and the electrons in the d-orbitals from the metal core experience 
repulsion. This leads to a splitting of the originally degenerate d-orbitals. Crystal field theory 
does not attempt to describe bonding. Crystal field theory and molecular orbital theory were 
then combined to ligand field theory which gives more insight into chemical bonding in metal 
complexes. 
The stability of complexes is not only governed by electronic factors but also by steric 
interactions. 
4.1 Introduction 
Diaryl-functionalized 2,2'-bipyridines (bpy), 1,10-phenanthrolines (phen) and 2,2':6',2"-ter-
pyridines (tpy) are commonly utilized scaffolds in metallosupramolecular chemistry. The aryl 
groups bear substituents which can be further elaborated or which contain desired 
functionalities and the metal-binding domain provides the recognition features for interaction 
with specific metal centres. The development of the metal-ion templated synthesis of 
catenanes, knots and other topologically complex systems[77] was predicted on the 
organization of 6,6'-disubstituted bpy (or 2,9-disubstituted phen) ligands about tetrahedral 
copper(I) or silver(I) centres. Although the substituents adjacent to the nitrogen (neocuproin 
structure type) are critical for the stability of copper(I) complexes,[185] formation of stable 
complexes with octahedral metal centres requires that the aryl substituents are attached to 
other positions (ferroin structure type). The synthesis of families of ligands with neocuproin 
or ferroin metal-binding domains is time-consuming and strategies have been developed for 
the direct conversion of ferroin metal-binding domains to the neocuproin type. 
Ligands 35 and 34 (Scheme 4.2-1) have been previously reported,[95] and the complexation of 
35 with silver(I).[186] Ligand 35 was also used as a building block for the formation of a 
heterotopic ligand in which the central bpy domain is linked by polyethyleneoxy spacers to 
two 2,2':6',2" terpyridine (tpy) units. The flexibility of this ligand permits the binding of 
iron(II) and formation of a [1+1] ferramacrocycle.[187] Apart from these studies, the 
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complexation of 35 and 34 remains unexplored. Heteroditopic bpy-tpy ligands[188-195] are 
versatile building blocks in supramolecular chemistry, as they can behave as switches or 
tuners if one coordination site is transformed into a chromophore and the other coordination 
side is free (e. g. for coordination to a metal), and they can act as bridging ligands for 
multinuclear assemblies with different metals in different coordination environments. A 
convergent synthesis of a heptaruthenium metallostar with a heteroditopic ligand was 
reported.[190] Photophysical and electrochemical properties were investigated on multinuclear 
assemblies[188-190, 195] bridged by heteroditopic ligands. Electronic communication (energy 
transfer) was observed in some examples. 
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4.2 Aims and Overview 
In this chapter, the formation of two ligands, 72 and 42 (Scheme 4.2-1) is described. They 
possess terminal alkene functionalities that are ideally suited to Grubbs' coupling and the 
assembly of polymeric or macrocyclic species. The diversity in coordination space has been 
extended beyond commonly studied 1 : 2 tetrahedral and 1 : 3 octahedral species to 1 : 2 
square planar metal centres, and the preparation and characterisation of palladium(II) 
complexes of ligands 34, 72 and 42 is described. Proof-of-principle conversion of 34 to 
ligands containing substituents adjacent to the nitrogen donors and the air-stable copper(I) 
complexes of these new ligands is described. The interconversion to the heteroditopic ligand 
73 that bears bipyridine and terpyridine binding sides is presented. 
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Scheme 4.2-1. Diversification of ligand families to ferroin structure type ligands, neocuproin structure 
type ligands or ferroin structure type ditopic ligands. 
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4.3 Results and Discussion 
 
Ligands for palladium(II) complexes 
 
Ligands 72 and 42 were prepared using caesium-directed Williamson's methodology by 
treating 35 with allyl bromide or 3-(2-bromoethoxy)prop-1-ene, respectively, in the presence 
of Cs2CO3 in DMF. For 72, the reaction was carried out in a microwave reactor at 100 °C and 
was complete in less than an hour. For 42, the reaction mixture was heated at 120 °C for 4 
days. Both ligands were obtained in high yield. The EI mass spectrum of each compound 
exhibited a parent ion (m/z = 421.2 for 72 and 508.2 for 42), and the appearance of the 
solution 1H and 13C NMR spectra of 72 and 42 confirmed the formation of symmetrical 
ligands. The spectra have been assigned using COSY, DEPT, HMQC and HMBC techniques. 
With the exception of the appearance of signals for the additional methylene groups in 42, the 
1H NMR spectra for 72 and 42 are almost identical, as are their 13C NMR spectra. However, 
whereas in 72, the signals for protons HB2 and HB6 (Scheme 4.2-1) appear at δ 7.14 and 7.18 
ppm, in 42, they overlap at δ 7.29 ppm. Since the 13C NMR spectroscopic signatures for the 
aromatic domain of the two ligands are virtually superimposable, the assignments of signals 
for CB2 and CB6 in 42 have been made by comparison with those of 72, assigned from the 
HMQC spectrum. 
 
 
Palladium(II) complexes: synthesis and solution characterisation 
The reaction of [Pd(CH3CN)4][BF4]2 with two equivalents of ligand 34 in CH3CN produced 
analytically pure [Pd(34)2][BF4]2 as a yellow solid. The highest mass peaks in the FAB mass 
spectrum came at m/z = 861.1 and 842.1, and were assigned to [Pd(34)2+F]+ and [Pd(34)2]+, 
respectively. Fragmentation by ligand loss was also observed. The complex was poorly 
soluble in most common solvents, and the NMR spectra were recorded in DMSO-d6. 
Compared to signals for the free ligand in DMSO-d6, the most diagnostic indication of 
complex formation is the large shift to higher frequency for the signal for bpy proton HA4. 
This presumably reflects the fact that in the square planar Pd(II) environment, the presence of 
the methoxy substituents restricts rotation about the Cpy–CPh bond, and the aryl ring twists out 
of the plane of the bpy unit (this is confirmed in the crystal structures of ligand and complex 
described below). The bpy protons most affected by this will be those facing the aryl π-cloud, 
i.e. HA4 and HA6 (Figure 4.3-1). As Figure 4.3-1 shows, the peaks for the bpy unit are rather 
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broad compared to those of the free ligand in the same solvent. Addition of free ligand to an 
NMR sample of [Pd(34)2][BF4]2 resulted in further broadening of the signal assigned to 
HA3+A4 as well as broadening of the resonance for HB4 and loss of resolution for the signals for 
HB2+B6/HB5. In spectra recorded for [Pd(34)2][BF4]2 plus one and a half equivalents of ligand, 
no signals arising from the free ligand were observed. This observation is consistent with that 
observed by Milani et al, in the DMSO-d6 solution 1H-NMR spectrum of [Pd(bpy)2][PF6]2, 
indicating that exchange occurs between free and coordinated ligand on the NMR 
spectroscopic timescale.[196] 
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Figure 4.3-1. 500 MHz NMR spectra of DMSO-d6 solutions of [Pd(34)2][BF4]2 (TOP) and ligand 34 
(BOTTOM). 
 
Structural characterisation of [Pd(34)2][BF4]2 (74) 
A solution of analytically pure [Pd(34)2][BF4]2 (74) in a mixture of DMF and Et2O in a vial 
surrounded by Et2O was left at 4 °C for several weeks after which time, X-ray quality yellow 
plates had grown. Interestingly, the complex co-crystallized with the free ligand (which must 
have originated from the complex) and the single crystal structure of [Pd(34)2][BF4]2·34 
determined. Figures 4.3-2a and 4.3-2b show the centrosymmetric structures of the [Pd(34)2]2+ 
cation and ligand 34, respectively. Bond distances and angles within the bpy and phenyl rings 
are unexceptional. As expected, the free ligand adopts a transoid conformation, but flips to a 
cisoid arrangement upon binding to palladium(II). The C–O bond distances and C–O–C bond 
angles in both ligand and complex (see figure caption) are consistent with delocalization of π-
4 DIVERSIFICATION OF LIGAND FAMILIES 
82 
character from phenyl ring to the oxygen atom. Two features of the structure deserve note: the 
ligand distortion in [Pd(34)2]2+, and the packing. In [M(bpy)2]n+ complexes and in the absence 
of electronic factors (i.e. crystal field stabilisation energy), the metal ion is typically in a 
tetrahedral environment. However, a square planar environment is preferred for a d8 metal 
centre such as palladium(II) or platinum(II). In such a bis(bpy) complex, steric interactions 
between the H6 protons on adjacent ligands lead to one of the two types of distortion 
illustrated in Scheme 4.3-1.[197] A search of the Cambridge Structural Database (v. 5.30)[198] 
using Conquest11[199] revealed 24 structures containing either a [Pd(bpy)2]2+ or [Pt(bpy)2]2+ 
motif, including substituted derivatives and [M(phen)2]2+ (phen = 1,10-phenanthroline).[200-217] 
Excluded from this set are compounds in which adjacent bpy domains are connected 
directly[69, 218, 219] or indirectly through the 6-positions. Of the 24 structures, twelve distort at 
the metal centre (distortion A in Scheme 4.3-1) and twelve undergo ligand distortion (B in 
Scheme 4.3-1, the so called 'bow-incline' distortion). These distortions have been discussed in 
detail by Marzilli,[214] but with a sample size of only six complexes. In [Pd(34)2]2+, H6... H6 
repulsions are relieved by ligand distortion B as shown in Figure 4.3-2b. 
 
Figure 4.3-2. a) Molecular structure of the [Pd(34)2]2+ cation in [Pd(34)2][BF4]2·34 with ellipsoids 
plotted at 50% probability level; b) Distortions of the bpy units alleviates steric hindrance between H6 
protons. Counterions and hydrogen atoms except for H6 have been omitted for clarity.  
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Scheme 4.3-1. Modes of distortion in [Pd(bpy)2]2+, [Pt(bpy)2]2+ and related cations. 
 
In ligand 34 (Figure 4.3-3), the bpy unit is planar, and the phenyl substituent is twisted 
23.44(9)° with respect to this plane. This compares to 32.2(6)° and 32.4(6)° in the two 
independent molecules of 34 in the previously determined structure of the ligand alone. In 
[Pd(34)2][BF4]2·34 the MeO group is oriented on the side opposite the N atom of the adjacent 
pyridine ring (Figure 4.3-3), whereas in the previous structure of 34, it lies on the same side of 
the molecule as the N atom. This difference probably originates from packing effects. In 34, 
molecules interact through weak C–Hmethyl...O hydrogen bonds to form interconnected, 
undulating chains; offset face-to-face π-stacking occurs between adjacent bpy domains and 
between adjacent phenyl rings. In [Pd(34)2][BF4]2·34, ligands and [Pd(34)2]2+ cations are 
interleaved to form stacks with the pyridine ring containing atom N1 in [Pd(34)2]2+ is π-
stacked over the bpy unit of the free ligand at a distance of 333 pm. The stacks are connected 
by non-classical hydrogen bonds between atom O3 of the free ligand and C24H241 of a 
methyl group of the [Pd(34)2]2+ cation (C24H241...O3i = 250 pm,  C24...O3i 325.8(2) pm, 
C24–H241...O3i = 135°, symmetry code i = –1 + x, 1 + y, –1 + z) (Figure 4.3-4). 
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Figure 4.3-3. a) Molecular structure of the 34 in [Pd(34)2][BF4]2·34 with ellipsoids plotted at 50% 
probability level. Counterions and hydrogen atoms have been omitted for clarity. 
 
 
Figure 4.3-4. a) Stacking of [Pd(34)2]2+ cations and ligand 34 in [Pd(34)2][BF4]2·34. b) Hydrogen 
bonding between free ligands and cations (see text). 
 
The reaction of [Pd(CH3CN)4][BF4]2 with two equivalents of either 72 or 42 resulted in the 
formation of [Pd(72)2][BF4]2 (75) or [Pd(42)2][BF4]2 (76), respectively, each isolated as a 
yellow solid. The two complexes were characterised by NMR spectroscopic and mass 
spectrometric methods, and by elemental analysis. A comparison of the 1H-NMR spectrum of 
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acetone-d6 solutions of ligand 72 and of the palladium(II) complex showed that the most 
significant changes were in the chemical shifts of the signals (assigned by 2D techniques) 
arising from protons HA4 (δ 9.00 to 9.33 ppm) and HA6 (δ 8.21 to 8.86 ppm), consistent with 
the formation of a square planar palladium(II) complex (see earlier discussion). A comparison 
of the 1H-NMR spectra of 42 and [Pd(42)2][BF4]2 was made using CD3CN/CDCl3 solutions of 
the compounds, and the change in the chemical shift of proton HA4 (δ 8.03 to 8.46 ppm) was 
indicative of coordination. Attempts to grow X-ray quality crystals of [Pd(72)2][BF4]2 and 
[Pd(42)2][BF4]2 were unsuccessful. Our interest in these complexes is the reactivity of the 
terminal alkene functionalities. Applications of Grubbs' catalysts to the formation of 
macrocyclic species have included the formation of macrocycles, catenanes and knots 
templated within a metal coordination sphere.[46, 79, 220-222] Molecular modelling indicated that 
in both [Pd(72)2]2+ and [Pd(42)2]2+, the terminal alkene chains are long enough to permit ring-
closing metathesis with concomitant formation of a palladium(II)-bound macrocyclic ligand. 
However, attempts at ring closure were unsuccessful with either first generation Grubbs' or 
Hoveyda-Grubbs' catalysts in CH2Cl2 or CH3NO2 at room temperature or reflux, and also 
under microwave heating conditions. In each case, the 1H-NMR spectrum of the crude 
mixture indicated no signs of the formation of a new double bond. The 1H-NMR spectrum of 
the crude mixture showed the presence of the unreacted palladium(II) complex. The problem 
lies probably in the lability of the palladium(II) complexes which release free ligands capable 
of poisoning the catalyst. Although ruthenium carbene catalysts exhibit an exceptional 
tolerance towards many functional groups, catalyst inhibition by complex-formation 
involving the reagents is known to be problematical.[140, 223] 
 
The ferroin-cuproin interconversion 
In order to broaden the scope of our investigation of 4-coordinate complexes with ligands 
related to 34, the attention was turned to the preparation of copper(I) complexes. The crucial 
factor for the isolation of air-stable complexes containing an [Cu(bpy)2]+ core is the presence 
of substituents in the 6- and 6'-positions.[185] The syntheses of ligands 77 and 78, and their 
reactions with copper(I) are described below.  
Ligand 77 was prepared by methylation of 34 using MeLi adapting the procedure reported for 
the methylation of 1,10-phenanthrolines and 2,2'-bipyridines.[8, 224, 225] The optimum yield of 
77 (82%) was obtained when MeLi (one equivalent) was added at –78 °C, and the reaction 
then carried out at room temperature followed by a period of heating. After quenching the 
reaction with water, oxidation with MnO2 resulted in the formation of 77. Ligand 78 was 
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subsequently synthesised by methylation of 77. Attempts to prepare 78 directly by the 
reaction of 34 with two or more equivalents of MeLi were unsuccessful. The highest mass 
peak in the ESI MS of each ligand corresponded to the parent ion. The symmetrical 
appearance of the 1H and 13C-NMR spectra of 78 was consistent with methylation at both the 
6- and 6'-positions, and this is confirmed by the disappearance of the signal assigned to HA6 
on going from 34 to 78 (Figures 4.3-5a and 4.3-5b). Figures 4.3-5c and 4.3-5d also illustrate 
that the introduction of the methyl substituents causes the signals for the remaining bpy 
protons and the ortho-protons of the phenyl substituent (HD2 and HD6) to shift to a lower 
frequency. This can be rationalized in terms of a change in the relative orientations of 
pyridine and aryl rings (see structural details below) which results in the ring protons lying 
over the π-cloud of the adjacent ring. The resonances for the aryl protons remote from the bpy 
unit and for the methoxy protons are only slightly affected by methylation. The 1H-NMR 
spectrum of 80 (Figure 4.3-5c) is readily assigned by comparison with those of 34 and 78 
(Figures 4.3-5), and the assignments have been confirmed by 2D techniques.  
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Figure 4.3-5. Room temperature 500 MHz NMR spectra of CDCl3 solutions of a) 34; b) 78; c) 77; d) 
79. Asterisks mark the residual CHCl3. Proton labelling is given in Scheme 4.2-1 and Scheme 4.3-3. 
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Single crystals of 78 were grown by slow evaporation of a CDCl3 solution of the ligand. The 
centrosymmetric molecular structure of 78 is shown in Figure 4.3-6. The plane of the aryl 
substituent deviates 55.16(6)° from the plane of the bpy unit, and so, as expected, 6,6'-
dimethyl substitution results in a significantly greater twist of the 3-anisyl groups than is 
observed in 34 (Figure 4.3-3). This deviation affects the way in which the molecules are able 
to pack. In 34, π-stacking is important, whereas in 78, there is no analogous stacking, and the 
molecules pack so that each 6-methyl or 6'-methyl substituent points obliquely towards a 
pyridine ring on an adjacent molecule. 
 
Figure 4.3-6. Molecular structure of 78 with ellipsoids plotted at 50% probability level. Hydrogen 
atoms have been omitted for clarity. 
 
In our initial attempts to synthesise the monomethyl derivative 77, one equivalent of MeLi 
was added to 34 at room temperature. After quenching the reaction in water, and oxidation of 
the intermediate using MnO2, spot thin layer chromatography showed the presence of two 
products. These colourless compounds were separated by column chromatography, and the 
first fraction was identified as 77. The highest mass peak in the ESI MS of the second 
product, 79, was observed at m/z = 763.4 (i.e. approximately twice the molecular mass of 77). 
The CDCl3 solution 1H NMR spectrum of 79 showed the presence of two MeO signals (δ 3.81 
and 3.72 ppm, relative integrals 1 : 1), both shifted to lower frequency with respect to those in 
77 (δ 3.88 and 3.84 ppm). A singlet at δ 2.62 ppm (relative integral with respect to each OMe 
= 1 : 1) replicated that in 77. Figure 4.3-5d shows the aromatic region of the 1H NMR 
spectrum of 79 (see Scheme 4.3-2 for atom labelling). 
Crucial observations that aid identification of 79 are a similarity between the phenyl regions 
of the spectra of 77 and 78, the appearance of a singlet at δ 7.54 ppm, significant changes in 
the chemical shifts of signals for the bpy protons, and the loss of one bpy signal with respect 
to the number of resonances in 77. A comparison of the 13C and DEPT NMR spectra revealed 
the presence of ten quaternary 13C nuclei in 79 compared to nine in 77. The NMR and ESI 
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MS data are consistent with C–C bond formation between two bpy units of 77 to produce 79. 
The equivalence of the bpy units deduced from the 1H and 13C NMR spectra gave two 
possibilities: the formation of a tetramethoxyphenyl derivative of 2,2':3',3":2",2'''- or 
2,2':4',4":2",2'''-quaterpyridine (Scheme 4.3-2). The singlet in the 1H-NMR spectrum can be 
assigned to either HE3 or HE4, and the appearance in the NOESY spectrum of a cross peak 
from this singlet to the signal for HF2 confirms an assignment of HE4. Single crystals of 79 
were not forthcoming. To date, attempts at metal complexation using 79 have been 
unsuccessful. 
 
 
Scheme 4.3-2. a) Compound 79; b) structures of two isomers of quaterpyridine. 
 
 
Treatment of [Cu(NCMe)4][PF6] with either ligand 77 or 78 led to the formation of red 
[Cu(77)2][PF6] (80) or [Cu(78)2][PF6] (81), respectively. The highest mass peaks in the ESI 
mass spectra of the products were assigned to [M–PF6]+ in each case, with isotope 
distributions matching those calculated. The diagnostic changes in the 1H-NMR spectrum on 
going from 77 (in CDCl3) to [Cu(77)2]+ (in CD3CN) involve the signals for protons HA4 and 
HC4. Both signals are shifted to higher frequency (δ 8.00 to 8.24 ppm for HA4, and δ 7.66 to 
7.83 ppm for HC4), while the remaining signals are little affected. Similarly, on going from 78 
to [Cu(78)2]+, the signal assigned to HC4 is the only resonance to undergo significant 
perturbation (δ 7.64 to 7.98 ppm). This mirrors the effects described earlier for coordination 
of ligands 34 and 72 to palladium(II). 
 
Crystals of [Cu(77)2][PF6]·0.1C2H4Cl2·0.15CH2Cl2 of X-ray quality were grown by slow 
vapour diffusion of Et2O to a mixture of CH2Cl2 and C2H4Cl2 containing [Cu(77)2][PF6]. 
Figure 4.3-7 depicts the structure of the [Cu(77)2]+ cation. The structure suffers from 
disorders in the cation, anion and solvent molecules. In the cation, the methyl group of one 
ligand is disordered over two sites modelled with 70% (atom C50 in Figure 4.3-7) and 30% 
4.3 RESULTS AND DISCUSSION 
89 
occupancies. In the other ligand, one methoxyphenyl unit (the one containing atom O11, 
Figure 4.3-7) is disordered and has been modelled over two sites with 70/30% occupancies. 
Despite the problems associated with the structure, it confirms that the coordination geometry 
of the copper(I) centre approaches tetrahedral (angle between the least squares planes of the 
two bpy domains = 70.0(1)°). In the ligand containing atoms N1 and N2, the phenyl ring 
containing atom C21 is approximately coplanar with the bpy rings (angles between the least 
squares planes of the rings = 6.5(2) and 11.9(5)°), while the second phenyl ring is twisted 
through 67.7(2)° with respect to the bpy unit. The coplanar rings are π-stacked with those of 
adjacent cations (alternating distances between least squares planes = 349 pm and 366 pm). 
Extensive C–Hphenyl...O, C–Hmethyl...O and C–Hbpy...F hydrogen bonding contribute to the solid 
state packing. 
 
Figure 4.3-7. a) Molecular structure of the [Cu(77)2]+ (80+) cation in 
[Cu(77)2][PF6]·0.1C2H4Cl2·0.15CH2Cl2 with ellipsoids plotted at 30% probability level. Counterions and 
hydrogen atoms have been omitted for clarity. For disordered sites (see text), only the major 
occupancy atoms are shown. 
 
 
The interconversion towards the heteroditopic bpy-tpy ligand 73 
5-Bromo-5'-(3-methoxyphenyl)-2,2'-bipyridine (82) was prepared in a statistical Suzuki 
coupling reaction by reacting the dibromo compound 32 with roughly one equivalent of 3-
methoxyphenylboronic acid in the presence of a palladium catalyst under biphasic conditions. 
Unreacted starting material (32) and the disubstituted compound 34 were removed as side 
products via column chromatography on silica gel. Treatment of 82 with n-butyllithium 
initiated halogen-metal exchange and addition of excess DMF and aqueous work-up produced 
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aldehyde 83 in moderate yield. The bpy-tpy ligand 73 was synthesised following a known 
procedure[189] by reacting aldehyde 83 with 2-acetyl pyridine in the presence of potassium 
hydroxide and ammonia in ethanol at 50 °C for 30 min. The ligand was obtained in 26% 
yield. The EI mass spectrum for each compound exhibited a parent ion (m/z = 340.0 for 82, 
290.1 for 83, 493.2 for 73) and 1H and 13C-NMR spectra confirmed the formation of the 
compounds. The spectra have been assigned using COSY, DEPT, HMQC and HMBC 
techniques. 
 
Scheme 4.3-3. Reagents and conditions: a) 3-methoxyphenylboronic acid (0.93 eq), [Pd(PPh3)4] (2.7 
mol%), Na2CO3 (5 eq), toluene/H2O, reflux, 20h, 40%; b) n-butyllithium (1.05 eq), DMF (20 eq), 
toluene, -78 °C, then H 2O, r.t., 29%; c) 2-acetyl pyridine (2.2 eq), KOH (2.2 eq), NH3, EtOH, 50 °C, 
26%. 
 
Figure 4.3-8 shows the 1H-NMR spectrum of the heteroditopic ligand 73 along with 
assignments. 
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Figure 4.3-8. Room temperature 500 MHz NMR spectrum of CDCl3 solution of 73. The asterisk marks 
the residual CHCl3. Proton labelling is given in Scheme 4.2-1. 
 
Single crystals of 73 were grown by slow evaporation of a CDCl3 solution of the ligand. The 
molecular structure with transoid conformation around the bipyridine and the terpyridine 
units is shown in Figure 4.3-9. 
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Figure 4.3-9. Molecular structure of 73. Hydrogen atoms have been omitted for clarity. 
 
The arrangement of molecules of 73 in the solid state is depicted in Figure 4.3-10. The 
molecules exhibit parallel displaced pi-stacking over tpy domains. Adjacent molecules with 
the same spatial arrangement form stacks at a distance of 329 pm and adjacent molecules with 
opposite spatial arrangement stack at a distance of 335 pm (see Figure 4.3-10b). The distances 
were determined from the parallel least square planes of the tpy units. 
 
Figure 4.3-10. a) View in packing along the crystallographic a-axis; b) pi-stacking between adjacent 
tpy domains.  
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4.4 Summary  
The preparation of two ligands, 72 and 42, which possess bpy domains terminated in alkene 
functionalities and the syntheses and characterisation of [Pd(72)2][BF4]2 and [Pd(42)2][BF4]2 
have been described. For the related complex [Pd(34)2][BF4]2 in which 34 is 5,5'-bis(3-
methoxyphenyl)-2,2'-bipyridine, the labile nature of the complex leads to co-crystallization 
with free ligand to give [Pd(34)2][BF4]2·34. Rather than undergoing distortion the 
coordination sphere towards a tetrahedral geometry, the H6 … H6 repulsions between the two 
bpy domains in [Pd(34)2]2+ are alleviated by a “bow-incline” distortion, within each ligand. 
Compound 34 has been converted to 5,5'-bis(3-methoxyphenyl)-6-methyl-2,2'-bipyridine (77) 
and 5,5'-bis(3-methoxyphenyl)-6,6'-dimethyl-2,2'-bipyridine (78) to produce ligands capable 
of forming air-stable copper(I) complexes. The syntheses of [Cu(77)2][PF6] and 
[Cu(78)2][PF6] and crystal structures of 78 and [Cu(77)2][PF6]·0.1C2H4Cl2·0.15CH2Cl2 have 
been described. By altering the conditions under which 34 is methylated, competitive 
formation of 5,5',5'',5'''-tetrakis(3-methoxyphenyl)-2,2':3',3":2",2'''-quaterpyridine (79) occurs. 
The preparation of heteroditopic ligand 73 and its crystal structure have been described. 
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5 Complexes of [Ru(bpy)3]2+-type bearing Pyrene 
Moieties 
Photosynthesis[226] is one the most crucial biological processes on Earth, since it provides 
oxygen which is essential for most living creatures. It is a process used by plants, algae, and 
many species of bacteria to reduce carbon dioxide and fix it into biomass. The energy needed 
for this process comes from sunlight that is absorbed by proteins called photosynthetic 
reaction centres containing chlorophyll. Leaves appear green because they contain 
chlorophyll, a green pigment common to all photosynthetic cells. Chlorophyll molecules 
absorb visible light of all wavelengths except green, and this is responsible for the green 
colour perception to our eyes. Photosynthesis can be regarded as the opposite of cellular 
respiration, where glucose is converted and carbon dioxide and water and energy is released. 
 
5.1 Introduction 
Excimers 
An excimer[227] (originally short for excited dimer) is a dimer formed from two molecular 
species, at least one of which is in an electronic excited state. The lifetime of an excimer is 
usually very short. The aromatic excimer of pyrene (Figure 5.1-1) was first observed by 
Förster and Kasper[228] in a concentrated solution of pyrene by fluorescence spectroscopy. In a 
10-5 M solution of pyrene in hexane, the excited monomer is the predominant species with a 
violet fluorescence at λmax = 377 nm and the spectrum has vibronic structure. However, at 
higher concentrations, the blue fluorescence (λmax = 480 nm) of the excimer becomes the 
major emission feature in the spectrum. Figure 5.1-1c shows the proposed mechanism for the 
photophysics of pyrene.[229] The lowest lying singlet excited state S1 is populated during 
irradiation. The energy can dissipate via internal conversion or fluorescence occurs (with hν1) 
and brings the molecule back to its ground state S0. Other relaxation processes including 
intersystem crossing and quenching also remove the excited state S1. The aromatic molecule 
in the S1 state undergoes a reaction of the excited singlet with a ground state molecule of the 
same type at high concentrations, producing an electronically excited dimer (excimer). As 
described for the monomeric species, fluorescence from the excimer (with hν2) and relaxation 
processes occur and yield the ground state S0. 
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Figure 5.1-1. a) Pyrene emission spectra as a function of concentration: 10-2 M to 10-5 M in hexane. 
b) Molecular structure of pyrene. c) Proposed reaction scheme of pyrene photophysics and excimer 
formation in solution. Adapted from reference.[227] 
 
Excimers were investigated in seeded supersonic molecular beams[230] where their electronic 
states and excited state dynamics can be characterised in detail. They play an important role in 
several areas of photophysics, including photodimerisation[231, 232] and molecular probing.[233, 
234]
 
 
Dual emission in transition metal complexes 
Kasha’s rule[235] says that photon emission (fluorescence or phosphorescence) occurs from the 
lowest-energy excited state in a species and the emission spectrum is therefore independent of 
the excitation energy. More precisely,[236] fluorescence (spin-allowed emission) typically 
takes place from the lowest vibrational state of the lowest excited singlet level, 
phosphorescence (spin forbidden emission) usually occurs from the lowest vibrational state of 
the lowest excited triplet state, and intersystem crossing (ISC) happens usually from the 
lowest singlet electronic state, because vibrational relaxation is exceedingly fast. These 
descriptions are true for most luminescent organic systems with only a few exceptions. 
Phosphorescence is the predominant form of emission in d3 (Cr(III)), and d6 (Ru(II), Rh(III) 
and Ir(III)) transition metal complexes.[236] 
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Dual emission defies Kasha’s rule and was reported for small molecules[237-240] at low 
temperature and in rigid media where thermal energy is not sufficient to overcome even low-
energy barriers. 
DeArmond[241] classified multiple emissions of tris-chelated complexes with bidentate 
diimine ligands into the “spatially isolated” and “distinct orbital” type. Examples for the first 
type are [Rh(bpy)n(phen)3-n]3+ (n = 1,2) complexes[242] where pi-pi*-emissions are determined 
from the bpy and the phen moiety. These ligands are separated in space. [Ir(phen)2Cl2]+[243] 
exhibits an emission coming from a pi-pi*-transition and an emission from a d-pi*-transition. 
They have different orbital origins and the phenomenon is therefore called “distinct orbital”. 
Nearly all heteroleptic ruthenium(II) complexes exhibit a single emissive state except for a 
few isolated systems that possess two emissive states.[238-241, 244]. Tor et al.[245, 246] published 
mononuclear and dinuclear ruthenium(II) complexes with two simultaneous emissive states 
that were controlled by structural features. 
 
 
Enhanced lifetimes and “energy reservoir” effects 
Transition metal complexes incorporating the motif [Ru(bpy)3]2+ are particularly interesting 
due to their exceptional combination of luminescence and redox properties.[102] Bi-
chromophoric systems containing a [Ru(bpy)3]2+ group and covalently linked arenes have 
been studied[247, 248] and pyrene was identified as having its lowest lying triplet state at similar 
energy to the luminescent metal-based triplet level. Ford and Rodgers noted first that the 
luminescence lifetime of ruthenium(II) polypyridyl complexes can be prolonged by the 
presence of a coupled aromatic chromophore.[249] Ruthenium(II) and pyrene units were 
tethered via saturated[249-252] or unsaturated[253] bonds. The excited state lifetime of the 
[Ru(bpy)3]2+ unit can depend on the number of attached pyrene chromphores[253] and a linear 
relationship between the number of pyrene chromophores and lifetime was found in a 
particular system.[250] The basis of this behaviour is depicted in Scheme 5.1-1. Light can be 
absorbed by either the ruthenium or the pyrene unit and the observed 3MLCT luminescence 
can receive contributions from the 1pyrene level over different pathways. Thermal 
redistribution between close lying ruthenium and pyrene centred triplet levels (path e) has a 
lifetime increasing effect. The pyrene unit acts in this respect as an “energy reservoir”. 
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Scheme 5.1-1. Schematic representation of energy levels of relevant excited states. a) intersystem 
crossing (ISC) with ΦISC=1; b) singlet-singlet energy transfer, 1pyrene → 1MLCT; c) direct ISC, 1pyrene 
→ 
3MLCT; d) ISC localized at pyrene followed by e) thermal redistribution between triplet levels. 
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5.2 Aims and Overview 
In this chapter, the syntheses and characterisation of 5,5'-di(pyren-1-yl)-2,2'-bipyridine (84), 
homoleptic iron(II) and ruthenium(II) complexes, [Fe(84)3](BF4)2 (85) and [Ru(84)3](PF6)2 
(86), and two heteroleptic ruthenium(II) complexes, [Ru(84)(bpy)2](PF6)2 (87, bpy = 2,2'-
bipyridine) and [Ru(84)(bmpb)2](PF6)2 (88, bmpb = 5,5'-bis(3-methoxyphenyl)-2,2'-bi-
pyridine), are described (see Scheme 5.2-1). Crystal structures for compounds 84, 86, 87 and 
88 were obtained and intramolecular and intermolecular interactions were investigated in the 
solid state. The [Ru(bpy)3]2+ and the pyrene domain are prominent chromophores, and intra-
molecular interactions were studied via absorption and emission spectroscopy and lifetimes of 
the excited states were determined. 
 
 
  84       85 (M = Fe(II)) 
         86 (M = Ru(II)) 
 
  87       88 
 
Scheme 5.2-1. Novel bipyridine ligand 84 bearing pyrene groups, homoleptic iron(II) (85) and 
ruthenium(II) (86) complexes and heteroleptic ruthenium(II) complexes, 87 and 88, with that ligand. 
bmpb = 5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine. 
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5.3 Synthesis 
The preparation of 5,5'-di(pyren-1-yl)-2,2'-bipyridine (84), its homoleptic ruthenium(II) 
complex 86 and iron(II) complex 85 and the heteroleptic ruthenium(II) complexes 87 and 88 
with that ligand are described below. 
The bis(pyrene) compound 84 was synthesised with relative ease by Suzuki coupling of 5,5'-
dibromo-2,2'-bipyridine (32) with commercially available pyren-2-ylboronic acid in biphasic 
conditions in the presence of [Pd(PPh3)4] under rigorous exclusion of light. The reaction 
mixture was heated to reflux for three days and the precipitate was collected and washed with 
water and ether to yield spectroscopically pure 84 in excellent yield (see Scheme 5.3-1). The 
ligand is very poorly soluble in CH2Cl2, not soluble in most other common solvents 
(including DMSO) and very soluble in its protonated form, for instance, in mixtures of 
trifluoroacetic acid and CH2Cl2. 
 
 
      32             84 
 
Scheme 5.3-1. Reagents and conditions: a) pyren-2-ylboronic acid (2.15 eq), [Pd(PPh3)4] (10 mol%), 
Na2CO3 (4 eq), toluene/H2O, reflux, 3 d, 99%. 
 
Complex 89 was prepared according to the literature procedure[105] for its smaller analogue 
cis-dichlorobis(bipyridine)ruthenium(II). Commercial ruthenium trichloride trihydrate and the 
ligand 34 were heated to reflux in DMF. Purification was performed by several steps of 
filtration and crystallization producing the desired complex in good yield. The compound is 
poorly soluble in the most common solvents. 1H-NMR spectroscopy showed the expected 
number of signals with the expected relative integrals for the molecule with the cis-
configuration. The highest mass peaks in the FAB mass spectrum came at m/z = 908.1, 873.3 
and 838.2, and were assigned to [89]+, [89-Cl]+ and [89-2Cl]+, respectively. 
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      34              89 
Scheme 5.3-2. Reagents and conditions: a) RuCl3·3 H2O (0.63 eq), DMF, reflux, 4 h, 44%. 
 
The homoleptic ruthenium(II) complex 86 and the homoleptic ruthenium(II) complexes 87 
and 88 were prepared by heating ligand 84 and the corresponding ruthenium(II) precursors in 
a microwave reactor yielding the desired complexes in good to very good yields. 
The synthesis of complex 86 required high thermal excitation and a mixture of ligand 84 and 
0.34 equivalents of [Ru(DMSO)4Cl2] were therefore heated to 250 °C in ethylene glycol. The 
counterion was exchanged by adding an aqueous solution of ammonium hexafluorophosphate 
to the reaction mixture and the precipitate was collected. Filtration over Al2O3 produced 
analytically pure 86 (see Scheme 5.3-3). 
 
 
   84        86 
Scheme 5.3-3. Reagents and conditions: a) [Ru(DMSO)4Cl2] (0.34 eq), µW, ethylene glycol, 250 °C, 
2h; b) NH4PF6, 83%. 
 
The iron(II) complex 85 was made by heating ligand 84 with an excess of the required iron 
salt in a microwave reactor. The resulting precipitate was washed with water and ether. ESI-
MS showed the highest mass peak at m/z = 863.1 that was assigned to [85-2BF4]2+. Due to its 
poor solubility, only a 1H-NMR spectrum could be measured in DMSO-d6. Furthermore, 
decolouration of the initially red solution was observed after several hours along with the 
disappearance of the resonances attributable to the compound in the 1H-NMR spectrum (the 
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free ligand is not soluble in DMSO). The replacement of ligands by non-innocent solvent 
molecules in the labile complex explains these observations. 
 
   84        85 
Scheme 5.3-4. Reagents and conditions: a) [Fe(BF4)2] · 6H2O (1.0 eq), µW, CH3CN, 110 °C, 30 min, 
21%. 
 
The ruthenium(II) complexes 87 and 88 were made in an analogous manner as described for 
86 (see Scheme 5.3-5 and Scheme 5.3-6). Equimolar mixtures of ligand 84 and cis-
[Ru(bpy)2Cl2] or 89 were heated in a microwave reactor to 140 °C, respectively. The work-up 
procedure was as described for 86. Purification of compound 88 necessitated column 
chromatography. 
 
        87 
Scheme 5.3-5. Reagents and conditions: a) cis-[Ru(bpy)2Cl2] (1.0 eq), µW, EtOH, 140 °C, 1 h; 
b) NH4PF6, 94%. 
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Scheme 5.3-6. Reagents and conditions: a) 89 (1.03 eq), µW, EtOH, 140 °C, 1 h; b) NH 4PF6, 62%. 
5 COMPLEXES OF [RU(BPY)3]2+- TYPE BEARING PYRENE MOIETIES 
102 
 
5.4 Crystal Structures and Characterisation 
 
Single crystals of 84 suitable for X-ray analysis were obtained by layering ethyl acetate upon 
a dichloromethane and trifluoroacetic acid solution of 84. After several weeks, X-ray quality 
pale yellow plates of the unprotonated ligand had grown (the trifluoroacetic acid had 
evaporated). The structure of the centrosymmetric ligand is shown in Figure 5.4-1. 
Bond distances and angles within the bpy and pyrene rings are unexceptional. As expected, 
the ligand adopts a transoid conformation but flips to a cisoid arrangement upon binding to a 
metal ion. There is a surprisingly highly ordered geometry in the solid state. The two least 
squares planes of the two pyridine moieties perfectly overlap and are therefore in line. The 
same planarity is noticed for the two pyrene moieties having perfectly parallel least square 
planes. Moreover, the least square planes between one pyridine unit and one pyrene unit are 
twisted 45.1(1)° with respect to each other. Figure 5.4-1 illustrates the described geometrical 
features. 
 
Figure 5.4-1. Molecular structure of 84 depicted in capped stick representation. Hydrogen atoms have 
been omitted for clarity. a) Front view that displays the transoid arrangement of the nitrogen atoms; b) 
View along the two parallel least square planes of the pyrene moieties; c) View along the two in line 
least spare planes of the pyridine moieties. The angle between one pyrene least square plane and 
one pyridine least square plane is 45.1(1)°. 
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The packing of 84 is shown in Figure 5.4-2 and Figure 5.4-3. Contrary to expectations, no pi-
stacking was observed. A stacked formation in the crystal structure of pyrene was discovered 
by Robertson and White in 1947.[254] Simple aromatic residues often prefer to associate via 
enthalpically favourable edge to face C-H ··· pi interactions rather than to interact through 
parallel pi-pi stacking interactions.[255-258] Analysis of the close contacts in the packing of 84 
indicates that the stabilisation occurs over C-H ··· pi interactions within a distance of 260 pm 
between the hydrogen atom and the centre of mass of an aromatic ring from another molecule 
in proximity (see Figure 5.4-2). The least square planes in which the hydrogen atom and the 
centroid of the ring that form the non classical hydrogen bond are inscribed, span an angle of 
45°. The edge to face arrangements can also be seen as the origin of the known herringbone 
structure of crystalline benzene.[259-261] Figure 5.4-3a displays the view along the 
crystallographic a-axis, emphasising the herringbone structure of the packing pattern for 
ligand 84 similar to those found in the crystal structure of benzene.  
 
Figure 5.4-2. Molecular structure of 84 displaying the C-H ··· pi interactions between the individual 
molecules in the packing.  The distance between the hydrogen atoms (white dots) and the centroid 
(red dots) of the aromatic ring is 260 pm. The planes of the aromatic ring in the pyrene unit and the 
plane in which the hydrogen lies are tilted 45°. 
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Figure 5.4-3. Stacking of 84 in the solid state. a) View along the crystallographic a-axis with the 
herringbone pattern; b) View along the crystallographic b-axis; c) View along the crystallographic c-
axis. Hydrogen atoms have been omitted for clarity. 
 
 
 
 
 
 
Single crystals of 87 and 88 suitable for X-ray analysis were grown by slow liquid diffusion at 
room temperature of diethyl ether to a solution of the complex in dimethylformamide or 
acetonitrile, respectively. The molecular structures of the heteroleptic ruthenium(II) 
complexes are shown in Figure 5.4-4. Bond lengths and bond angles appeared in the expected 
range. Both complexes exhibit distorted octahedral geometry around the metal centre with 
ruthenium-nitrogen bond lengths between 205.6(2) pm and 206.2(2) pm for 87 and between 
204.4(2) pm and 205.9(2) pm for 88. 
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Figure 5.4-4. Molecular structures depicted as capped stick representations as they were found in the 
single crystals of heteroleptic ruthenium(II) complex cations: a) 872+; b) 882+. Solvent molecules, 
counterions and hydrogen atoms have been omitted for clarity. 
 
Single crystals of 86 suitable for X-ray analysis were obtained by slow liquid diffusion of 
ethyl acetate into a solution containing the ruthenium(II) complex in dimethylformamide. The 
molecular structure is depicted in Figure 5.4-5a. Bond lengths and bond angles are 
unexceptional and ruthenium-nitrogen bond lengths were found between 205.1(3) pm and 
205.5(3) pm. The ligands wrap around the slightly distorted octahedral metal centre such that 
the pyrene moieties adopt an endo-conformation by pointing towards the metal centre. Views 
along the crystallographic axis of the spacefilling model are shown in Figure 5.4-5. Two intra-
molecular C-H ··· pi interactions between two ligands that have roughly perpendicular pyrene 
moieties were determined within a distance of 251.1(5) pm. The cation is chiral but the 
complex crystallized in the non-chiral space group C2/C and so both enantiomers are present in 
the unit cell. 
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Figure 5.4-5. a) Molecular structure of 86 depicted as capped stick representations as it was found in 
the single crystal. The fashion in which the ligands wrap around the metal centre is depicted by space-
filling representations and views along b) the crystallographic a-axis; c) the crystallographic b-axis; d) 
the crystallographic c-axis. Solvent molecules, counterions and hydrogen atoms have been omitted for 
clarity.  
 
Τhe bpy unit is planar in the free ligand 84 and has a transoid conformation. Upon 
coordination to ruthenium(II), it flips to an cisoid conformation with distortion to planarity up 
to 11.7(1)° allowing a chelating binding mode. The least square planes of the two pyrene 
moieties are parallel in 84 whereas in the ruthenium(II) complexes angles from 18.92(9)° to 
85.5(3)° were calculated. The results are summarized in Table 5.4-1. 
 
 
Table 5.4-1. Angles between selected least squares planes as they were found in the crystal 
structure. Values are given in [°]. 
plane 84 87 88 86 
py-py in bpy-
moiety 
0.00 
0.8(1), 2.7(1), 
7.22(8)[a] 
3.1(1), 10.8(1), 
11.7(1)[a] 1.6(2), 5.8(2) (2x)  
pyrene-pyrene 
moiety 
0.00 76.22(7) 18.92(9) 27.8(1) (2x), 
85.1(3) 
[a]
 angle in the coordinated ligand 84. 
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In contrast to the packing pattern of ligand 84, pi-stacking plays an important role in the 
packing of the ruthenium complexes 87, 88 and 86. In 87, one pyrene moiety participates in 
pi-stacking to the adjacent pyrene group of another complex molecule at a distance of 353 pm 
(distance of parallel least squares planes of the two pyrene units). These pyrene units form a 
stack of offset parallel planes with alternating distances of 353 pm and 711 pm (see Figure 
5.4-6a). The short contact analysis of 88 reveals that both pyrene groups interact via pi-
stacking at a rough distance of 365 pm in a nearly parallel displaced manner to neighbouring 
pyrene moieties, and also the bis(methoxyphenyl)bipyridine ligand exhibits stacking 
interactions at a distance of ca. 380 pm (see Figure 5.4-6b). There are pi-stacking interactions 
from all six pyrene groups of homoleptic complex 86 in a nearly parallel, but displaced, 
manner at a distance of 344 pm (see Figure 5.4-6c). 
 
 
Figure 5.4-6. Intermolecular packing interactions as they were found in the crystal structures of a) 87; 
b) 88; c) 86. Solvent molecules, counterions and hydrogen atoms have been omitted for clarity. 
 
At room temperature the 1H-NMR spectrum of 86 exhibits the expected resonances with 
appropriate integrals, but several peaks experience a considerable shift to lower frequency (up 
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to δ 6.88 ppm) and are broadened. In the protonated free ligand [84+H]+ and in the 
heteroleptic ruthenium(II) complexes 87 and 88, all resonances have sharp peak shapes and 
the protons from the pyrene moiety usually appear in the range of δ 8.5 ppm to δ 7.7 ppm. 
1H-NMR spectra of 86 were recorded at variable temperatures and assignments have been 
made with COSY and NOESY techniques (see Figure 5.4-7). At 295 K signals P9 and P8 are 
very broad (200 Hz and 80 Hz line width at half height) and signal P7 and P6 are broad 
(20 Hz line width at half height). Upon heating, the signals sharpen and at 355 K the fine 
structure of all peaks is resolved.  
The strong shift to lower frequencies and the broadness of some resonances deserve further 
note.  
 
Figure 5.4-7. Variable temperature 500 MHz NMR spectra in DMSO-d6 solutions of homoleptic 
ruthenium(II) complex 86. Proton labelling is given on the left and temperatures at which the spectra 
were recorded are given on the right. 
 
The crystal structure of 86 reveals the very close proximity of protons P7, P8 and P9 to a 
nearly perpendicular pyrene moiety. Facing the aryl pi-cloud, these protons experience a 
strong shielding effect and are therefore shifted upfield. Moreover, the pyrene groups are not 
equivalent by symmetry in the solid state and only fast rotation around the carbon-carbon 
bond that bridges the pyrene to the bpy unit will render them chemically equivalent. A slow 
rotation on the NMR time scale leading to coalescence of signals from conformationally 
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different units explains the broadness of the peaks. Upon heating, the signals sharpen and 
differences in the conformations are no longer distinguishable due to a fast rotation on the 
NMR timescale. 
The 1H-NMR spectrum of the homoleptic iron(II) complex [Fe(84)3](BF4)2 (85) displays a 
similar pattern most likely caused by the same effects as described for 86. 
More characterisation details (NMR, MS, IR, UV-Vis, emission, elemental analysis) for all 
compounds presented in this chapter are described in the experimental part of this thesis and 
are unexceptional. 
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5.5 Photophysical Properties 
The UV absorption and emission spectra of ligand 84 and its protonated form (84H+) in 
CH2Cl2 are shown in Figure 5.5-1. Comparison of the absorption and emission profiles with 
the spectra of pyrene allows the following proposed assignments. For 84, the strong 
absorption band at λ = 357 nm originates from a S0 → S2 transition and the weak shoulder at 
λ ≈ 420 nm might have its origin in a S0 → S1 transition. These transitions are red shifted by 
22 nm and 30 nm with respect to transitions in pyrene due to the extended conjugation. The 
emission at λmax = 444 nm is broad and was determined in a 10-5 M solution in CH2Cl2. Due to 
the poor solubility of 84, it is not possible to prepare solutions of higher concentration and 
study potential excimer formation. The solubility of 84 can be considerably enhanced by 
protonation and the intense band at λ = 357 nm is red shifted into the visible region of the 
spectrum with its maximum lying at λ = 454 nm. The solution changes colour upon 
protonation from pale yellow to intense red. The emission of the protonated form is orange 
with λmax = 609 nm. 
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Figure 5.5-1. Absorption and emission spectra of ligand 84 (Absorption black solid line, emission 
dotted black line) and the protonated ligand 84H+ (Absorption red solid line, emission dashed red line). 
 
 
The ruthenium(II) complexes 86, 87, 88 are bichromophoric species composed of pyrene and 
ruthenium(II) tris(diimine) domains. Table 5.5-1 summarized their steady-state spectroscopic 
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properties. The absorption and the emission spectra of 87 are depicted in Figure 5.5-2. The 
shoulder at λ ≈ 480 nm might be assigned as MLCT in nature, the band at λ = 405 nm can be 
a pi-pi*-transition from the pyrene domain or a MLCT transition. The emission profile of 87 
exhibits two emission peaks, with λem = 495 nm and λem = 645 nm, respectively. 
Identification of species displaying authentic dual emission can be difficult, as possible 
contributions from luminescent impurities have to be excluded. Ruthenium(II) complex 87 
exhibits clean NMR and mass spectra and correct elemental analysis. There is no indication of 
any impurities. The most likely impurities, ligand 84 and [Ru(bpy)3]2+, have their emission 
maxima at different wavelengths (see Table 5.5-1). 
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Figure 5.5-2. Absorption (black solid line) and emission (red dotted line) spectra of 87 in 10-5 M 
acetonitrile solutions. λexc = 355 nm. 
 
An excitation spectrum records the intensity of the emission at a fixed wavelength while the 
excitation monochromator is varied. In a “well-behaved” system, the absorption spectrum and 
the excitation spectrum (corrected for instrumentation factors) are expected to match. 
Excitation spectra of 87 in acetonitrile were measured for the two emissions, λem = 495 nm 
and λem = 645 nm, and are displayed in Figure 5.5-3. The emission at higher energy exhibits a 
maximum at λ = 356 nm in the excitation spectrum and is ascribed to the fluorescence 
properties of the pyrene domain. The orange emission shows a maximum at λ = 484 nm in the 
excitation spectrum and has its origin probably from an emission of the 3MLCT state. 
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Furthermore, it can be noticed that irradiation at λexc = 356 nm contributes mainly to emission 
at λem = 495 nm and to a smaller extent to an emission at λem = 645 nm. Excitation at 
λexc = 484 nm populates only the emissive 3MLCT level. These conclusions were verified by 
emission spectra with λexc = 356 nm and λexc = 484 nm, respectively. 
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Figure 5.5-3. Uncorrected excitation spectra of 87 in acetonitrile solution with λem = 495 nm (black 
solid line) and λem = 645 nm (red dotted line). Asterisks mark stray light  
 
The photophysical properties of heteroleptic ruthenium(II) complex 88 are described in Table 
5.5-1. 
The complexes 86 and 85 are isostructural and differ in the metal which is iron(II) or 
ruthenium(II). Another difference lies in their stability, as the iron(II) complex 85 decomposed 
in a DMSO solution and no such lability is expected, nor was found, for the corresponding 
ruthenium(II) complex 86. For 85, the optical properties are listed in Table 5.5-1 but should be 
considered with caution due to its instability in DMSO solutions and possible decomposition 
that will cause absorption and emission from the ligand. The absorption spectrum of 10-5 M 
solutions of 85 in acetonitrile showed a band at λ = 544 nm (ε = 8100 M-1 cm-1) which is 
responsible for the red colour of the compound and is diagnostic of the formation of a 
tris(bpy) iron(II) complex. The emission has its maximum at λ = 479 nm which is about 35 
nm red shifted compared to the free ligand, the emission of which was not detected in the 
solution. 
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Emission and absorption spectra of an acetonitrile solution of 86 are shown in Figure 5.5-4. 
The absorption pattern is comparable to those for 87 and 88 with a broad maximum at λ = 401 
nm. In contrast to 87, no emission from the 3MLCT occurs upon irradiation. The emission at 
λ = 476 nm most likely has its origin in fluorescence from an excited 1pyrene state. 
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Figure 5.5-4. Absorption (black solid line) and emission (red dotted line) spectra of 86 in 10-5 M 
acetonitrile solutions. λexc = 355 nm. 
 
 
The luminescence decay times were detected after irradiation at λirr =467 nm of air-
equilibrated and degassed samples in acetonitrile. The decay traces were mathematically 
analyzed according to an exponential decay law, I(t) = a1 exp(-t/τ1) + a2 exp(-t/τ2) + … 
providing τ = 5.0, 2.6, 4.1 µs for 87, 88 and 86. The decay traces did not fit to a mono-
exponential curve, and so bi-or tri-exponential expressions have been used instead. Lifetimes 
in Table 5.5-1 and Table 5.5-2 are listed for the slowest decay rate. The luminescence lifetime 
is roughly one order of magnitude longer in 87, 88 and 86 than in [Ru(bpy)3]2+.  
 
As in other examples in the literature[247, 249-253, 262-264], a lifetime increasing effect or “energy 
reservoir effect” attributable to the pyrene domains was observed. 
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Table 5.5-1. Parameters for photophysical properties in degassed acetonitrile solutions. 
 absorption emission 
 λmax/nm ε/(M-1 cm-1) λmax/nm Φ τ 
      
[Ru(bpy)3]2+[101] 450 18000 608 0.086 900 ns 
      
pyrene[227] 355 47000 377 n.d. 328 ns 
 
     
84[a] 357 55500 444 0.24 n.d. 
 
     
84H+[a] 432 14500 609 0.035 n.d. 
      
[Fe(84)3]2+ (852+) 544 8140 479 n.d. n.d. 
      
[Ru(84)3]2+ (862+) 401 43200 476 1.0 · 10-3 4.1(2) µs 
      
[Ru(84)(bpy)2]2+ 
(872+) 405 47700 
495 
645 
3.1 · 10-4 
3.0 · 10-3 
5.0(2) µs 
      
[Ru(84)(dmbp)2]2+ 
(882+) 403 40200 646 4.5 · 10
-3
 2.6(1) µs 
[a]in degassed CH2Cl2. 
 
In degassed acetonitrile solutions of ruthenium(II) complexes 87 and 88, the luminescence 
quantum yields obtained by using λexc = 450 nm gave Φ =3.0 · 10-3 and 4.5 · 10-3 for 
emissions around λ = 645 nm, respectively. Table 5.5-1 summarises all quantum yields. 
 
Table 5.5-2. Lifetime of the luminescence of selected ruthenium(II) complexes in degassed and air-
equilibrated acetonitrile solutions. 
 [Ru(bpy)3]2+[251] 86 87 88 
air-equilibrated 220 ns 160(10) ns 180(10) ns 200(10) ns 
O2-free 900 ns 4.1(2) µs 5.0(2) µs 2.6(1) µs 
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5.6 Summary and Outlook 
The preparation of symmetric ligand 84 which possesses a bpy domain and pyrene units 
linked over one carbon bond in the 5 and 5'-positions is described. The compound changes 
colour upon protonation from pale yellow to red and the maximum of the luminescence is 
considerably shifted. The bpy domain can therefore be used for protonation and obviously 
also for coordination to a metal ion. Particular output signals can be addressed by external 
stimuli and this makes this compound a promising building block for molecular logic 
elements.[265]  
The coordination behaviour of ligand 84 was initially demonstrated by two homoleptic 
complexes, [Fe(84)3](BF4)2 (85) and [Ru(84)3](PF6)2 (86), which are very similar in structure 
but different in their stability and inertness. The iron(II) complex 85 was thermodynamically 
unstable in solutions with non-innocent solvent molecules contrary to the expected behaviour 
of compounds of the [Fe(bpy)3]2+ type. The crystal structure of the isostructural ruthenium(II) 
complex 86 illustrated a sterically demanding environment with the three pyrene domains on 
either side of the complex with exceptionally short intramolecular C-H ··· pi interactions. In 
order to broaden the scope of the investigated compounds, two heteroleptic ruthenium 
complexes, [Ru(84)(bpy)2](PF6)2 (87, bpy = 2,2'-bipyridine) and [Ru(84)(bmpb)2](PF6)2 (88, 
bmpb = 5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine), were prepared and their crystal structures 
were studied. The photophysical properties of all the compounds were examined. Heteroleptic 
ruthenium(II) complex 87 was found to be dual emitting with emissions from excited pyrene 
and 3MLCT states upon irradiation at λexc = 355 nm, whereas excitation at λexc = 484 leads to 
exclusive emission from the 3MLCT state. For 86, only emission from a pyrene state was 
observed. It is therefore desirable to synthesise the ruthenium(II) complex with two 84 and 
one bpy ligand, [Ru(84)2(bpy)](PF6)2, which is assumed to display properties lying 
somewhere in between the two other complexes. Furthermore, advanced optical 
measurements such as transient spectroscopy and low temperature luminescence should 
reveal more features of these compounds. 
Analysis of the time resolved emissions indicated a significant increase in lifetimes for 
ruthenium(II) complexes decorated with pyrene units (86, 87, 88) compared to [Ru(bpy)3]2+. 
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6 Experimental Part 
6.1 General Experimental 
Chemicals 
The following chemicals were obtained commercially and were used without further 
purification: ammonium chloride (Aldrich), ammonium hexafluorophosphate (Alfa Aesar), 3-
bis(triphenylphosphino)propane nickel(II) chloride (Strem), barium hydroxide octahydrate 
(Aldrich), 1,1'-bis(diphenylphosphanyl)ferrocenedichloropalladium(II) (Aldrich), bromine 
(Aldrich), 2-bromobenzylamine (Alfa Aesar), 1-bromohexane (Aldrich), n-butyllithium in 
hexanes (1.6 M solution) (Aldrich), caesium carbonate (Lancaster), 2,5-dibromopyridine 
(Lancaster), 1,4-dichlorobenzene (Alfa Aesar), dichlorobis(triphenylphosphane)palladium(II) 
(Aldrich), 1,2-dimethoxyethane (Aldrich), ethyl diethoxyacetate (Aldrich), hexabutyldi-
stannane (Aldrich), first generation and second generation Grubbs’ and second generation 
Hoyveda-Grubbs’ catalysts (Aldrich), imidazole (Acros), iron(II) tetrafluoroborate hexa-
hydrate (Aldrich), lithium chloride (Merck), magnesium as ribbons (Riedel-de Haën), 
methanesulfonyl chloride (Acros), 4-methoxyphenylboronic acid (Aldrich), methyl lithium in 
hexane (1.6 M solution) (Acros), potassium carbonate (Prolabo), potassium hydroxide 
(Riedel-de Haën), potassium iodide (Prolabo), pyren-2-ylboronic acid (Aldrich), tetrabutyl-
ammonium fluoride trihydrate (Acros), tetrakis(triphenylphosphane)palladium(0) (Aldrich), 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate (Aldrich), thionyl chloride (Prolabo), 
triethylamine (Riedel de Haën), trifluoromethanesulfonic anhydride (Alfa Aesar) 
triisopropylsilyl chloride (Acros), trimethyl borate (Aldrich), tris(dibenzylideneacetone)di-
palladium(0) (Strem), potassium iodide (Prolabo), sulfuric acid (Riedel-de Haën), p-
toluenesulfonic acid monohydrate (Aldrich), ∆-TRISPHAT tetrabutylammonium salt 
(Aldrich), zinc powder (Fluka). 
 
Solvents 
All solvents were commercially available. For chromatography, technical grade solvents were 
destilled prior to use. Reactions were performed in solvents of reagents grade quality or 
better and in dry and oxygen free solvents if necessary. Solvents were dried either by 
distilling over sodium (THF and diethyl ether) or sodium hydride (dichloromethane), or on a 
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solvent purification system “Pure Solv MD-5” (using several columns) by Innovative 
Technology inc. 
For photophysical measurements, only HPLC quality solvents were used. 
 
Column chromatography, preparative layer chromatography and spot thin layer chromato-
graphy 
All silica column chromatography was performed using Merck silica gel 60 (0.063–0.200 
mm). Fluka aluminium oxide 17994 and Merck aluminium oxide 90 standardized were used 
in alumina columns and for filtrations. Preparative layer chromatography was performed on 
silica gel (PLC plates 20 x 20 cm, silica gel 60 F254, 2 mm, Merck) and aluminium oxide 
(PLC plates 20 x 20 cm, aluminium oxide 60 F254, 1.5 mm, Merck). Spot thin layer 
chromatography was performed on silica gel plates (POLYGRAM® SILG/UV254 and TLC 
silica gel 60 F254, Merck) and alumium oxide plates (TLC aluminium oxide 60 F254, neutral, 
Merck).  
 
Microwave reactor 
Microwave reactions were carried out in a Biotage Initiator 8 reactor with sealed tubes 
allowing pressures of up to 20 bars. 
 
NMR spectroscopy 
NMR spectra were recorded on Bruker AM250 (250 MHz), Bruker AVANCE 300 (300 
MHz), Bruker DPX400 (400 MHz), Bruker DRX500 (500 MHz) and on Bruker DRX600 
(600 MHz). For full assignments COSY, DEPT, HMBC, HMQC and NOESY experiments 
were recorded on the Bruker DRX500 by either V. Jullien or J. Beves or K. Harris or A. 
Hernandez-Redondo. The measurements on the Bruker DRX600 were conducted by D. 
Häussinger. J. Beves performed measurements at variable temperatures. 
1H and 13C spectra were recorded at 25 °C and chemical shifts are relative to residual solvent 
peaks (1H: CDCl3 7.26 ppm, CD2Cl2 5.32 ppm, DMSO-d6 2.50 ppm, acetone-d6 2.05 ppm, 
acetonitrile-d3 1.94 ppm, methanol-d4 3.31 ppm; 13C: CDCl3 77.00 ppm, CD2Cl2 54.00 ppm, 
DMSO-d6 39.51 ppm, acetone-d6 29.92 ppm, acetonitrile-d3 1.39 ppm, methanol-d4 49.15 
ppm). An external reference was used for 19F (CF35Cl3 in CDCl3) and 31P (H3PO4) spectra. 
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Mass spectrometry 
FAB (NBA matrix) and electron impact (EI) mass spectra were recorded by P. Nadig using 
Finnigan MAT 312 and VG 70-250 instruments, respectively. Electrospray ionisation (ESI) 
mass spectra were measured using Finnigan MAT LCQ or Bruker esquire 3000plus 
instruments. 
 
Infrared spectroscopy 
IR spectra were recorded on a Shimadzu FTIR-8400S spectrophotometer with neat samples 
using a golden gate attachment.  
 
Melting points 
Melting points were determined on a Stuart Scientific melting point apparatus SMP3. 
 
UV-Vis spectroscopy 
Electronic absorption spectra were recorded on Varian-Cary 5000 or on Agilent 8453 
spectrophotometers. 
 
Emission spectroscopy 
Emission spectroscopy was performed on a Shimadzu RF-5301 PC spectrofluorophotometer. 
The excitation and emission slits were kept as close as possible and prior to the 
measurements, blank samples of the solvent were measured to assure that the solvent does not 
emit as well. 
 
Lifetime measurements 
The lifetime of the fluorescence was measured with an Edinburgh Instruments mini-τ 
apparatus equipped with an Edinburgh Instruments EPL-475 picosecond pulsed diode laser 
(λexc = 467.0 nm, pulse width = 75.5 ps) with the appropriate wavelength filter. The same 
solutions as for the fluorescence measurements were used. 
 
Microanalysis 
The microanalyses were performed with a Leco CHN-900 microanalyser by W. Kirsch. 
 
Electrochemistry 
Electrochemical measurements were done on an Eco Chemie Autolab PGSTAT 20 using a 
glassy carbon working electrode, a platinum mesh for the counter electrode, and a silver wire 
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as the reference electrode. The redox potentials (E1/2ox, E1/2red [V]) were determined by cyclic 
voltammetry (CV) and by square wave and differential pulse voltammetry. The compounds 
were dissolved and measured in dry and degassed acetonitrile in the presence of 0.1 M [n-
Bu4N][PF6] unless otherwise stated. The scanning rate for the CV was 100 mV·s-1 in all cases 
and ferrocene (Fc) was added as an internal standard at the end of every experiment. 
 
Atomic absorption spectroscopy and atomic emission spectroscopy 
Measurements were performed on a Shimadzu AA-6300 atomic absorption spectrophoto-
meter using a flame (acetylene/air) to atomise the samples. A sodium hallow cathode lamb 
(lamb current 12 mA, wavelength 489 nm, slit width 0.2 nm) was used as radiation source. 
The fuel gas flow rate was kept at 1.8 L/min and the support gas rate was kept at 15.0 L/min. 
 
X-ray diffraction 
The determination of the cell parameters and the collection of the reflection intensities of the 
single crystals were performed on an Enraf-Nonius Kappa CCD diffractometer (graphite 
monochromated MoKα radiation) by M. Neuburger or on a Stoe IPDS instrument by J. 
Zampese. For the data reduction, solution and refinement, the programs COLLECT,[266] 
DENZO/SCALEPACK,[267] SIR92,[268] Stoe IPDS software,[269] SHELXL97[270] and 
CRYSTALS (version 12)[271] were used by either M. Neuburger or S. Schaffner or J. 
Zampese. Structures have been analysed using Mercury v. 1.4.2.[199] 
 
 
Quantum yields 
Luminescence quantum yields Φ were obtained by using equation 1, [Ru(bpy)3]2+ as standard 
(R, ΦR = 0.028 in air-equilibrated water)[272] for emissions around 620 nm and coumarin 307 
(R, ΦR = 0.95 in methanol)[273] as standard for emissions around 470 nm. 
 
Φ = ΦR x Int/IntR x AR/A x n2/nR2  (1) 
 
The area of the luminescence (Int) was calculated from spectra on an energy scale, n is the 
refractive index for the solvent (nwater = 1.333, nMeCN = 1.3442, nMeOH = 1.329, nDCM = 1.4242) 
and AR and A are absorbance values for the reference or the compound, respectively. 
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6.2 Experimental for Compounds in Chapter 1 
 
Sodium 2,2-diethoxyacetate (12) 
 
 
12 
Ethyl 2,2-diethoxyacetate (115 g, 650 mmol) and NaOH (26.0 g, 650 mmol) were dissolved 
in 150 mL H2O and 250 mL EtOH. The suspension was heated to reflux for 5 hours. 
Evaporation of solvents yielded pure 12 (110 g, 646 mmol, 99%) as a colourless solid. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 6.48 (s, 1H, CH), 3.61-3.51 (m, 4H, CH2), 1.18 (t, 
3J = 7.0 Hz, 6H, CH3). 
 
N-(2-Bromobenzyl)-2,2-diethoxyacetamide (14) 
 
 
14 
Sodium 2,2-diethoxyacetate (12) (22.8 g, 134 mmol) was dissolved in 100 mL dry diethyl 
ether. To the ice-cooled suspension was added drop wise SOCl2 (15.9 g, 134 mol) over 
10 min. The reaction mixture was heated to reflux for 30 min. In the meantime a solution of 
50 mL pyridine, 80 mL toluene and (2-bromophenyl)methanamine (25 g, 134 mmol) was 
prepared. The latter solution was then transferred over 30 min to the in situ-formed acid 
chloride and stirred for 1 h at 0 °C. Ice-cooled water (250 mL) was added and the organic 
layer was separated. The aqueous phase was extracted with toluene (2 × 100 mL) and the 
combined organic phases were washed with 2% HCl (150 mL) and water (150 mL). The 
solvents were removed in vacuo yielding 14 (30.7 g, 97.1 mmol, 72 %) as a colourless oil.   
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1H-NMR (300 MHz, CDCl3): δ/ppm = 7.55 (dd, J = 1.3, 7.9 Hz, 1H, H1), 7.38 (dd, J = 1.8, 
7.7 Hz, 1H, H4), 7.29 (td, J = 1.3, 8.0 Hz, 1H, H2), 7.15 (td, J = 1.8, 7.7 Hz, 1H, H3), 7.08 (sb, 
1H, NH), 4.83 (s, 1H, CH), 4.55 (d, J = 6.2 Hz, 2H, CH2NH), 3.75-3.56 (m, 4H, OCH2), 1.24 
(t, J = 6.9 Hz, 6H, CH3). 
 
8-Bromo-isoquinoline-3-ol (15) 
N
OH
Br
1
45
6
7
 
15 
N-(2-Bromobenzyl)-2,2-diethoxyacetamide (14) (7.20 g, 22.7 mmol) was dissolved in 30 mL 
concentrated H2SO4 (95%) at 5 °C. The reaction mixture was stirred at room temperature for 
16 h. Water (350 mL) was added under ice-cooling, a brown polymeric residue removed and 
the solution was neutralized to pH 7 with NH3 (aq, 33%). The yellow precipitate was 
recrystallized in 150 mL EtOH (dissolved EtOH, filtered hot to remove a colourless 
impurity). The desired product 15 formed fine, yellow crystals (1.61 g, 7.19 mmol, 32%).  
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 9.08 (s, 1H, H1), 7.63-7.54 (m, 2H, H5+7), 7.37(t, 1 H, 
H6), 6.99 (s, 1H, H4). 
 
8-Bromoisoquinoline-3-(trisisopropyl)silyl ether (16) 
 
16 
Imidazole (340 mg, 5.00 mmol) was added to a solution of 8-bromo-isoquinoline-3-ol (15) 
(448 mg, 2.00 mmol) and trisisopropylchlorosilane (463 mg, 2.40 mmol) in dry DMF 
(50 mL). The mixture was stirred for 3 h, diluted with 5% aqueous NaHCO3 (200 mL) and 
extracted twice with CH2Cl2 (30 mL). The combined organic extracts were washed with water 
and the solvents removed in vacuo. Filtration over SiO2 (pentane : diethyl ether (10:1)) 
yielded 623 mg (1.64 mmol, 82%) of a colourless solid. 
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1H-NMR (300 MHz, CDCl3): δ/ppm = 9.20 (s, 1H, H1), 7.65-7.55 (m, 2H), 7.37-7.32 (m, 1H), 
6.96 (s, 1H, H4), 1.50-1.40 (m, 3H, CH), 1.13 (d, J = 7.3 Hz, 18 H, CH3).  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 178.0, 160.0, 150.3, 141.0, 130.2, 127.9, 125.4, 
122.5, 103.9, 18.0 (CH3), 12.6 (CH).  
MS (ESI): m/z = 380.1 [16 + H+] (calc. 380.1). 
 
4-Methoxyphenylboronic acid  
B(OH)2
OMe
1
2
 
 
To a slight excess of Mg (3.60 g, 149 mmol) activated with a grain of I2 in 50 mL dry THF 
was added drop wise 4-bromoanisole (16.9 mL, 135 mmol) in 50 mL dry THF to maintain 
slight reflux. The reflux was continued under argon for additional 45 min. The cooled solution 
was transferred to a degassed solution of trimethyl borate (30 mL, 264 mmol) in 250 mL of 
dry THF at –78 °C. The reaction mixture was stirred for 2 h and then allowed to warm at 
room temperature before hydrolysis with 300 mL of 4M hydrochloric acid. The solvents were 
removed and the milky precipitate was taken in 300 mL water and 300 mL diethyl ether. The 
organic phase was extracted twice with 200 mL 1M NaOH. The combined aqueous extracts 
were acidified to pH 1 with 37% HCl before extraction with two portions of diethyl ether 
(200 mL). The solvents were evaporated in vacuo to yield a white solid (12.6 g 82.9 mmol, 
62%). 
 
1H-NMR (300 MHz, acetone/D2O (~3:1)): δ/ppm = 7.73 (d, J = 8.5 Hz, 2H, H1), 6.84 (d, 
J = 8.6 Hz, 2H, H2), 3.74 (s, 3H, CH3). 
 
1,4-Dihexylbenzene  
 
 
N-Hexyl-1-bromide (70 mL, 500 mmol) in 50 mL dry diethyl ether was added drop wise, over 
30 min, to a suspension of Mg (13.4 g, 550 mmol) in 100 mL dry diethyl ether to maintain 
slight reflux. After complete addition, the solution was refluxed for additional 30 min. The n-
CHAPTER 6 
124 
hexylmagnesium bromide, cooled to room temperature was transferred, over 30 min, to an 
ice-cooled and stirred mixture of 1,4-dichlorobenzene (29.4 g, 200 mmol) and [(dppp)Cl2Ni] 
(108 mg, 200 µmol) in dry diethyl ether (200 mL). The cooling bath was removed and the 
solvent began to boil after an induction period of about 1 h. The mixture was then refluxed 
over night, cooled to 0 °C and quenched carefully with water (10 mL), followed by 2M HCl 
(100 mL). After separation of the layers, the aqueous phase was extracted with diethyl ether 
(2 × 50 mL), and the combined organic phases were washed with water (50 mL) and dried 
(MgSO4). The solvent was removed to yield the crude but analytically pure title compound 
151 (48.2 g, 196 mmol, 98%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 7.09 (s, 4H, Harom), 2.57 (t, 3J = 7.7 Hz, 4H, Ha), 1.65-
1.52 (m, 4H, Hb), 1.37-1.26 (m, 12H, Hc+b+e), 0.89 (t, 3J = 7.1 Hz, 6H, Hf). 
 
1,4-Dibromo-2,5-dihexylbenzene (9) 
 
9 
Bromine (67.1 g, 420 mmol) was added drop wise, over 30 min, to a stirred and ice-cooled 
solution of 1,4-dihexylbenzene (151) (49.3 g, 200 mmol) and iodine (~500 mg, 0.01 eq) under 
rigorous exclusion of light. After 1 d at room temperature, 20% aqueous KOH solution (100 
mL) was added and the mixture was shaken under slight warming until the colour 
disappeared. The mixture was then cooled to room temperature, the aqueous solution was 
decanted and the remaining residue was recrystallized from EtOH to yield title compound 9 
(65.9 g, 163 mmol, 82%) as colourless crystals. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 7.35 (s, 2H, Harom), 2.64 (t, J = 7.7 Hz, 4H, Ha), 1.60-
1.49 (m, 4H, Hb), 1.41-1.24 (m, 12H, Hc+d+e), 0.90 (t, 3J = 7.1 Hz, 6H, Hf). 
 
4-Bromo-2,5-dihexyl-4'-methoxybiphenyl (10) 
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10 
1,4-Dibromo-2,5-dihexylbenzene (9) (23.9 g, 59.2 mmol), 4-methoxyphenylboronic acid 
(4.50 g, 29.6 mmol) and Na2CO3 (5.02 g, 47.4 mmol) were dissolved in 800 mL toluene, 150 
mL EtOH and 50 mL H2O. The solution was degassed with argon (30 min) before addition of 
[Pd(PPh3)4] (867 mg, 750 µmol). The reaction mixture was heated to reflux for 16 h, extracted 
twice with water (200 mL) and purified by column chromatography (SiO2, 0.4% ethyl acetate 
in pentane) to yield title compound 10 (10.1 g, 23.4 mmol, 79%) as a colourless oil.  
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 7.41 (s, 1H, H1), 7.19 (d, J = 8.8 Hz, 2H, H3), 7.01 (s, 
1H, H2), 6.93 (d, J = 8.8 Hz, 2H, H4), 3.85 (s, 3H, OCH3), 2.68 (t, J = 7.7 Hz, 2H, Ha), 2.49 (t, 
3J = 7.7 Hz, 2H, Ha'), 1.65-1.52 (m, 2H, CH2), 1.46-1.11 (m, 14H, CH2), 0.88-0.75 (m, 6H, 
CH3).  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 158.6, 140.7, 140.0, 139.1, 133.5, 133.0, 131.8, 
130.2, 123.0, 113.5, 55.3 (OCH3), 35.8, 32.4, 31.7, 31.5, 31.1, 30.0, 20.2, 20.1, 22.6, 22.5, 
14.1 (2 CH3). 
MS (EI): m/z = 430.2 [10] (calc. 430.2). 
 
Boronic acid 11 
 
 
11 
Bromo compound 10 (4.28 g, 9.92 mmol) was dissolved in 500 mL anhydrous THF and 
cooled to –78 °C. N-Buthyllithium (12.4 mL, 1.6M solution in hexane, 19.8 mmol) was added 
drop wise to this solution. The reaction mixture was stirred over a period of 2 h at this 
temperature whereby a slight yellow colouring was observed. Trimethyl borate (2.2 mL, 
19.8 mmol) was added, and the reaction mixture (now colourless) was stirred at room 
temperature over night. Hydrochloric acid (200 mL, 4M) was added and the solvents were 
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removed in vacuo. The white precipitate was dissolved in 150 mL diethyl ether and 150 mL 
water. The organic phase was separated and the solvent removed to yield a white solid 
(4.06 g, 10.3 mmol, quant.) which was used without further purification for the next step. 
 
1H-NMR (300 MHz, acetone/D2O (~6:1)): δ/ppm = 7.47 (s, 1H, H1), 7.17 (d, 3J = 8.8 Hz, 2H, 
H3)), 6.94 (d, 3J = 8.8 Hz, 2H, H4), 6.87 (s, 1H, H2), 3.79 (s, 3H, OCH3), 2.79 (t, J = 7.7 Hz, 
2H, Ha), 2.49 (t, J = 7.7 Hz, 2H, Ha'), 1.58-1.46 (m, 2H, CH2), 1.42-1.03 (m, 14H, CH2), 0.83-
0.72 (m, 6H, CH3). 
MS (ESI): m/z = 509.3 [11+ CF3CO2-] (calc. 509.4). 
 
Compound 18 
N
OMe
OH
1
45
6
7
8
9
10
11
a
b
c
d
e
f
 
18 
8-Bromo-isoquinoline-3-ol (15) (167 mg, 746 µmol), boronic acid 11 (340 mg, 859 µmol), 
potassium tert-butoxide (209 mg, 1.87 mmol) dissolved in 150 mL anhydrous 
dimethoxyethane. The solution was set under argon (30 min) before addition of [Pd(PPh3)4] 
(86.0 mg, 74.6 µmol) and heated to reflux over night. The residue was washed with CH2Cl2 
on SiO2 in order to remove less polar impurities. The crude product was used without further 
purifications for triflation. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 8.20 (s, 1H, H1), 7.50-7.48 (m, 2H), 7.35 (d, 
3J = 8.8 Hz, 2 H, H10)), 7.15 (s, 1 H), 7.05-6.99 (m, 4 H), 6.89 (s, 1 H), 3.86 (s, 3 H, OMe), 
2.57-2.49 (m, 2H, Ha), 2.40-2.19 (m, 2H, Ha'), 1.40-0.91 (m, 16H, Hb-e), 0.79 (t, J = 6.8 Hz, 
3H, Hf), 0.72 (t, J = 7.1 Hz, 3H, Hf').  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 162.0, 158.5, 142.7, 142.3, 141.4, 141.0, 138.3, 
137.8, 135.8, 134.2, 131.5, 131.0, 130.9, 130.3, 124.5, 124.2, 120.6, 113.5, 106.5, 55.3 
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(OCH3), 32.8, 32.6, 31.5, 31.3, 31.2, 29.2, 29.0, 25.6, 22.5, 22.4, 14.0 (CH2CH3), 13.0 
(CH2CH3). 
MS(ESI): m/z = 496.3 [18 + H+] (calc. 496.3). 
 
Trifluoro-methanesulfonic acid 8-(2,5-dihexyl-4'-methoxy-biphenyl-4-yl)-isoquinolin-3-yl 
ester (19) 
N
OMe
OTf
1
45
6
7
8
9
10
11
a
b
c
d
e
f
 
19 
Three steps 
Triisopropylsilyl ether 16 (6.77 g, 17.8 mmol) and boronic acid 11 (8.72 g, 22.0 mmol) were 
dissolved in 90 mL dimethoxyethane and 15 mL H2O. The solution was degassed with argon 
(30 min) before addition of [Pd(PPh3)4] (825 mg, 712 µmol) and Ba(OH)2·8 H2O (7.30 g, 
23.2 mmol)  and refluxed over night. The TIPS-protecting group was partially removed 
during the reaction. In order to complete the deprotection, the reaction mixture was 
evaporated to dryness, dissolved in 100 mL THF, TBAF·3H2O (6.18 g, 19.6 mmol) was 
added and the reaction mixture was stirred during a period of 30 min. The solution was 
concentrated to dryness and the residue was filtered on SiO2 (CH2Cl2 → CH2Cl2 : MeOH 
(9:1)) in order to remove less polar impurities. The crude phenol was dissolved in 250 mL 
anhydrous CH2Cl2 and 40 mL anhydrous NEt3. The solution was cooled to –10 °C and 
trifluoromethanesulfonic anhydride (4.5 mL, 26.7 mmol) were added slowly. The reaction 
mixture was stirred for 16 h at room temperature, washed with saturated NH4Cl and purified 
by column chromatography (SiO2, pentane:Et2O (20:1)) to provide triflate 19 (7.22 g, 65% 
with respect to 16) as a slightly yellow oil. 
 
The crude 18 was dissolved in 50 mL dry CH2Cl2 and 1.1 mL abs. NEt3. The solution was 
cooled to –78 °C and trifluoromethanesulfonic anhydride (270 µL, ~2 eq) were added slowly. 
The reaction mixture was stirred for 16 h at room temperature washed with saturated NH4Cl 
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and purified by column chromatography (SiO2, pentane:Et2O (10:1)) to provide triflate 19 
(176 mg, 280 µmol, 38% with respect to 15) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 8.81 (t, 4J = 0.8 Hz, 1H, H1), 7.93-7.81 (m, 2 H), 7.62-
7.56 (m, 2 H), 7.32 (d, J = 8.8 Hz, 2H, H10), 7.19 (s, 1 H), 7.10 (s, 1 H), 7.00 (d, 3J = 9.0 Hz, 
2H, H11), 3.89 (s, 3H, OMe), 2.58-2.55 (m, 2H, Ha), 2.42-2.28 (m, 2Ha'), 1.40-0.91 (m, 16H, 
Hb-e), 0.80 (t, J = 6.8 Hz, 3H, Hf), 0.73 (t, J = 7.1 Hz, 3H, Hf').  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 158.6, 152.4, 151.7, 141.7, 141.2, 138.6, 138.4, 
137.9, 135.4, 134.0, 131.4, 131.2, 131.0, 130.3, 129.3, 127.8, 126.0, 113.5, 110.6, 76.6 (CF3), 
55.3 (OCH3), 32.8, 32.6, 31.5, 31.3, 31.1, 29.7, 29.2, 28.9, 22.5, 22.3, 14.0 (CH2CH3), 13.9 
(CH2CH3).  
19F-NMR (282.4 MHz, CDCl3): δ/ppm = –73.4 (s).  
MS (ESI): m/z = 628.3 [19 + H+] (calc. 628.3). 
 
Biisoquinoline 20 
 
20 
Triflate 19 (1.68 g, 2.68 mmol), 1.75 g zinc (10 eq, activated by treatment of 20 g in 100 mL 
acetic acid for 1 h. After filtration the powder was washed three times with distilled water. It 
was dried under vacuum for 6 h at 120 °C), dry KI (1.78 g, 10.7 mmol) and [PdCl2dppf] (218 
mg, 268 µmol) were dissolved in 1.8 mL dry DMF and stirred for 16 h at 90 °C. The mixture 
was hydrolysed with 10% aqueous HCl (40 mL) and extracted with diethyl ether. The red 
solution was filtered three times over Al2O3 before purification by column chromatography 
(SiO2, pentane: Et2O (20:1)) to yield 20 (950 mg, 992 µmol, 74%) as a colourless solid. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 9.12 (s, 2H, H10), 8.94 (s, 2H, H3), 7.98 (d, 3J = 8.1 Hz, 
2H, H5), 7.76 (t, 3J = 7.5 Hz, 2H, H6), 7.52 (d, J = 7.6 Hz, 2H, H7), 7.36 (d, J = 7.7 Hz, 4H, 
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H18), 7.23 (s, 2H, H13/16), 7.20 (s, 2H, H13/16), 7.02 (d, J = 7.7 Hz, 4H, H19), 3.91 (s, 6 H, 
OCH3), 2.65-2.55 (m, 4H, Ha), 2.49-2.37 (m, 2H, Ha'), 2.36-2.22 (m, 2H, Ha''), 1.52-0.93 (m, 
32H, Hb-e), 0.82 (t, J = 7.2 Hz, 6H, Hf), 0.71 (t, J = 7.2 Hz, 6H, Hf').  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 158.6 (C20), 151.4 (C10), 149.8, 141.2, 140.6, 138.6, 
137.7, 136.9, 136.4, 134.4, 131.4, 130.9, 130.4 (C18), 130.0, 128.4 (C7), 127.6, 126.9 (C5), 
117.5 (C3), 113.5 (C19), 55.3, 32.9, 32.7, 31.5, 31.4, 31.3, 31.1, 29.2, 28.9, 22.5, 22.3, 14.0 
(CH3), 13.9 (CH3).  
MS (ESI): m/z = 957.6 [20 + H+] (calc. 957.6). 
 
Deprotected biisoquinoline 21 
N
HO
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21 
Biisoquinoline 20 (130 mg, 136 µmol) was refluxed in 5 g pyridinium chloride for 24 h. The 
mixture was cooled to 90 °C, water (20 mL) was added and the solution was neutralized with 
0.5M KOH to pH 7. The solution was extracted with CH2Cl2 (3 × 20 mL) and filtered over 
silica gel to yield a colourless solid (111 mg, 119 µmol, 96%). 
Pyridinium chloride was synthesised by drop wise addition of 108 mL HCl (37%) to 100 mL 
of pyridine at 0 °C. The product was dried under vacuum for 3 days. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 9.17 (s, 2H, H10), 8.96 (s, 2H, H3), 8.00 (d, 3J = 8.1 Hz, 
2H, H5), 7.78 (t, J = 7.5 Hz, 2 H, H6), 7.54 (d, J = 7.6 Hz, 2H, H7), 7.30-7.20 (m, 8H, 
H13+16+18), 6.96 (d, J = 7.7 Hz, 4H, H19), 6.30(sb, 2H, OH), 2.65-2.55 (m, 4H, Ha), 2.49-2.37 
(m, 2H, Ha'), 2.36-2.22 (m, 2H, Ha''), 1.52-0.93 (m, 32H, Hb-e), 0.81 (t, J = 7.2 Hz, 6H, Hf), 
0.71 (t, J = 7.2 Hz, 6H, Hf').  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 155.0, 151.4, 149.5, 141.4, 140.7, 138.6, 137.7, 
137.0, 136.2, 134.2, 131.4, 131.0, 130.5, 130.3, 128.7, 127.6, 127.0, 118.3, 115.2, 33.0, 32.7, 
31.5, 31.4, 31.2, 29.7, 29.3, 29.0, 22.5, 22.4, 14.1, 14.0. 
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MS (ESI): m/z = 929.6 [21 + H+] (calc. 929.6). 
 
Ligand 7 
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7 
Dihydroxy biisoquinoline 21 (782 mg, 842 µmol), 3-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)-
prop-1-ene (28) (859 mg, 3.45 mmol) and Cs2CO3 (1.12 g, 3.45 mmol) were dissolved in 50 
mL freshly distilled DMF. The reaction mixture was stirred for 16 h at 90 °C. Water (15 mL) 
was added, leading to a milky solution, which was extracted with CH2Cl2 (5 × 10 mL) and 
Et2O (3 × 40 mL). The combined organic layers were dried over Na2SO4 and the crude 
product was purified by column chromatography (SiO2, pentane: Et2O (20:1) → Et2O) to 7 
(794 mg, 620 µmol, 74%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 9.11 (s, 2H, H10), 8.93 (s, 2H, H3), 7.97 (d, J = 8.1 Hz, 
2H, H5), 7.75 (t, J = 7.5 Hz, 2H, H6), 7.51 (d, J = 7.6 Hz, 2H, H7), 7.33 (d, J = 8.8 Hz, 4H, 
H18), 7.21 (s, 2H, H13/16), 7.18 (s, 2H, H13/16), 7.02 (d, J = 8.8 Hz, 4H, H19), 6.02-5.84 (m, 2H, 
HD1), 5.33-5.16 (m, 4H, HD2), 4.22 (t, J = 5.1 Hz, 4H, HE1), 4.06-4.03 (m, 4H, HE7), 3.93(t, 
3J = 5.1 Hz, 4H, HE2), 3.79-3.58(m, 16H, HE3-E6), 2.64-2.54 (m, 4H, Ha), 2.49-2.37 (m, 2H, 
Ha'), 2.36-2.22 (m, 2H, Ha''), 1.52-0.75 (m, 38H, Hb-e, f), 0.70 (t, J = 7.3 Hz, 6H, Hf').  
13C-NMR (75.5 MHz, CDCl3): δ/ppm = 157.8, 151.5, 151.4, 149.4, 141.2, 140.6, 138.6, 
137.7, 134.8, 134.5, 131.4, 130.9, 130.3, 130.0 (2 C), 128.5, 128.4, 127.6, 127.0, 117.1, 
114.2, 72.3, 70.9, 70.8 (2 C), 69.9, 69.5, 67.5, 33.0, 32.7, 31.5, 31.3, 31.1, 29.7, 29.2, 29.0, 
22.5, 22.3, 14.1, 14.0.   
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MS (ESI) m/z = 1273.81 [7 + H+] (calc. 1273.8). 
 
2-(2-(2-(Allyloxy)ethoxy)ethoxy)ethanol (26) 
 
26 
Finely crushed potassium hydroxide (56.1 g, 1.00 mol) and triethylene glycol (67.0 mL, 
500 mmol) were put in a 500 mL flask. Allyl bromide (10.5 mL, 100 mmol) was added drop 
wise to the suspension at 90 °C. The heating was continued after complete addition for 3 h at 
90 °C. To the cooled solution was added 250 mL water. The aqueous phase was extracted 
with toluene (3 × 30 mL) to remove the bis-allyl product. The aqueous phase was then 
extracted with CH2Cl2 (3 × 100 mL) to isolate the analytically pure mono-allyl alcohol 26 
(7.34 g, 38.6 mmol, 39%) as a light yellow oil after solvent removal. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 5.93-5.78 (m, 1H, Hh), 5.24-5.15 (m, 2H, Hi), 3.95 (dt, 
J = 5.7, 13.1 Hz, 2H, Hg), 3.70-3.55 (m, 12H, Ha,b,c,d,e,f), 2.55 (sb, OH). 
 
2-(2-(2-(Allyloxy)ethoxy)ethoxy)ethyl methanesulfonate (27) 
 
27 
A degassed solution of 26 (7.34 g, 49.5 mmol) in anhydrous CH2Cl2 (200 mL) in presence of 
freshly distilled NEt3 (41.4 mL, 297 mmol) was placed at –10 °C in a two-necked flask 
equipped with an argon gas inlet and a dropping funnel. Mesyl chloride (5.75 mL, 74.3 mmol) 
in anhydrous CH2Cl2 (30 mL) was slowly added to the mixture. The reaction was followed by 
TLC until complete disappearance of the starting materials (4 h). The solution was washed 
with water (4 × 100 mL) and the combined organic phases were extracted with CH2Cl2 
(50 mL). The organic phases were combined, dried over MgSO4 and the solvent was 
evaporated. The crude product was purified by column chromatography (Al2O3, CH2Cl2) to 
give title compound 27 (8.59 g, 38.0 mmol, 77%) as a slightly yellow oil.  
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1H-NMR (300 MHz, CDCl3): δ/ppm = 6.02-5.94 (m, 1H, Hh), 5.36-5.09 (m, 2H, Hi), 4.33-
4.30 (m, 2H, Ha), 3.94 (td, 3J = 6.7, 1.5 Hz, 2H, Hg), 3.70 (mc, 2H, Hb), 3.61-3.49 (m, 8H, 
Hc,d,e,f), 3.06 (s, 3 H, CH3). 
 
3-(2-(2-(2-Bromoethoxy)ethoxy)ethoxy)prop-1-ene (28) 
 
28 
In a 500 mL two-necked flask equipped with a magnetic stirrer and a condenser was prepared 
a solution of the mesylate compound 27 (8.59 g, 40.0 mmol), lithium bromide (20.8 g, 
240 mmol) in acetone (200 mL, analytical grade). The reaction mixture was heated to reflux 
over night. The acetone was evaporated and the crude mixture was dissolved in CH2Cl2 and 
washed with water (3 × 50 mL). The organic phase was dried over MgSO4 and filtered. 
Evaporation of the solvent yielded the analytically pure bromide 28 (7.73 g, 36.6 mmol, 92%) 
as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ/ppm = 5.92-5.79 (m, 1H, Hh), 5.25-5.10 (m, 2H, Hi), 3.96 (td, 
J = 1.5, 5.5 Hz, 2H, Hg), 3.75 (t, J = 6.4 Hz, 2H, Hb), 3.65-3.53 (m, 8H, Hc,d,e,f), 3.41 (t, 
J = 6.3 Hz, 2H, Ha). 
 
[Fe(7)3][BF4]2 (22) 
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Ligand 7 (55.3 mg, 43.4 µmol) was dissolved in CH2Cl2 and [Fe(BF4)2·6 H2O] (14.6 mg, 
43.7 µmol) in MeOH was added and the solution turned immediately red. The solution was 
refluxed over night and purified by column chromatography (SiO2, Et2O→ Et2O: MeOH 
(20:1)) to yield a red solid (54.7 mg, 13.5 µmol, 93%). The 1H-NMR displayed a very 
complex spectrum due to an expected hindered rotation around the bond between the biphenyl 
part and the isoquinoline that renders the two sides different and gives rise to several isomers 
and desymmetrization. ESI-MS showed one peak of the double charged product and on TLC 
only one spot was seen. 
 
MS (ESI): m/z = 1938.2 [Fe(7)3]2+ (calc. 1938.2). 
 
Grubbs’ reaction (23) 
N
O
N
O
9
3
5 6
7
8
13
1211
a
b
c
d
e f
2
4
10
1415
16
17
18
19
20
O
O
O
O
O
O
E1
E2
E3
E4
E5
E6
E7
D
Fe1/3
2 BF4
2
 
23 
The iron complex 22 (150.0 mg, 37.0 µmol) was dissolved in 185 mL freshly distilled CH2Cl2 
(2·10-4M solution) and Grubbs catalyst (1st generation) (45.7 mg, 55.5 µmol) were added. The 
reaction mixture was stirred at room temperature over a period of 7 days under argon 
atmosphere. Every second day 30 mg of catalyst was added. The reaction was quenched with 
ethoxyethene (2 mL) and purified twice with column chromatography (SiO2, Et2O→ Et2O: 
MeOH (20:1)) leading to 153 mg of the crude product. The 1H-NMR spectrum showed the 
disappearance of the terminal allyl signals and one new broad singlet at δ 5.88 ppm that 
corresponds to the newly formed double bond. 
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Hydrogenation (24) 
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24 
The iron complex 23 (150 mg, 37.0 µmol) was dissolved in 20 mL CH2Cl2 and 30 mg of Pd/C 
(10% Pd) was added. Hydrogen gas was bubbled through the solution during a period of 8 h. 
The solution was filtered over Celite yielding after evaporation of the solvent 152 mg of a red 
solid. The 1H-NMR showed no longer the peak at δ 5.88 ppm. 
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6.3 Experimental for Compounds in Chapter 2 
 
5,5'-Dibromo-2,2'-bipyridine (32) 
 
 
32 
To a flask evacuated and put under Nitrogen, 2,5-dibromopyridine (16.2 g, 69.0 mmol) was 
dissolved in abs. toluene (500 mL) and n-Bu6Sn2 (20.0 g, 34.5 mmol) was added. Nitrogen 
was bubbled through the stirred solution for 1 h before [Pd(Ph3)4] (1.60 g, 1.38 mmol) was 
added. The reaction mixture was refluxed during 3 d until all starting material was consumed 
(TLC control). To the reaction mixture a NaOH-solution (0.1M, 400 mL) was added and the 
organic phase was separated. The water phase was extracted with CH2Cl2 (3 × 100 mL). The 
combined organic phases were dried over Na2SO4. After chromatography (SiO2, CH2Cl2) 
compound 32 could be isolated as a colourless solid (8.5 g, 27.2 mmol, 79%). 
 
An alternative synthesis starts with 2,2'-bipyridine (3.43 g, 22.0 mmol) which was dissolved 
in HBr (48%). The reaction mixture was reduced to dryness. The precipitate formed was 
collected and dried in vacuum (99%). The latter and bromine (7.0 g, 43.8 mmol were placed 
in a sealed tube and heated to 180 °C during 72 h. The mixture was then allowed to cool and 
the hard solid was powdered and treated with Na2SO3 to remove unreacted bromine, then 
basified with sodium hydroxide solution (500 mL, 3M). Chromatography (SiO2, CH2Cl2) 
yielded 4.11 g (13.1 mmol, 21%) 32. 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.70 (d, 4J = 2.8 Hz, 2H, H6), 8.27 (d, 3J = 8.8 Hz, 2H, 
H3), 7.93 (dd, 3J = 8.8 Hz, 4J = 2.8 Hz, 2H, H4).  
13C-NMR (100.6 MHz, CDCl3): δ/ppm = 153.7, 150.3, 139.6, 122.2, 121.4.  
MS (EI): m/z = 313.9 [32 + H+] (calc. 313.9).  
IR (ATR): ν∼/cm-1 = 3049w, 2920w, 2850w, 1537m, 1454m, 1356s, 1084s, 858s.  
Anal. calc. for C10H6N2Br2 C 38.25, H 1.93, N 8.92; found C 38.20, H 1.91, N 8.82. 
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5,5'-Bis(3-methoxyphenyl)-2,2'-bipyridine (34) 
 
34 
3-Methoxyphenylbononic acid (33) (3.63 g, 23.9 mmol) was added to 5,5'-dibromo-2,2'-
bipyridine (32) (3.00 g, 9.55 mmol) followed by toluene (200 mL), Na2CO3 (5.06 g, 
47.8 mmol) and water (70 mL). The biphasic mixture was then degassed for 20 min by 
bubbling nitrogen through the solution. [Pd(PPh3)4] (500 mg, 432 µmol) was added and the 
mixture was heated to reflux for 20 h. After cooling to room temperature, the phases were 
separated and the aqueous layer extracted with CH2Cl2 (3 × 50 mL). The organic extracts 
were combined and dried with MgSO4. After purification via chromatography (SiO2, CH2Cl2 : 
MeOH (100:1)) a colourless solid (3.28 g, 8.90 mmol, 90%) could be isolated.  
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 8.94 (d, 4J = 2.8 Hz, 2H, HA6), 8.51 (d, 3J = 8.2 Hz, 
2H, HA3), 8.04 (dd, 3J = 8.2 Hz, 4J = 2.4 Hz, 2H HA4), 7.40 (t, 3J = 7.8 Hz, 2H, HB5), 7.26 (dd, 
3J = 7.8 Hz, 4J = 2.4 Hz, 2H, HB6), 7.19 (d, 4J = 2.3 Hz, 2H, HB2), 6.98 (dd, 3J = 7.9 Hz, 
4J = 2.1 Hz, 2H, HB4), 3.90 (s, 6 H, OMe).  
13C-NMR (100.6 MHz, CDCl3): δ/ppm = 160.2, 154.3, 147.5, 138.9, 136.5, 135.5, 130.2, 
121.1, 119.5, 113.6, 112.8, 55.4.  
MS (EI): m/z = 368.2 [M+] (calc 368.2).  
IR (ATR): ν∼/cm-1 = 3007w, 2939w, 2839w, 1595s, 1501m, 1460m, 1429m,1367m, 1305m, 
1236m, 1224s, 1045m, 1028m, 864m, 694s. 
 Anal. calc. for C24H20N2O2 C 78.24 H, 5.47, N 7.60, O 8.69;.Found C 78.03, H 5.48, N 7.56.  
 
3,3'-(2,2'-Bipyridine-5,5'-diyl)diphenol (35) 
 
 
35 
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Pyridinium chloride (30 g) and 5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine (34) (2.15 g, 5.84 
mmol) were refluxed during 4 h. The reaction mixture was allowed to cool to 120 °C, when 
water (300 mL) was added. The solution was neutralized to pH 7 with NaHCO3. The product 
35 was filtered off, washed with water and ether and dried to yield a pale yellow powder (2.16 
g, 6.35 mmol, 98%). 
 
1H-NMR (400 MHz, DMSO-d6): δ/ppm = 9.87 (sb, 2 OH), 8.97 (d, 4J = 2.8 Hz, 2H, HA6), 
8.50 (d, 3J = 8.2 Hz, 2H, HA3), 8.21 (dd, 3J = 8.1 Hz, 4J = 2.2 Hz, 2H, HA4); 7.33 (t, 
3J = 8.0 Hz, 2H, HB5); 7.23 (d, 3J = 7.8 Hz, 2H, HB6); 7.16 (d, 4J = 2.3 Hz, 2 HB2); 6.86 (dd, 
3J = 7.8 Hz, 4J = 2.2 Hz, 2 HB4).  
13C-NMR (100.6 MHz, DMSO-d6): δ/ppm = 158.0, 153.1, 146.9, 137.7, 135.9, 135.4, 130.2, 
120.7, 117.5, 115.4, 113.5.  
MS (EI): m/z = 340.1 [M+] (calc. 340.1).  
IR (ATR): ν∼/cm-1 = ~3100br, 1585s, 1470s, 1443m, 1371m, 1325m, 1312m, 1298m, 1196s, 
1151w, 1072w, 1020m, 997m, 889m, 823m, 777m, 736m, 679s. 
Anal. calc. for C22H16N2O2·1.5 H2O C 71.92 H 5.21 N 7.62; found C 72.13 H 4.81 N 7.55. 
 
2-(Allyloxy)ethanol (36) 
 
Finely crushed potassium hydroxide (84.2 g, 1.50 mol) and ethylene glycol (83.0 mL, 
1.50 mol) were put in a 500 mL flask. Allyl bromide (64.9 mL, 750 mmol) was added drop 
wise to the suspension at 80 °C. The heating was continued after complete addition for 2 h at 
80 °C. To the cooled solution was added 1 L water. The aqueous phase was extracted with 
toluene (3 × 30 mL) to remove the bis-allyl product (22.6 g, 21%). The aqueous phase was 
then extracted with CH2Cl2 (3 × 100 mL) to isolate the analytically pure mono-allyl alcohol 
36 (26.9 g, 263 mmol, 35%) as a light yellow oil after solvent removal. 
 
1H NMR (400 MHz, CDCl3) δ/ppm =  5.99 – 5.80 (m, 1H, Hd), 5.28 (dq, J = 1.6, 17.2 Hz, 1H, 
He, trans), 5.19 (ddd, J = 1.2, 2.9 Hz, 10.4 Hz, 1H, He, cis), 4.05 – 4.01 (m, 2H, Hc), 3.76 – 3.71 
(m, 2H), 3.57 – 3.52 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ/ppm =  134.48 (Cd), 117.24 (Ce), 72.10, 71.26, 61.80. 
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IR (ATR): ν∼/cm-1 = 3279mbroad, 3086mbroad, 2924m, 2862m, 1643m, 1543w, 1420m, 1350w, 
1258w, 1211w, 1111s, 1065s, 995m, 926m, 887w, 833w. 
 
2-(Allyloxy)ethyl methanesulfonate (38) 
 
A degassed solution of 36 (16.5 g, 162 mmol) in anhydrous CH2Cl2 (200 mL) in presence of 
freshly distilled NEt3 (100 mL) was placed at –78 °C in a two-necked flask equipped with an 
argon gas inlet and a dropping funnel. Mesyl chloride (20.0 mL, 258 mmol) in anhydrous 
CH2Cl2 (30 mL) was slowly added to the mixture. The reaction was followed by TLC until 
complete disappearance of the starting materials (4 h).  The solution was washed with water 
(4 × 100 mL) and the combined organic phases were extracted with CH2Cl2 (2 × 100 mL). 
The organic phases were combined, dried over MgSO4 and the solvent was evaporated 
yielding analytically pure 38 (27.8 g, 154 mmol, 95%) as a pale yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ/ppm =  5.94 – 5.82 (m, 1H), 5.28 (dq, J = 1.6, 17.2 Hz, 1H), 
5.20 (ddd, J = 1.3, 2.8, 10.4 Hz, 1H), 4.38 – 4.34 (m, 2H), 4.05 – 4.01 (m, 2H), 3.72 – 3.67 
(m, 2H), 3.04 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm =  133.94, 117.61, 72.13, 69.12, 67.70, 37.62. 
 
3-(2-Bromoethoxy)prop-1-ene (40) 
 
A solution of the mesylate compound 38 (27.8 g, 154 mmol), lithium bromide (67.0 g, 
771 mmol) in acetone (500 mL, analytical grade) was prepared in a 1 L two-necked flask 
equipped with a magnetic stirrer and a condenser. The reaction mixture was heated to reflux 
over night. The acetone was evaporated and the crude mixture was dissolved in CH2Cl2 
(250 mL) and washed with water (3 × 100 mL). The organic phase was dried over MgSO4 and 
filtered. Evaporation of the solvent yielded the analytically pure bromide 40 (13.5 g, 
81.8 mmol, 53%) as a yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ/ppm =  5.91 – 5.77 (m, 1H, Hd), 5.24 (dd, J = 1.6, 17.2 Hz, 1H, 
He, trans), 5.14 (ddt, J = 1.2, 1.7, 10.4 Hz, 1H, He, cis), 3.99 (ddd, J = 0.8, 2.0, 5.6 Hz, 2H, Hc), 
3.69 (t, J = 6.2 Hz, 2H), 3.41 (t, J = 6.2 Hz, 2H). 
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13C NMR (101 MHz, CDCl3) δ/ppm =  134.08 (Cd), 117.16(Ce), 71.72, 69.67, 30.23(Ca). 
IR (ATR): ν∼/cm-1 = 3078w, 2970m, 2854m, 1728m, 1574w, 1458m, 1420m, 1350m, 1281m, 
1219m, 1095s, 987m, 926s. 
b.p.: 55-60 °C (1 mbar). 
Anal. calc. for C5H9BrO C 36.39 H 5.50; found C 36.43 H 5.43. 
 
2-(2-(Allyloxy)ethoxy)ethanol (37) 
 
 
37 
Finely crushed potassium hydroxide (52.1 g, 929 mmol) and diethylene glycol (68.0 mL, 
743 mmol) were put in a 500 mL flask. Allyl bromide (32.4 mL, 372 mmol) was added drop 
wise to the suspension at 90 °C. The heating was continued after complete addition for 3 h at 
90 °C. To the cooled solution was added 1 L water. The aqueous phase was extracted with 
toluene (3 × 30 mL) to remove the bis-allyl product (13.9 g, 20%). The aqueous phase was 
then extracted with CH2Cl2 (3 × 100 mL) to isolate the analytically pure mono-allyl alcohol 
37 (22.7 g, 155 mmol, 42%) as a light yellow oil after solvent removal. 
 
1H-NMR (400 MHz, CDCl3): δ/ppm = 5.97-5.84 (m, 1 Hf), 5.31-5.17 (m, 2 Hg), 4.03 (dt, 
3J = 6.0 Hz, 4J = 1.6 Hz, 2 He), 3.74 (mc, 2 H), 3.69-3.66 (m, 2 H), 3.63-3.59 (m 4 H).  
13C-NMR (100.6 MHz, CDCl3): δ/ppm = 134.5, 117.4, 72.5, 72.3, 70.4, 69.4, 61.8.  
 
2-(2-(Allyloxy)ethoxy)ethyl methanesulfonate (39) 
 
39 
A degassed solution of 37 (22.2 g, 152 mmol) in anhydrous CH2Cl2 (250 mL) in presence of 
freshly distilled NEt3 (150 mL) was placed at –78 °C in a two-necked flask equipped with an 
argon gas inlet and a dropping funnel. Mesyl chloride (20.0 mL, 258 mmol) in anhydrous 
CH2Cl2 (30 mL) was slowly added to the mixture. The reaction was followed by TLC until 
complete disappearance of the starting materials (4 h).  The solution was washed with water 
(4 × 100 mL) and the combined organic phases were extracted with CH2Cl2 (2 × 100 mL). 
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The organic phases were combined, dried over MgSO4 and the solvent was evaporated 
yielding analytically pure 39 (33.0 g, 147 mmol, 96%) as a pale yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ/ppm = 5.95 – 5.84 (m, 1H), 5.30 – 5.24 (m, 1H), 5.19 (ddd, 
J = 1.2, 2.9, 10.4 Hz, 1H), 4.40 – 4.36 (m, 2H), 4.01 (ddd, J = 1.4, 3.1, 5.7 Hz, 2H), 3.80 – 
3.76 (m, 2H), 3.69 – 3.65 (m, 2H), 3.62 – 3.58 (m, 2H), 3.07 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm = 134.48, 117.27, 72.21, 70.69, 69.31, 69.24, 69.04. 
 
3-(2-(2-Bromoethoxy)ethoxy)prop-1-ene (41) 
 
41 
A solution of the mesylate compound 39 (30.0 g, 134 mmol), lithium bromide (59.1 g, 
669 mmol) in acetone (500 mL, analytical grade) was prepared in a 1 L two-necked flask 
equipped with a magnetic stirrer and a condenser. The reaction mixture was heated to reflux 
over night. The acetone was evaporated and the crude mixture was dissolved in CH2Cl2 
(250 mL) and washed with water (3 × 100 mL). The organic phase was dried over MgSO4 and 
filtered. Evaporation of the solvent yielded the analytically pure bromide 41 (18.5 g, 
88.5 mmol, 66%) as a yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ/ppm = 5.96 – 5.84 (m, 1H), 5.27 (dq, J = 1.6, 17.2 Hz, 1H), 
5.18 (ddd, J = 1.2, 3.0, 10.4 Hz, 1H), 4.05 – 4.00 (m, 2H), 3.81 (t, J = 6.4 Hz, 2H), 3.70 – 
3.66 (m, 2H), 3.63 – 3.58 (m, 2H), 3.47 (t, J = 6.4 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ/ppm = 134.58, 117.17, 72.25, 71.20, 70.54, 69.34, 30.21. 
Anal. calc. for C7H13BrO C 40.21 H 6.27; found C 40.89 H 6.52. 
 
[Ru(35)3](PF6)2 (50) 
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3,3'-(2,2'-Bipyridine-5,5'-diyl)diphenol (35) (200 mg, 587 µmol) and [Ru(DMSO)4Cl2] (94.8 
mg, 196 µmol) were suspended in ethylene glycol (7 mL). The reaction mixture was stirred in 
the microwave for 30 min at 230 °C. The resulting orange solution was added to 100 mL of a 
NH4PF6-solution (4.00 mmol). An orange precipitate formed which was filtered and washed 
with water (300 mL) and ether (100 mL) yielding the ruthenium complex 50 (271 mg, 98%). 
 
1H NMR (400 MHz, CD3CN) δ/ppm =  8.60 (d, J = 8.5 Hz, 6H), 8.30 (dd, J = 1.9, 8.5 Hz, 
6H), 8.00 (d, J = 1.8 Hz, 6H), 7.23 (t, J = 8.1 Hz, 12H), 6.93 – 6.83 (m, 18H). 
19F NMR (376 MHz, CD3CN) δ/ppm =  -73.98 (d, J = 706.5). 
13C NMR (101 MHz, CD3CN) δ/ppm = 158.61, 156.53, 150.90, 140.48, 137.38, 136.81, 
131.59, 125.35, 119.67, 117.49, 114.93. 
MS (ESI): m/z = 561.4 [M-2PF6]2+, 1121.6 [M- PF6-H]+, 1267.4 [M- PF6]+. 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 467.0 [13900], 321.0 [102000]. 
Emission (MeCN, λmax(nm)) = 625. 
IR (ATR): ν∼/cm-1 =  3522w, 3105w, 1740m, 1599m, 1583m, 1462m, 1448m, 1375m, 1304m, 
1204m, 1165m, 997w, 893m, 824s, 779m, 731w, 698w. 
Anal. calc. for C66H48F12N6O6P2Ru · 2H2O C 54.74, H 3.62, N 5.80; found C 54.77, H 3.68, 
N 5.64. 
 
[Ru(44)3](PF6)2 (51) 
 
 
Ligand 44 (248 mg, 363 µmol), [Ru(DMSO)4Cl2] (58.7 mg, 121 µmol) and Ethanol (10 mL) 
were put in a microwave vessel. The reaction mixture was heated to 140 °C for 25 min, 
cooled to room temperature, reduced to 2 mL and poured to a saturated NH4PF6-solution. An 
orange precipitate was formed. The solution was extracted with CH2Cl2 (3 × 20 mL). 
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Chromatography (SiO2, CH2Cl2 → CH2Cl2 : MeOH (50:1)) yielded an orange solid (137 mg, 
56.0 µmol, 46%). 
 
1H-NMR (500 MHz, CDCl3): δ/ppm = 8.80 (d, 3J = 8.8 Hz, 6 H, HA3), 8.36 (dd, 3J = 8.5 Hz, 
4J = 1.5 Hz, 6 H, HA4), 7.87 (d, 4J = 1.5 Hz, 6H, HA6), 7.29 (t, 3J = 8.0 Hz, 6 H, HB5), 6.92 (d, 
3J = 8.5 Hz, 6 H, HB6), 6.83-6.82 (m, 12H, HB2+B4),  5.86-5.81 (m, 6 H, HD1), 5.23-5.08 (m, 
12 H, HD2), 4.05-4.00 (sb, 12 H, HE1), 3.97 (d, 3J = 5.5 Hz, 12 H, HE7), 3.80 (tb, 12 H, HE2), 
3.72-3.62 (m, 36 H, HE3+E4+E5), 3.57 (mc, 12 H, HE6). 
13C-NMR (125.8 MHz, CDCl3): δ/ppm = 159.7 (CB3), 155.1 (CA2), 147.8 (CA6), 140.7 (CB1), 
136.8 (CA4), 135.1 (CA5), 134.6 (CD1), 131.0 (CB5), 125.2 (CA3), 119.2 (CB4), 117.0 (CD2), 
116.4 (CB6), 112.8 (CB3), 72.1 (CE7), 70.7, 70.5, 70.5 (CE2), 69.4 (CE6), 69.3 (CE1), 67.5. 
MS (ESI): m/z = 1077.9 [M-2PF6]2+ (calc. 1077.5), 2299.4 [M-PF6]+ (calc. 2299.9). 
Anal. calc. for C120H144F12N6O24P2Ru · H2O C 58.51, H 5.97, N 3.41; found C 58.54, H 6.12, 
N 2.97. 
 
[Fe(34)3](PF6)2 (45)  
 
 
Ligand 34 (249 mg, 676 µmol) was dissolved in 2 mL of CH2Cl2 and 10 mL of CH3CN. An 
excess of [FeCl2 · 4 H2O] (45.0 mg, 355 µmol) in H2O was added and the solution turned 
immediately red. The reaction mixture was refluxed for 2 days and the organic solvents have 
been removed in vacuum and an excess of NH4PF6 was added. The water phase was extracted 
with CH2Cl2 (3 50 mL) and the combined organic layers were dried over MgSO4. Removal of 
the solvents and recrystallisation from CH2Cl2/Et2O yielded pure 45 (90 mmol, 35%). 
 
1H NMR (400 MHz, CDCl3) δ/ppm =  8.52 (d, J = 8.3, 6H), 8.24 (d, J = 8.4, 6H), 7.52 (s, 
6H), 7.18 (t, J = 8.0, 6H), 6.85 – 6.71 (m, 12H), 6.68 (s, 6H), 3.57 (s, 18H). 
13C NMR (101 MHz, CDCl3) δ/ppm = 159.77, 156.80, 151.27, 139.30, 136.57, 134.99, 
130.21, 123.63, 118.58, 114.83, 111.81, 54.76. 
MS (ESI): m/z = 580.5 [M-2PF6]2+ (calc. 580.2). 
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mp.: 179-182 °C. 
IR (ATR): ν∼/cm-1 = 2935w, 2833w, 1717w, 1601m, 1582m, 1504m, 1470s, 1448m, 1433m, 
1371m, 1304w, 1288m, 1246w, 1219m, 1173w,  1153m, 1051m, 1024m, 995m, 822s, 777m, 
729m, 687w, 667m, 619m, 606m, 555m. 
Anal. calc. for C72H60F12FeN6O6P2 C 59.60 H 4.17 N5.79; found C 59.30 H 4.36 N 5.55. 
 
[Ru(34)3](PF6)2 (49)  
 
 
 
5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine (34) (115 mg, 313 µmol) and [Ru(DMSO)4Cl2] 
(50.5 mg, 104 µmol) in EtOH (7 mL) were stirred in a microwave at 140 °C for 1h. The 
reaction mixture was reduced to 5 mL and 50 mL of an aqueous NH4PF6 solution 
(2.00 mmol) was added. The precipitate was separated by filtration and washed with H2O and 
ether yielding analytically pure complex 49 (142 mg, 94.9 µmol, 91%). 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.62 (d, J = 8.5 Hz, 3H, HA3), 8.36 (d, J = 8.5 Hz, 3H, 
HA4), 8.06 (s, 3H, HA5), 7.34 (t, J = 8.0 Hz, 3H, HB5), 7.04 (d, J = 7.7 Hz, 3H, HB6), 6.97 (d, 
J = 8.3 Hz, 3H, HB4), 6.94 (s, 3H, HB2), 3.70 (s, 9H, OMe). 
13C NMR (126 MHz, CD3CN) δ/ppm = 161.3 (CB3), 156.7 (CA2), 151.0 (CA6), 140.3 (CA5), 
137.1 (CB1), 136.8 (CA4), 131.6 (CB5), 125.5 (CA3), 120.5 (CB6), 116.4 (CB4), 113.3 (CB2), 56.2 
(COMe). 
MS (ESI): m/z = 603.1 [M-2PF6]2+ (calc. 603.2). 
mp.: 151-153°C. 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 470 [10900], 321 [110000]. 
Emission (MeCN, λmax(nm)) = 636.  
IR (ATR): ν∼/cm-1 = 2970w, 2839w, 1736m, 1582s, 1466s, 1366w, 1304w, 1219s, 1173m, 
1026m, 825s, 779m, 694w. 
Anal. calc. for C72H60F12N6O6P2Ru C 57.80, H 4.04, N 5.62; found C 57.81, H 4.02, N 5.52. 
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3-Methoxyphenylboronic acid (33) 
B
OMe
HO OH
 
33 
1-Bromo-3-methoxybenzene (18.5 mL, 145 mmol) was dissolved in 500 mL anhydrous THF 
and cooled to –78 °C. N-butyl lithium (100 mL, 1.6M solution in hexane, 160 mmol) was 
added drop wise to this solution. The reaction mixture was stirred over a period of 2 h at this 
temperature whereby a slight yellow colouring was observed and LiCl precipitated. Trimethyl 
borate (17.8 mL, 160 mmol) was added, and the reaction mixture (now colourless) was stirred 
at room temperature over night. Hydrochloric acid (250 mL, 4M) was added and the solvents 
were removed in vacuo. The solvents were removed and the milky precipitate was taken in 
300 mL water and 300 mL diethyl ether. The organic phase was extracted twice with 200 mL 
1M NaOH. The combined aqueous extracts were acidified to pH 1 with 37% HCl before 
extraction with to portions of diethyl ether (200 mL). The solvents were evaporated in vacuo 
to yield a white solid (18.3 g, 120 mmol, 83%).  
 
MS (EI): m/z = 152.1 [M]+ (calc. 152.06). 
 
Ligand 42 
 
 
5,5'-Bis(3'-hydroxyphenyl)-2,2'-bipyridine  (1.63 g, 4.79 mmol), 3-(2-bromoethoxy)prop-1-
ene (1.57 g, 9.63 mmol) and Cs2CO3 (6.24 g, 19.0 mmol) were dissolved in dry DMF 
(200 mL). The reaction mixture was heated for 4 d at 120 °C. Removal of DMF, column chro-
matography (SiO2, CH2Cl2 : MeOH (66:1)) and filtration over Al2O3 yielded 42 as a 
colourless crystalline solid (2.17 g, 4.27 mmol, 89%). 
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1H NMR (500 MHz, CDCl3) δ/ppm = 8.97 (d, J = 2.1 Hz, 2H, HA6), 8.54 (d, J = 8.2 Hz, 2H, 
HA3), 8.06 (dd, J = 2.3, 8.3 Hz, 2H, HA4), 7.45 (t, J = 7.9 Hz, 2H, HB5), 7.32 – 7.26 (m, 4H, 
HB2+B6), 7.03 (dd, J = 2.2, 8.2 Hz, 2H, HB4), 6.05 – 5.94 (m, 2H, HD1), 5.37 (dd, J = 1.6, 17.2 
Hz, 2H, HD2,trans), 5.27 (dd, J = 1.2, 10.4 Hz, 2H, HD2,cis), 4.29 – 4.24 (m, 4H, HE1), 4.19 – 
4.14 (m, 4H, HE3), 3.92 – 3.86 (m, 4H, HE2). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.3 (CB3), 154.70 (CA2), 147.7 (CA6), 138.9 (CB1), 
136.2 (CA5), 135.2 (CA4), 134.5 (CD1), 130.1 (CB5), 120.9 (CA3), 119.7 (CB6), 117.4 (CD2), 
114.0 (CB4), 113.6 (CB2), 72.4 (CE3), 68.4 (CE2), 67.5 (CE1). 
MS (EI): m/z = 508.2 [M·+] (calc. 508.2), 424.2[(M-C5H8O) ·+] (calc. 424.2), 340.1[(M-
2C5H8O) ·+] (calc. 340.1). 
mp.: 96-98 °C. 
IR (ATR): ν∼/cm-1 = 3005w, 2932w, 2856w, 1605m, 1576s, 1464m, 1452s, 1441m, 1358m, 
1300m, 1279m, 1205s, 1142m, 1130m, 1099m, 1068m,  1016m,  947m, 937m, 918m, 835m, 
781s, 694s. 
Anal. calc. for C32H32N2O2 C 75.57 H 6.34 N 5.51; found C 75.54 H 6.50 N 5.39. 
 
Ligand 43 
 
Ligand 43 was synthesised according to the procedure described for 42 from 5,5'-bis(3'-
hydroxyphenyl)-2,2'-bipyridine (2.40 g, 7.05 mmol), 3-(2-(2-bromoethoxy)ethoxy)prop-1-ene 
(3.24 g, 15.5 mmol) and Cs2CO3 (8.00 g, 24.5 mmol). Column chromatography (SiO2, 
CH2Cl2 : MeOH (49:1)) yielded 43 as a colourless crystalline solid (3.33 g, 5.58 mmol 79%). 
 
1H NMR (500 MHz, CD2Cl2) δ/ppm = 8.93 (s, 2H, HA6), 8.55 (d, J = 8.2 Hz, 2H, HA3), 8.06 
(dd, J = 2.2, 8.3 Hz, 2H, HA4), 7.43 (t, J = 7.9 Hz, 2H, HB5), 7.29 (d, J = 7.7 Hz, 2H, HB6), 
7.26 – 7.22 (m, 2H, HB2), 6.99 (dd, J = 2.1, 8.2 Hz, 2H, HB4), 5.97 – 5.87 (m, 2H, HD1), 5.27 
(dd, J = 1.6, 17.2 Hz, 2H, HD2,trans), 5.16 (dd, J = 1.5, 10.4 Hz, 2H, HD2,cis), 4.26 – 4.16 (m, 
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4H, HE1), 4.01 (mc, 4H, HE5), 3.92 – 3.84 (m, 4H, HE2), 3.76 – 3.67 (m, 4H, HE3), 3.65 – 3.59 
(m, 4H, HE4).  
13C NMR (126 MHz, CD2Cl2) δ/ppm = 160.0 (CB3), 155.2 (CA2), 148.2 (CA6), 139.6 (CB1), 
136.8 (CA5), 135.8 (CA4), 135.6 (CD1), 130.73 (CB5), 121.3 (CA3), 120.1 (CB6), 117.0 (CD2), 
114.7 (CB4), 113.9 (CB2), 72.6 (CE5), 71.4 (CE3), 70.2 (CE2), 70.1 (CE4), 68.2 (CE1). 
MS (EI): m/z = 596.3 [M·+] (calc. 596.3), 508.2, 495.2, 481.2, 468.2 [(M-C7H14O) ·+] (calc. 
468.2), 453.2.   
mp.: 73-75 °C. 
IR (ATR): ν∼/cm-1 = 3010w, 2872m, 1724w, 1605m, 1578s, 1460s, 1441m, 1362w, 1298m, 
1277m, 1231w, 1202m, 1119m, 1099m, 1059m, 1018w,  933m, 841s, 777s, 744w, 692m, 
611m. 
Anal. calc. for C36H40N2O6 C 72.46 H 6.76 N 4.69; found C 72.26 H 6.66 N 4.49.  
 
Ligand 44 
 
Ligand 44 was synthesised according to the procedure described for 42 from 5,5'-Bis(3'-
hydroxyphenyl)-2,2'-bipyridine (1.11 g, 3.26 mmol), 3-(2-(2-(2-bromoethoxy)ethoxy)-
ethoxy)prop-1-ene (2.06 g, 8.15 mmol) and Cs2CO3 (4.25 g, 13.0 mmol). Column 
chromatography (SiO2, CH2Cl2 : MeOH (49:1)) yielded 44 as a colourless solid (2.01 g, 
2.93 mmol, 90%). 
 
1H NMR (500 MHz, CD2Cl2) δ/ppm = 8.94 (d, J = 1.8 Hz, 2H, HA6), 8.56 (d, J = 8.2 Hz, 2H, 
HA3), 8.07 (dd, J = 2.1, 8.3 Hz, 2H, HA4), 7.43 (t, J = 7.9 Hz, 2H, HB5), 7.29 (d, J = 7.7 Hz, 
2H, HB6), 7.25 (d, J = 1.9 Hz, 2H, HB2), 6.99 (dd, J = 2.1, 8.2 Hz, 2H, HB4), 5.96 – 5.85 (m, 
2H, HD1), 5.26 (dd, J = 1.6, 17.2 Hz, 2H, HD2,trans), 5.15 (dd, J = 1.3, 10.4 Hz, 2H, HD2,cis), 
4.24 – 4.19 (m, 4H, HE1), 3.99 (d, J = 5.6 Hz, 4H, HE7), 3.88 – 3.86 (m, 4H, HE2), 3.73 – 3.68 
(m, 4H, HE3), 3.67 – 3.60 (m, 8H), 3.59 – 3.55 (m, 4H) . 
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13C NMR (101 MHz, CD2Cl2) δ/ppm = 160.0 (CB3), 155.2 (CA2), 148.1 (CA6), 139.6 (CB1), 
136.7 (CA5), 135.7 (CA4), 135.6 (CD1), 130.7 (CB5), 121.3 (CA3), 120.1 (CB6), 116.9 (CD2), 
114.6 (CB2), 113.9 (CB4), 72.5, 71.3, 71.1 (2 C), 70.2, 70.1, 68.2 (CE1). 
MS (EI): m/z = 685.4 [M·+] (calc. 685.4). 
mp.: 57-58 °C. 
IR (ATR): ν∼/cm-1 =  2868m, 1599m, 1582m, 1464s, 1364m, 1300m, 1232w, 1209m, 1126m, 
1107m, 1067m, 932m, 633w. 
Anal. calc. for C40H48N2O8 C 70.16 H 7.06 N 4.09; found C 70.03 H 7.06 N 4.00. 
 
[Fe(42)3](BF4)2 (46)  
 
 
Ligand 42 (735 mg, 1.45 mmol) was dissolved in acetonitrile (40 mL) and an aqueous 
solution (40 mL) of iron(II) tetrafluoroborate hexahydrate (488 mg, 1.45 mmol) was added. 
The solution turned red immediately and was heated at reflux for 12 h. A 1H NMR spectrum 
of the crude product showed still roughly 10% of unreacted ligand, 300 mg of iron(II) tetra-
fluoroborate hexahydrate were added and the solution was heated at reflux for three more 
days. The reaction mixture was filtered over Celite and Al2O3 in order to remove excess 
[Fe(BF4)2]. The analytically pure red solid was dried in vacuo (848 mg, 438 µmol, quant.). 
 
1H NMR (400 MHz, CDCl3) δ/ppm = 8.91 (d, J = 8.3 Hz, 6H HA3), 8.36 (d, J = 7.7 Hz, 6H, 
HA4), 7.54 (s, 6H, HA6), 7.27 (t, J = 8.0, 6H, HB5), 6.93 (d, J = 8.4 Hz, 6H, HB6), 6.79 (m, 12H, 
HB2+B4), 5.96 – 5.83 (m, 6H, HD1), 5.33 – 5.23 (m, 6H, HD2, trans), 5.18 (dd, J = 1.4, 10.4 Hz, 
6H, HD2,cis), 4.08 – 3.98 (m, 24H), 3.77 – 3.70 (m, 12H). 
13C NMR (101 MHz, CDCl3) δ/ppm = 159.8, 157.5, 150.6, 140.5, 137.8, 135.2, 134.4, 131.0, 
125.4, 119.2, 117.4, 116.5, 112.8, 72.3, 68.3, 67.7. 
MS (ESI): m/z = 790.8 [M-2BF4]2+ (calc. 790.3). 
Anal. calc. for C96H96B2F8FeN6O12 C 65.69 H 5.51 N 4.79; found C 65.37 H 5.54 N 4.72. 
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[Fe(43)3](BF4)2 (47)   
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Ligand 43 (1.84 g, 3.08 mmol) and iron(II) tetrafluoroborate hexahydrate (1.04 g, 3.08 mmol) 
were dissolved in acetonitrile (300 mL) and heated at reflux for three days. Filtration over 
Al2O3 and removal of the solvent yielded iron complex 47 (1.93 g, 999 µmol, 93%) as a red 
oil. 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.66 (d, J = 8.5 Hz, 6H, HA3), 8.44 (dd, J = 1.8, 8.5 
Hz, 6H, HA4), 7.75 (d, J = 1.3 Hz, 6H, HA6), 7.33 (t, J = 8.0 Hz, 6H, HB5), 7.06 (d, J = 7.7, 6H, 
HB6), 6.96 (dd, J = 2.1, 8.3 Hz, 6H, HB4), 6.89 (s, 6H, HB2), 5.92 – 5.82 (m, 6H, HD1), 5.22 
(dd, J = 1.7, 17.3 Hz, 6H, HD2, trans), 5.10 (dd, J = 1.5, 10.4 Hz, 6H, HD2, cis), 3.99 – 3.91 (m, 
24H, HE1+E5), 3.71 – 3.65 (m, 12H, HE2), 3.61 – 3.56 (m, 12H, HE3), 3.53 (mc, 12H, HE4). 
19F NMR (376 MHz, CDCl3) δ/ppm = = -153.1 (s). 
13C NMR (126 MHz, CD3CN) δ/ppm = 160.5 (CB3), 158.8 (CA2), 153.5 (CA6), 140.0 (CA5), 
137.7 (CA4), 137.1 (CB1), 136.3 (CD1), 131.7 (CB5), 125.3 (CA3), 120.6 (CB6), 117.2 (CB4), 
117.0 (CD2), 113.4 (CB2), 72.5 (CE5), 71.4 (CE3), 70.4 (CE4), 70.2 (CE2), 68.7 (CE1). 
MS (ESI): m/z = 923.2 [M-2BF4]2+ (calc. 922.9) 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 336 [102700], 544 [8960].  
Emission (MeCN, λexc = 340 nm, λmax(nm)) = 406.   
IR (ATR): ν∼/cm-1 = 2922m, 2905m, 2870m, 1636m, 1599w, 1582m, 1504w, 1468m, 1408m, 
1373w, 1302m, 1246w, 1213m, 1124m, 1092m, 1059m, 995w, 943w, 876m, 827s, 781m, 
739m, 694m, 660m, 644m, 623w, 602w. (as PF6 salt). 
Anal. calc. for C108H120N6O18B2F8Fe·2 H2O C 63.10 H 6.08 N 4.09; found C 63.10 H 6.10 N 
4.24 
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[Fe(44)3](BF4)2 (48) 
 
 
Ligand 44 (666 mg, 973 µmol) and iron(II) tetrafluoroborate hexahydrate (328 mg, 973 µmol) 
were dissolved in acetonitrile (50 mL) and water (50 mL) and heated at reflux for five days. 
The acetonitrile was removed and the aqueous phase was extracted with CH2Cl2 (3 x 40 mL). 
The combined organic layers were dried over MgSO4, filtered and the solvent was removed in 
vacuo to yield a red oil (681 mg, 298 µmol, 92%). 
 
1H NMR (400 MHz, CDCl3) δ/ppm = 8.84 (s, 6H), 8.42 (s, 6H), 7.54 (s, 6H), 7.26 (s, 6H), 
6.92 (s, 6H), 6.79 (s, 12H), 5.92 – 5.75 (m, 6H), 5.21 (d, J = 17.0, 6H), 5.10 (d, J = 10.3, 6H), 
4.11 – 3.88 (m, 24H), 3.79 (s, 12H), 3.75 – 3.61 (m, 36H), 3.57 (s, 12H). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.7, 157.4, 150.6, 140.5, 137.8, 135.1, 134.6, 131.0, 
125.0, 119.1, 117.0, 116.5, 112.7, 72.1, 70.7, 70.5 (2 C), 69.4, 69.3, 67.6. 
19F NMR (376 MHz, CDCl3) δ/ppm = -153.2. 
MS (ESI): m/z = 1054.9 [M-2BF4]2+ (calc. 1055.0) 
 
Macrocycle 54  
 
 
Iron complex 47 (1.93 g, 955 µmol) and (1,3-bis-(2,4,6-trimethylphenyl)-2-imidazol-
idinylidene)dichloro(o-isopropoxyphenylmethylene)ruthenium(II) (75.0 mg, 120 µmol) were 
dissolved in absolute CH2Cl2 (955 mL) and stirred at r.t. for 30 days under N2. After 8 days, 
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75 mg and after 20 days 30 mg of catalyst were again added. The reaction was quenched with 
ethyl-vinylether (5 mL) and the solvents removed in vacuo yielding a red solid. 1H NMR and 
ESI-MS confirmed almost full conversion (>95%). The compound was used further without 
purification.  
 
MS (ESI): m/z = 881.1 [M-2BF4]2+ (calc. 880.9) 
 
Macrocycle 57  
 
Crude iron complex 54 (200 mg, ~100 µmol) was dissolved in acetonitrile. Na2EdtaH2 (192 
mg, 517 µmol) and Na2CO3 (192 mg, 517 µmol) in 30 mL water were added. The reaction 
mixture was stirred at 50 °C for 1 h, after 30 min the red colour had disappeared. Most of the 
acetonitrile has been distilled of and the solution was extracted with CH2Cl2 (3 x 100 mL). 
The combined organic layers were dried over MgSO4, filtered and the solvent was removed in 
vacuum to yield a brownish oil. Purification was attempted via Column chromatography 
(SiO2, CH2Cl2 : MeOH (1%-7%)) yielding macrocyclic ligand 57 (170 mg, 99.6 µmol, 70%, 
70% pure) as an colourless oil. The crude compound was hydrogenated in the next step 
without further purification. 
 
1H NMR (600 MHz, CD2Cl2) δ/ppm = 8.89 (d, J = 1.8 Hz, 6H, HA6), 8.49 (d, J = 8.3 Hz, 6H, 
HA3), 8.00 (dd, J = 2.3, 8.2 Hz, 6H, HA4), 7.38 (t, J = 7.9 Hz, 6H, HB5), 7.24 (d, J = 7.6 Hz, 
6H, HB6), 7.22 – 7.21 (m, 6H, HB2), 6.95 (dd, J = 1.7, 8.3 Hz, 6H, HB4), 5.82 – 5.77 (m, 6H, 
CH2CH), 4.20 – 4.15 (m, 12H, HE1), 4.01 – 3.98 (m, 12H, HE2), 3.85 – 3.81 (m, 12H, HE3), 
3.69 – 3.65 (m, 12H, HE5), 3.62 – 3.56 (m, 12H, HE4). 
13C NMR (151 MHz, CD2Cl2) δ/ppm = 160.0 (CB3), 155.1 (CA2), 148.1 (CA6), 139.5 (CB1), 
136.7 (CA5), 135.7 (CA4), 130.7 (CB5), 129.9 (CH2CH), 121.3 (CA3), 120.1 (CB6), 114.7 (CB4), 
114.0 (CB2), 71.6 (CE1), 71.4 (CE2), 70.2 (CE3), 70.1 (CE4), 68.2 (CE5). 
MS (ESI): m/z = 1728.6 [M+Na]+ (calc. 1728.7). 
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[Fe(309)](BF4)2 (56)  
 
 
To a solution of crude iron complex 54 (955 µmol) in 150 mL EtOH and 150 mL of CH2Cl2, 
500 mg of Pd/C (25 mol% Pd) were added. The reaction mixture was stirred in a hydrogen 
atmosphere (1 bar) at r.t. for 12 h. 1H NMR and ESI-MS confirmed full conversion. The 
compound was used further without purification.  
 
MS (ESI): m/z = 884.0 [M-2BF4]2+ (calc. 883.9) 
 
 
Macrocycle 31  
 
To a solution of crude iron complex 56 (~955 µmol) in acetonitrile (200 mL), Na2EdtaH2 
(1.86 g, 5.00 mmol) and Na2CO3 (1.06 g, 10.0 mmol) in 20 mL water were added. The 
reaction mixture was stirred at 50 °C for 3 h, after 30 min the red colour had disappeared. The 
organic solvent was removed in vacuum and the aqueous residue was extracted with CH2Cl2 
(5 x 50 mL). The combined organic layers were dried over MgSO4, filtered and the solvent 
was removed in vacuum to yield a brown oil (1.65 g). From the residue 4/15 parts (440 mg) 
were purified via preparative thin layer chromatography (Al2O3, CH2Cl2/MeOH (1.1%), 6h 
elution) on 8 plates to yield macrocyclic ligand 31 (113 mg, 26%, three steps) as a colourless 
oil. 
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1H NMR (500 MHz, CD2Cl2) δ/ppm = 8.90 (d, J = 1.8, 6H, HA6), 8.50 (d, J = 8.3 Hz, 6H, 
HA3), 8.01 (dd, J = 2.2, 8.3 Hz, 6H, HA4), 7.39 (t, J = 7.9 Hz, 6H, HB5), 7.24 (d, J = 7.9 Hz, 
6H, HB6), 7.22 (d, J = 1.8, 6H, HB2), 6.96 (dd, J = 2.1, 8.2, 6H, HB4), 4.20 – 4.14 (m, 12H, 
HE1), 3.86 – 3.80 (m, 12H, HE2), 3.69-3.66 (m, 12H, HE3), 3.60 – 3.54 (m, 12H, HE4), 3.49 – 
3.43 (m, 12H, HE5), 1.65 – 1.58 (m, 12H, CH2CH2). 
13C NMR (126 MHz, CD2Cl2) δ/ppm = 160.0 (CB3), 155.2 (CA2), 148.1 (CA6), 139.5 (CB1), 
136.6 (CA5), 135.6 (CA4), 130.7 (CB5), 121.3 (CA3), 120.0 (CB6), 114.6 (CB4), 113.9 (CB2), 71.6 
(CE1), 71.4 (CE2), 70.7 (CE3), 70.2 (CE4), 68.2 (CE5), 27.0 (CH2CH2). 
MS (ESI): m/z = 1735.0 [M+Na]+ (calc. 1734.8). 
IR (ATR): ν∼/cm-1 = 2920m, 2862m, 1722w, 1682m, 1597m, 1580m, 1462s, 1439m, 1362w, 
1298m, 1281w, 1231w, 1205m, 1103s, 1063m, 1018m, 995s,  937w, 839s, 779s, 744m, 
694m, 652w, 604m. 
Anal. calc. for C102H114N6O18·2 H2O C 70.08 H 6.80 N 4.81; found C 70.18 H 6.94 N 4.92. 
 
Macrocycle 55  
 
Tetradentate ligand 55 was obtained after preparative layer chromatography Al2O3, 
CH2Cl2/MeOH (1.1%), 6h elution) after an analogous reaction sequence as described for 31. 
1H NMR (400 MHz, CD2Cl2) δ/ppm =  8.88 – 8.83 (m, 4H), 8.45 (d, J = 8.3, 4H), 7.97 (dd, J 
= 2.3, 8.3 Hz, 4H), 7.38 (t, J = 7.9, 4H), 7.26 – 7.18 (m, 8H), 6.99 – 6.92 (m, 4H), 4.21 – 4.13 
(m, 8H), 3.82 – 3.75 (m, 8H), 3.57 (mc, 8H), 1.68 (mc, 8H). 
MS (ESI): m/z = 988.0 [M+Na] + (calc. 988.1). 
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[Fe(31)](BF4)2 (56)  
 
Ligand 31 (26.1 mg, 15.2 µmol) and iron(II) tetrafluoroborate hexahydrate (5.1 mg, 
15.2 µmol) were dissolved in acetonitrile (20 mL) and refluxed for 4 d. The solvent was 
removed and the residue filtered over SiO2 (CH2Cl2/MeOH (10%)). After removal of the 
solvents a red residue (29.7 mg, quant.) could be obtained. 
 
1H NMR (400 MHz, CDCl3) δ/ppm = 9.19 – 8.78 (m), 8.64 – 8.14 (m), 7.78 – 7.42 (m), 7.43 
– 7.08 (m), 7.05 – 6.58 (m), 6.42 (s), 4.31 – 3.27 (m), 3.18 (s), 1.76 – 1.46 (m). 
MS (ESI): m/z = 883.5 [M-2BF4]2+(calc. 883.9). 
 
[Zn(31)](ClO4)2 (58) 
 
 
 
To a solution of Ligand 31 (23.3 mg, 13.6 µmol) in CH2CL2 (1 mL) of a 13.6 mM solution of 
[Zn(ClO4)2]·6 H2O in MeCN was added and the reaction mixture was stirred at r.t. over night. 
The solvents were removed under reduced pressure yielding a yellow oil (26.6 mg, 13.5 µmol, 
99%). 
 
1H NMR (400 MHz, CD2Cl2) δ/ppm = 9.02 – 7.87 (m, 18H), 7.57 – 6.43 (m, 24H), 4.04 (mc, 
12H), 3.86 – 3.17 (m, 48H), 1.56 (s, 12H). 
13C NMR (101 MHz, CD2Cl2) δ/ppm = 160.3, 148.5, 145.9, 141.0, 139.9, 136.3, 131.3, 125.0, 
120.3, 120.0, 116.4, 114.0, 113.9, 71.7, 71.4, 70.7, 70.6, 70.0, 68.4, 68.3, 27.2, 27.0, 26.9. 
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MS (ESI): m/z = 888.6 [M-2ClO4]2+ (calc. 887.9). 
UV-Vis (MeCN, λmax (nm) [ε/ (cm-1 M-1)]) = 293 [82000], 344[21600]. 
Emission (MeCN, λexc = 354 nm, λmax(nm)) = 468.    
 
[Ru(31)](PF6)2 (59) (mixture of two geometrical isomers) 
 
 
Ligand 31 (162 mg, 94.3 µmol) and [Ru(DMSO)4Cl2] (45.7 mg, 94.3 µmol) were suspended 
in EtOH (10 mL). The reaction mixture was stirred in the microwave (140 °C, 1h) leading to a 
homogeneous orange-brown solution. The solution was reduced to 5 mL and treated with 50 
mL of an aqueous NH4PF6 solution (163 mg, 1 mmol). The precipitate was collected by 
filtration and washed with water and ether. Column chromatography (Al2O3, CH2Cl2/MeOH 
(0%→3%)) and preparative thin layer chromatography (Al2O3, CH2Cl2/MeOH (2%), 4h 
elution) on 2 plates yielded an orange solid (38.6 mg, 18.4 µmol, 19 %). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.94 – 8.74 (m, 18H, HA3, Iso1+Iso2), 8.49 (d, J = 8.4, 2H, 
HA4, Iso1), 8.40 (d, J = 8.4 Hz, 4H, HA4, Iso2), 8.37 (d, J = 8.1 Hz, 4H, HA4, Iso1), 8.30 (d, J = 8.2 
Hz, 8H, HA4, Iso2), 7.93 (s, 4H, HA6, Iso2), 7.91 (s, 2H, HA6,Iso1), 7.90 (s, 2H, HA6, Iso1), 7.84 (s, 
4H, HA6, Iso2), 7.83 (s, 4H, HA6, Iso2), 7.80 (s, 2H, HA6, Iso1), 7.37 – 7.27(m, 18H, HB5, Iso1+Iso2), 
7.21 (d, J = 7.6 Hz, 2H, HB6, Iso1), 7.00 – 6.88 (m, 34H, HB2/B4B6, Iso1+Iso2), 6.85 – 6.76 (m, 12H, 
HB2/B4/B6, Iso1+Iso2), 6.71 (s, 4H, HB2, Iso2), 6.45 (s, 2H, HB2, Iso1), 4.18 – 3.90 (m, 36H, HE1), 3.89 
– 3.69 (m, 36H, HE2), 3.68 – 3.58 (m, 36H, HE3/E4), 3.58 – 3.48 (m, 36H, HE3/E4), 3.48 – 3.32 
(m, 36H, HE5), 1.57 (s, 36H, CH2CH2). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.8, 159.7, 159.6, 155.2, 155.1, 155.1, 148.3, 148.0, 
141.1, 141.0, 140.7, 137.1, 135.4, 135.2, 135.2, 131.1, 131.0, 130.9, 125.2, 119.9, 119.5, 
119.3, 118.9, 116.8, 116.6, 116.4, 113.8, 113.3, 113.2, 112.8, 112.4, 71.1, 71.03, 70.98, 70.87, 
70.83, 70.77, 70.64, 70.05, 69.95, 69.52, 69.35, 69.09, 67.87, 67.73, 67.62, 67.55, 26.51, 
26.30, 26.26, 26.18. 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.0 (d, J = 707 Hz). 
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MS (ESI): m/z = 906.6 [M-2PF6]2+ (calc. 906.8). 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 204 [105800], 323 [86010], 471 [8520].  
Emission (MeCN,  λexc = 366 nm, λmax(nm)) = 634.   
IR (ATR): ν∼/cm-1 = 2922m,  2856m,  1715w,  1666w,  1599m, 1580m, 1466m, 1369w, 
1302m, 1246m, 1213m, 1097m, 1059m, 1040m, 945w, 831s, 781m, 739m, 694w. 
mp.: 84-90 °C. 
Anal. calc. for C102H114F12N6O18P2Ru· H2O C 57.76 H  5.51 N 3.96; found C 57.77 H 5.67 
N 3.54 
 
 
Complexes RuII/RuIII Reduction 1 2 3 4 5 6 
        
Ru(bpy)32+ 0.89 -1.73 -1.93 -2.17    
492+ 0.93 -1.56 -1.66 -1-92 -2.31 -2.46 -2.65 
592+ 0.95 -1.57 -1.72 -1.91 -2.30 -2.46 -2.66 
In deoxygenated MeCN +0.1 M Bu4NPF6 at scan rate of 100 mV s-1. vs. Fc/Fc+. 
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6.4 Experimental for Compounds in Chapter 3 
 
[Ru(34)(bpy)2](PF6)2 (67) 
 
General procedure 67 
5,5'-bis(3-methoxyphenyl)-2,2'-bipyridine (34) (86.6 mg, 235 µmol) and cis-[Ru(bpy)2Cl2] 
(116 mg, 240 µmol) were suspended in 5 mL of EtOH. The reaction mixture was heated in a 
microwave reactor for 40 min to 140 °C. To the resulting orange solution was added 100 mL 
of an aqueous NH4PF6-solution (4.00 mmol). An orange precipitate formed which was filtered 
and washed with water (50 mL) and ether (50 mL) yielding the ruthenium complex 67 
(234 mg, 218 µmol, 93%) as an orange powder. 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.58 (d, J = 8.5 Hz, 2H, HA3), 8.51 (mc, 4H, HC3+C'3), 
8.33 (dd, J = 2.0, 8.5 Hz, 2H, HA4), 8.07 (td, J = 1.3, 8.0 Hz, 4H, HC4+C'4), 7.89 (d, J = 5.3 Hz, 
2H, HC6), 7.82 (d, J = 5.3 Hz, 2H, HC'6), 7.80 (d, J = 1.8 Hz, 2H, HA6), 7.48 – 7.40 (m, 4H, 
HC5+C'5), 7.36 (t, J = 8.0 Hz, 2H, HB5), 7.00 (dd, J = 2.0, 8.0 Hz, 4H, HB4+B6), 6.92 (t, J = 2.0 
Hz, 2H, HB2), 3.77 (s, 6H, OMe). 
13C NMR (126 MHz, CD3CN) δ/ppm = 161.35 (CB3), 158.28 (CC'2), 157.97 (CC2), 156.53 
(CA2), 153.13 (CA6), 150.01 (CC6 + CC'6), 140.63 (CB1), 138.91 (CC4/C'4), 138.86 (CC4/C'4), 
137.22 (CA5), 136.79 (CA4), 131.64 (CB5), 128.68 (CC5), 128.61 (CC'5), 125.53 (CA3/C3/C'3), 
125.33 (CA3/C3/C'3), 125.32 (CA3/C3/C'3), 120.38 (CB4/B6), 116.33 (CB4/B6), 113.31 (CB2), 56.21 
(OMe). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.1 (d, J = 706 Hz). 
MS (ESI): m/z = 391.2 [M-2PF6]2+ (calc. 391.1), 927.1 [M- PF6]+ (calc. 927.2) 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 467.0 [15000], 289.0 [85900]. 
Emission (CH2Cl2, λexc = 350 nm, λmax(nm)) = 616. 
m.p.: 327-329 °C. 
IR (ATR): ν∼/cm-1 =  3088w, 2934w, 1601w, 1578w, 1464m, 1447m, 1427m, 1285w, 1215w, 
1171w, 1051w, 1028w, 878w, 829s, 791m, 762m, 731m ,698w. 
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Anal. calc. for C44H36F12N6O2P2Ru C 49.31, H 3.39, N 7.86; found C 49.20, H 3.39, N 7.70. 
 
 
[Ru(43)(bpy)2](PF6)2 (68) 
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Complex 68 was synthesised according to procedure 67 with 5,5'-bis(3-(2-(2-(allyloxy)-
ethoxy)ethoxy)phenyl)-2,2'-bipyridine (PR157) (71.7 mg, 120 µmol) and cis-[Ru(bpy)2Cl2] 
(58.8 mg, 121 µmol). Column chromatography (SiO2, CH2Cl2 : MeOH (20:1)) yielded title 
compound 69 (141 mg, 108 µmol, 90%) as an orange solid. 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.58 (d, J = 8.6 Hz, 2H, HA3), 8.52 (mc, 4H, HC3+C'3), 
8.33 (dd, J = 2.0, 8.5 Hz, 2H, HA4), 8.12 – 8.06 (m, 4H, HC4+C'4), 7.89 (d, J = 5.5 Hz, 2H, 
HC6), 7.82 (d, J = 5.6 Hz, 2H, HC'6), 7.81 (d, J = 1.7 Hz, 2H, HA6), 7.47 – 7.42 (m, 4H, 
HC5+C'5), 7.35 (t, J = 8.0 Hz, 2H, HB5), 7.03 – 6.97 (m, 4H, HB4+B6), 6.93 (s, 2H, HB2), 5.95 – 
5.85 (m, 2H, HD2), 5.25 (dd, J = 3.3, 17.3 Hz, 2H, HD1, trans), 5.12 (dd, J = 1.4, 10.4 Hz, 2H, 
HD1, cis), 4.07 (dd, J = 5.3, 9.7 Hz, 4H, HE1), 3.97 (dd, J = 1.2, 4.2 Hz, 4H, HE5), 3.82 – 3.77 
(m, 4H, HE2), 3.65 (dd, J = 3.5, 5.7 Hz, 4H, HE3/E4), 3.57 (dd, J = 3.5, 5.6 Hz, 4H, HE3/E4). 
13C NMR (126 MHz, CD3CN) δ/ppm = 160.5 (CB3), 158.27 (CA2), 157.96 (CC'2), 156.51 
(CC2), 153.13 (2 CC3+C'3), 150.03 (CA6), 140.57 (CA5), 138.93 (CC4/C'4), 138.86 (CC4/C'4), 137.23 
(CB1), 136.77 (CA4), 136.34 (CD2), 131.66 (CB5), 128.69 (CC5/C'5), 128.62 (CC5/C'5), 125.54 
(CA3), 125.33 (2 CC5+C'5), 120.54 (CB6), 117.03 (CD1), 116.99 (CB4), 113.82 (CB2), 72.53 (CE5), 
71.44 (CE3/E4), 70.43 (CE3/E4), 70.23 (CE2), 68.75 (CE1). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.1 (d, J = 706 Hz). 
m.p.: 99-102 °C. 
MS (ESI): m/z = 1155.4 [M-PF6]+ (calc. 1155.3), 505.2 [M- 2 PF6]2+ (calc. 505.2). 
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Anal. calc. for C56H56F12N6O6P2Ru C 51.74, H 4.34, N 6.46; found C 51.78, H 4.25, N 6.24. 
 
[Ru(44)(bpy)2](PF6)2 (69) 
 
Complex 69 was synthesised according to procedure 67 with 5,5'-bis(3-(2-(2-(2-
(allyloxy)ethoxy)ethoxy)ethoxy)phenyl)-2,2'-bipyridine (44) (420 mg, 613 µmol) and cis-
[Ru(bpy)2Cl2] (300 mg, 619 µmol). Column chromatography (SiO2, CH2Cl2 : MeOH (20:1)) 
yielded title compound 69 (793 mg, 571 µmol, 93%) as an orange solid. 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.50 (d, J = 8.6 Hz, 2H, HA3), 8.48 – 8.41 (m, 4H, 
HC3+C'3), 8.13 (d, J = 8.3 Hz, 2H, HA4), 7.99 (t, J = 8.0 Hz, 2H, HC4/ C'4), 7.95 (t, J = 7.9 Hz, 
2H, HC4/C'4), 7.79 (d, J = 4.1 Hz, 4H, HC6+C'6), 7.65 (s, 2H, HA6), 7.49 – 7.45(m, 4H, HC5+C'5), 
7.22 (t, J = 8.0 Hz, 2H, HB5), 6.85 – 6.81(m, 6H, HB2+B4+B6), 5.88 –  5.80 (m, 2H, HD1), 5.20 
(dd, J = 1.4, 17.2 Hz, 2H, HD2, trans), 5.09 (d, J = 10.4 Hz, 2H, HD2, cis), 4.10 – 4.00 (m, 4H, 
HE1), 3.95 (d, J = 5.6 Hz, 4H, HE7), 3.83 – 3.79 (m, 4H, HE2), 3.70 – 3.68 (m, 4H, HE3/E4), 3.68 
– 3.62 (m, 8H, HE3/E4+E5), 3.59 – 3.53 (m, 4H, HE7). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.61 (CB3), 156.77 (CC2/C'2), 156.29 (CC2/C'2), 155.09 
(CA2), 151.72 (CC6/C'6), 151.44 (CC6/C'6), 148.10 (CA6), 140.47 (CA5), 138.33 (CC4/C'4), 138.25 
(CC4/C'4), 136.34 (CA4), 135.69 (CB1), 134.74 (CD1), 130.82 (CB5), 128.63 (CC5/C'5), 128.26 
(CC5/C'5), 124.57 (CC3/C'3), 124.50 (CC3/C'3), 124.28 (CA3), 119.57 (CB6), 117.13 (CD2), 116.50 
(CB4), 112.69 (CB2), 72.14 (CE7), 70.66  (CE3/E4), 70.56 (CE3/E4), 69.51 (CE2), 69.41 (CE6), 
67.64 (CE1). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.09 (d, J = 706 Hz). 
MS (ESI): m/z = 1243.2 [M-PF6]+ (calc. 1243.3), 549.1 [M- 2 PF6]2+ (calc. 549.2). 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 456.0 [16200], 318.0 [56900]. 
Emission (MeCN, λexc = 350 nm, λmax(nm)) = 636. 
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IR (ATR): ν∼/cm-1 =  3080w, 2864m, 1601m, 1580m, 1464w, 1445w, 1423w, 1369m, 1302m, 
1217m, 1095m, 1063m, 945w, 827s, 764m, 731m, 698w. 
m.p.: 77-79 °C. 
Anal. calc. for C60H64F12N6O8P2Ru C 51.91, H 4.65, N 6.05; found C 51.93, H 4.68, N 5.87. 
 
Complex 64 
 
 
Ruthenium complex 69 (193 mg, 139 µmol) and (1,3-bis-(2,4,6-trimethylphenyl)-2-imidazol-
idinylidene)dichloro(o-isopropoxyphenylmethylene)ruthenium (6.0 mg, 9.6 µmol) were 
dissolved in absolute CH2Cl2 (13.9 mL) and stirred at r.t. for 5 d under N2. 1H NMR and ESI-
MS indicated roughly 40% conversion to the desired cyclic molecule. Again 16 mg of catalyst 
were added immediately and 8 mg of catalyst were added after 7 days. After 5 days the 
starting material was consumed (ESI-MS). The crude complex was filtered over Al2O3 
(CH2Cl2 : MeOH (40:1)) and hydrogenated with molecular H2 (1 atm) and a catalytic amount 
of Pd/C (30 mg) in 20 mL of EtOH and 20 mL of CH2Cl2. Preparative thick layer chromato-
graphy (SiO2, CH2Cl2 : MeOH (25:1)) yielded title compound 64 (20.2 mg, 14.8 µmol, 10%) 
as a mixture of the pure complex and the complex with one sodium cation coordinated to the 
ether chain as an orange solid. 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.63 (d, J = 8.1 Hz, 2H, HC'3), 8.56 (t, J = 8.0 Hz, 4H, 
HC3+A3), 8.35 (dd, J = 2.0, 8.5 Hz, 2H, HA4), 8.22 (td, J = 1.2, 7.9 Hz, 2H, HC'4), 8.09 – 8.03 
(m, 2H HC4), 7.90 (d, J = 5.0 Hz, 2H, HC6), 7.84 (d, J = 5.5 Hz, 2H, HC'6), 7.82 (d, J = 1.8 Hz, 
2H, HA6), 7.58 – 7.52 (m, 2H, HC'5), 7.42 (t, J = 6.6 Hz, 2H, HC'5), 7.38 (t, J = 8.0 Hz, 2H, 
HB5), 7.27 (d, J = 7.8 Hz, 2H, HB6), 6.96 (dd, J = 2.2, 8.2 Hz, 2H, HB4), 6.75 – 6.70 (m, 2H, 
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HB2), 3.98 (t, J = 6.1 Hz, 4H, D1), 3.76 (t, J = 6.0 Hz, 4H, D2), 3.72 – 3.45 (m, 8H), 3.42 – 
3.35 (m, 4H), 2.35 – 2.24 (m, 4H, D7), 1.65 – 1.52 (m, 4H, D8) . 
13C NMR (126 MHz, CD3CN) δ/ppm = 160.78 (CB3), 158.33 (CC2/C'2), 158.23 (CC2/C'2), 156.71 
(CA2), 153.54 (CA6), 150.26 (CC2 + CC'2), 140.34 (CB1), 140.14 (CC'4), 139.22 (CC4), 137.04 
(CA5), 136.33 (CA4), 132.06 (CB5), 129.47 (CC'5), 128.99(CC5), 125.97 (CC3/C'3/A3), 125.89 
(CC3/C'3/A3), 125.55 (CC3/C'3/A3), 120.88 (CB6), 118.85 (CB4), 113.01 (CB2), 71.95, 71.78, 71.60, 
71.22, 70.10 (CD2), 68.70 (CD1), 34.57 (CD7), 26.97 (CD8). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.09 (d, J = 706 Hz). 
MS (ESI, 130 °C): m/z = 1217.6 [M-PF6]+ (calc. 1217.3), 536.2 [M- 2 PF6]2+ (calc. 536.2). 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 457.0 [14700], 354 [39200, shoulder], 321.0 
[45700], 290 [86800]. 
Emission (MeCN, λexc = 350 nm, λmax(nm)) = 641. 
IR (ATR): ν∼/cm-1 =  2921m, 2892w, 2853m, 1728m, 1717m, 1601m, 1585w, 1464m, 1446m, 
1423m, 1372w,  1352w, 1302w, 1275m, 1243m, 1215m, 1121m, 1093m, 1055m, 1032m, 
940w, 876w, 829s, 792m, 767s, 740w, 732m, 695m, 690m, 660m. 
Anal. calc. for C58H62F12N6O8P2Ru·2.5H2O·0.35NaCl C 48.80, H 4.73, N 5.89; found C 
49.06, H 4.85, N 4.48. 
 
 
[Ru2(55)(bpy)4](PF6)4 (65) 
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Dinuclear Complex 65 was synthesised according to procedure 67 with ligand 55 (10.8 mg, 
11.2 µmol) and cis-[Ru(bpy)2Cl2] (10.8 mg, 22.4 µmol). Preparative thick layer 
chromatography (Al2O3, CH2Cl2 : MeOH (20:1)) yielded title compound 65 (12.1 mg, 5.1 
µmol, 46%) as an orange solid. 
 
1H NMR (600 MHz, CD3CN) δ/ppm = 8.48 (mc 8H, HC3+C'3), 8.41 (dd, J = 2.7, 8.5 Hz, 4H, 
HA3), 8.19 – 8.14 (m, 4H, HA4), 8.06 – 7.96 (m, 8H, HC4+C'4), 7.89 – 7.82 (m, 4H, HC6), 7.81 – 
7.75 (m, 8H, HA6+C'6), 7.43 – 7.35 (m, 8H, HC5+C'5), 7.32 (t, J = 8.1 Hz, 4H, HB5), 6.98 (dd, J = 
2.0, 8.7 Hz, 4H, HB4), 6.91 (mc, 8H, HB2+B6), 4.06 – 4.02 (m, 8H, HD1), 3.71 (mc, 8H, HD2), 
3.48 (mc, 8H, HD3), 1.59 – 1.55 (mc, 8H, HD4). 
13C NMR (151 MHz, CD3CN) δ/ppm = 160.01 (CB3), 157.55 (CC2), 157.25 (CC'2), 155.70 
(CA2), 152.40 (CC6 + CC'6), 149.26 (CA6), 139.86 (CA5), 138.21 (CC'4), 136.40 (CB1), 135.99 
(CA4), 131.03 (CB5), 128.05 (CC5), 127.96 (CC'5), 124.85 (CC'3), 124.67 (CC3), 124.55 (CA3), 
119.68 (CB6), 116.16 (CB4), 113.65 (CB2), 71.12 (CD3), 69.30 (CD2), 68.24 (CD1), 26.64 (CD4). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.09 (d, J = 706 Hz). 
MS (ESI): m/z = 1041.3 [M-2 PF6]2+(calc. 1041.2), 646.0 [M- 3 PF6]3+ (calc. 645.8), 448.2 
[M- 4 PF6]4+ (calc. 448.1). 
m.p.: 192-196 °C. 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 457.0 [19700], 315.0 [shoulder, 61800], 290.0 
[114300]. 
Emission (CH2Cl2, λexc = 450 nm, λmax(nm)) = 617. 
IR (ATR): ν∼/cm-1 = 3086w, 2922m, 2853m, 1601m, 1582m, 1464m, 1445m, 1369w, 1301w, 
1211m, 1119m, 1055w, 825s, 761m. 
Anal. calc. for C100H92F24N12O8P4Ru2 C 50.64, H 3.91, N 7.09; found C 50.58, H 4.12, 
N 7.13. 
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[Ru3(31)(bpy)6](PF6)6 (66) 
 
Trinuclear Complex 66 was synthesised according to procedure 67 with ligand 31 (27.3 mg, 
15.9 µmol) and cis-[Ru(bpy)2Cl2] (23.6 mg, 48.6 µmol). The mixture of the two 
diastereoisomers (ratio 5:1 from NMR) was synthesised as an orange solid (56.2 mg, 
14.7 µmol, 92%). Attempts to separate the two diastereoisomers chromatographically were 
not successful.  
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.55 (d, J = 8.6 Hz, 6H, HA3), 8.50 (t, J = 7.5 Hz, 12H, 
HC3+C'3), 8.29 (d, J = 8.5 Hz, 6H, HA4), 8.11 – 8.01 (m, 12H, HC4+C'4), 7.88 (d, J = 5.3 Hz, 6H, 
HC6), 7.81 (d, J = 5.4 Hz, 6H, HC'6), 7.79 (d, J = 1.5 Hz, 6H, HA6), 7.47 – 7.39 (m, 12H, 
HC5+C'5), 7.30 (t, J = 7.9 Hz, 6H, HB5), 6.99 – 6.90 (m, 18H, HB2+B4+B6), 4.09 – 4.00 (m, 12H, 
HD1), 3.79 – 3.71(m, 12H, HD2), 3.63 – 3.55 (m, 12H, HD3/D4), 3.55 – 3.47 (m, 12H, HD3/D4), 
3.42 – 3.33 (m, 12H, HD5), 1.52 (mc, 12H, HD6). 
13C NMR (126 MHz, CD3CN) δ/ppm = 160.54 (CB3), 158.25 (CC'2), 157.95 (CC2), 156.49 
(CA2), 153.12 (CC6 + CC'6), 149.99 (CA6), 140.56 (CB1), 138.95 (CC4/C'4), 138.88 (CC4/C'4), 
137.20 (CA5), 136.77 (CA4), 131.66 (CB5), 128.72 (CC'5), 128.65 (CC5), 125.54 (CC3/C'3), 125.33 
(CC3/C'3), 120.49 (CB4/B6), 116.98  (CB4/B6), 113.88  (CB2), 71.57  (CD5), 71.45  (CD3/D4), 70.86  
(CD3/D4), 70.21 (CD2), 68.75 (CD1), 27.25 (CD6). 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 457.0 [31200], 290.0 [181000]. 
Emission (CH2Cl2, λexc = 350 nm, λmax(nm)) = 621. 
m.p.: 170-176 °C. 
MS (ESI): m/z = 1765.7 [M-2 PF6]2+ (calc. 1766.4), 1128.5 [M- 3 PF6]3+ (calc. 1129.28), 
811.1 [M- 4 PF6]4+ (calc. 810.7) 619.8 [M- 5 PF6]5+ (calc. 619.6), 492.4 [M- 6 PF6]6+ (calc. 
492.2). 
IR (ATR): ν∼/cm-1 = 3061w, 2929m, 2864m, 1738m, 1728m, 1601m, 1582m, 1464m, 1447m, 
1369w, 1302w, 1217m, 1099m, 1059w, 827s, 761m. 
EXPERIMENTAL PART 
163 
Anal. calc. for C162H162F36N18O18P6Ru3 C 50.91, H 4.27, N 6.60; found C 50.63, H 4.19, 
N 6.20. 
 
 
Determination of sodium in 64 via atomic absorption spectroscopy 
Only ultrapure water (Milli-Q, >18 MΩ cm-3) and HPLC quality acetonitrile were used 
throughout these experiments. A sodium stock solution (10-4 M) was prepared by dissolving 
58.4 mg of NaCl in 100 mL of water and a 1 to 100 dilution of this solution. The standards 
were prepared by adding 1, 2, 3, 4, 6, 10 mL of the stock solution to a 100 mL volumetric 
flask. To each were 5 mL of acetonitrile added and the flask was filled to 100 mL with water 
yielding 1, 2, 3, 4, 6, 10 µM standard solutions. 
The sample was prepared by dissolving 8.9 mg of the ruthenium complex 64 (Mr 1386.6, 
64·0.35NaCl) in 2.5 mL of acetonitrile in a 50 mL flask which was then filled with water until 
the mark. This solution was diluted 1/100 with a 5% acetonitrile/water solution yielding a 
12.9 µM solution of 64. 
The atomic absorption of sodium of a blank and the standards were measured and a linear 
least square fit was calculated for standards 2,3,4, 6 and 10 µM solutions after correction of 
background absorption. The slope was calculated as 0.0113(3) a.u./µM and an intercept of  
0.001(1) was found. The atomic absorption of the sample was measured and the sodium 
concentration of the sample could then be calculated as 4.46 µM.  
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6.3 Experimental for Compounds in Chapter 4 
 
Ligand 42 
 
 
5,5'-Bis(3'-hydroxyphenyl)-2,2'-bipyridine  (1.63 g, 4.79 mmol), 3-(2-bromoethoxy)prop-1-
ene (1.57 g, 9.63 mmol) and Cs2CO3 (6.24 g, 19.0 mmol) were dissolved in dry DMF 
(200 mL). The reaction mixture was heated for 4 d at 120 °C. Removal of DMF, column chro-
matography (SiO2, CH2Cl2 : MeOH (66:1)) and filtration over Al2O3 yielded 42 as a 
colourless crystalline solid (2.17 g, 4.27 mmol, 89%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.97 (d, J = 2.1 Hz, 2H, HA6), 8.54 (d, J = 8.2 Hz, 2H, 
HA3), 8.06 (dd, J = 2.3, 8.3 Hz, 2H, HA4), 7.45 (t, J = 7.9 Hz, 2H, HB5), 7.32 – 7.26 (m, 4H, 
HB2+B6), 7.03 (dd, J = 2.2, 8.2 Hz, 2H, HB4), 6.05 – 5.94 (m, 2H, HD1), 5.37 (dd, J = 1.6, 17.2 
Hz, 2H, HD2,trans), 5.27 (dd, J = 1.2, 10.4 Hz, 2H, HD2,cis), 4.29 – 4.24 (m, 4H, HE1), 4.19 – 
4.14 (m, 4H, HE3), 3.92 – 3.86 (m, 4H, HE2). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.3 (CB3), 154.70 (CA2), 147.7 (CA6), 138.9 (CB1), 
136.2 (CA5), 135.2 (CA4), 134.5 (CD1), 130.1 (CB5), 120.9 (CA3), 119.7 (CB6), 117.4 (CD2), 
114.0 (CB4), 113.6 (CB2), 72.4 (CE3), 68.4 (CE2), 67.5 (CE1). 
MS (EI): m/z = 508.2 [M·+] (calc. 508.2), 424.2[(M-C5H8O) ·+] (calc. 424.2), 340.1[(M-
2C5H8O) ·+] (calc. 340.1). 
mp.: 96-98 °C. 
IR (ATR): ν∼/cm-1 = 3005w, 2932w, 2856w, 1605m, 1576s, 1464m, 1452s, 1441m, 1358m, 
1300m, 1279m, 1205s, 1142m, 1130m, 1099m, 1068m,  1016m,  947m, 937m, 918m, 835m, 
781s, 694s. 
Anal. calc. for C32H32N2O2 C 75.57 H 6.34 N 5.51; found C 75.54 H 6.50 N 5.39. 
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5,5'-Bis(3-(allyloxy)phenyl)-2,2'-bipyridine (72) 
 
 
5,5'-Bis(3'-hydroxyphenyl)-2,2'-bipyridine  (88.4 mg, 260 µmol), allyl bromide (1.0 mL, 
11.5 mmol) and Cs2CO3 (350 mg, 1.07 mmol) were heated in THF to 100 °C in a microwave 
reactor for 45 min. Column chromatography (SiO2, CH2Cl2 : MeOH (100:1)) yielded ligand 
72 as a colourless solid (106 mg, 252 µmol, 96%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.93 (d, J = 2.1 Hz, 2H, HA6), 8.50 (d, J = 8.2 Hz, 2H, 
HA3), 8.03 (dd, J = 8.2, 2.3 Hz, 2H, HA4), 7.42 (t, J = 7.9 Hz, 2H, HB5), 7.26 – 7.24 (m, 2H, 
HB6), 7.22 – 7.21 (m, 2H, HB2), 6.98 (dd, J = 8.2, 2.4 Hz, 2H, HB4), 6.15 – 6.04 (m, 2H, HD1), 
5.47 (dd, J = 17.3, 1.5 Hz, 2H, HD2, trans), 5.33 (dd, J = 10.5, 1.3 Hz, 2H, HD2, cis), 4.63 (d, J = 
5.3 Hz, 4H, HE1). 
13C NMR (126 MHz, CDCl3) δ/ppm = 159.2 (CB3), 154.8 (CA2), 147.7 (CA6), 139.0 (CB1), 
136.3 (CA5), 135.3 (CA4), 133.1 (CD1), 130.2 (CB5), 121.0 (CA3), 119.7 (CB6), 117.9 (CD2), 
114.3 (CB4), 113.7 (CB2), 68.9 (CE1). 
m.p.: 135-137 °C. 
IR (ATR): ν∼/cm-1 = 2874m, 2869m, 1605m, 1578s, 1460s, 1435m, 1362w, 1297m, 1278m, 
1201s, 1175w, 1113m, 1099m, 1068m,  1016m,  947m, 934m, 937m, 918m, 841m, 779s.  
MS (EI): m/z = 421.2 [M+H] + (calc. 421.2).   
Anal. calc. for C28H24N2O2 · 0.2 H2O C 79.30 H 5.80 N 6.61; found C 79.13 H 6.10 N 6.31. 
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[Pd(34)2](BF4)2 (74) 
 
 
5,5'-Bis(3-methoxyphenyl)-2,2'-bipyridine (34) (227 mg, 617 µmol) in abs. CH2Cl2 (10 mL) 
was added to a solution of [Pd(CH3CN)4](BF4)2 (137 mg, 308 µmol) in abs. CH3CN (10 mL) 
and stirred at room temperature for 24 h. The solution turned pale yellow and a yellow 
precipitate was formed. All volatiles were removed in vacuum yielding the desired complex 
74 (313 mg, 308 µmol, quant.). 
 
 
1H NMR (500 MHz, DMSO) δ/ppm = 9.15 (sb, 4H, HA6), 8.90 (sb, 8H, HA3+A4), 7.43 (m, 8H, 
HB2+B6), 7.39 (t, J = 7.8 Hz, 4H, HB5), 7.13 (d, J = 7.4 Hz, 4H, HB4), 3.73 (s, 12H, OMe). 
13C NMR (101 MHz, DMSO) δ/ppm = 160.1 (CB3), 154.5 (CA2), 149.5 (CA6), 140.0 (CA3/A4), 
139.2 (CA5), 135.6 (CB1), 130.5 (CB5), 124.3 (CA3/A4), 119.7 (CB6), 115.6 (CB4), 112.8 (CB2), 
55.2 (OCH3). 
19F NMR (376 MHz, DMSO) δ/ppm = -149 (s). 
MS (FAB): m/z = 929.1 (0.68, [PdL2](BF4)+, calc. 929.2), 861.1 (8.70), 842.1 (9.35, [PdL2]+, 
calc. 842.2), 474.0 (37.05, [PdL]+, calc. 474.1), 369.1 (100, LH+, calc. 369.2). 
MS (ESI): m/z = 879.0 [M-2BF4+Cl]+ (calc. 878.7), 448.7 (?), 369.4 [LH+] (calc. 369.2). 
IR (ATR): ν∼/cm-1 = 3005w, 2932w, 2856w, 1738m, 1605m, 1576m, 1464m, 1452s, 1435m, 
1300m, 1231m, 1205m, 1063m, 1016m, 843m, 837m, 779s, 692s. 
 
Anal. calc. for C48H40B2F8N4O4Pd C 56.70, H 3.96, N 5.51; found C 56.53, H 4.10, N 5.41. 
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[Pd(72)2](BF4)2 (75) 
 
 
Complex 75 (85.1 mg, 75.9 µmol, 99.9%) was synthesised according to procedure for 74 
from ligand 72 (64.1mg, 152 µmol) and [Pd(CH3CN)4](BF4)2 (34.2 mg, 77.0 µmol). 
 
1H NMR (500 MHz, aceton-d6) δ/ppm = 9.33 (sb, 4H, HA6), 8.89 – 8.78 (m, 8H, HA3+A4), 7.47 
– 7.44 (m, 4H, HB2), 7.43 – 7.40 (m, 8H, HB5+B6), 7.17 – 7.10 (m, 4H, HB4), 6.10 – 5.98 (m, 
4H, Ha), 5.39 (dq, J = 1.7, 17.3 Hz, 4H, Hc), 5.24 (dq, J = 1.5, 10.6 Hz, 4H, Hb), 4.60 (dt, J = 
1.5, 5.2 Hz, 8H, -OCH2). 
13C NMR (126 MHz, aceton-d6) δ/ppm = 160.5 (CB3), 156.2 (CA2), 150.3 (CA6), 140.91 (CA5), 
140.90 (CA3/A4), 137.0 (CB1), 134.4 (OCH2CH), 131.6 (CB5), 125.3 (CA3/A4), 120.7 (CB6), 
117.8 (OCH2CHCH2), 117.1 (CB2), 114.5 (CB4), 69.5 (OCH2). 
19F NMR (376 MHz, acetone-d6) δ/ppm = -152.2 (s). 
MS (ESI): m/z = 473.3 [M- 2BF4]2+ (calc. 473.2). 
IR (ATR): ν∼/cm-1 = 3070m, 2924m, 2168m, 2037w, 1736w, 1582w, 1466m, 1373w, 1304m, 
1250m, 1211m, 1026s, 918m, 841m, 779m, 687m. 
 
Anal. calc. for C56H48B2F8N4O4Pd C 60.00, H 4.32, N 5.00; found C 60.64, H 4.49, N 4.80. 
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[Pd(42)2](BF4)2 (76) 
 
 
Complex 76 (129 mg, 99.4 µmol, quant.) was synthesised according to procedure 74 from 
ligand 42 (100 mg, 197 µmol) and [Pd(CH3CN)4](BF4)2 (44.1 mg, 99.3 µmol). 
 
1H NMR (500 MHz, CD3CN/CDCl3) δ/ppm = 8.76 (sb, 4H, HA6), 8.46 (sb, 8H, HA3+A4), 7.30 
(t, J = 7.9 Hz, 4H, HB5), 7.17 (s, 4H, HB2), 7.14 (d, J = 7.6 Hz, 4H, HB6), 7.00 (d, J = 8.2 Hz, 
4H, HB4), 5.92 – 5.79 (m, 4H, Ha), 5.25 (dd, J = 1.4, 17.3 Hz, 4H, Hb), 5.14 (d, J = 10.4 Hz, 
4H, Hc), 4.10 – 4.04 (m, 8H, CH2E1), 4.01 (d, J = 5.5 Hz, 8H, CH2E3), 3.75 – 3.68 (m, 8H, 
CH2E2). 
13C NMR (126 MHz, CD3CN/CDCl3) δ/ppm = 160.0 (CB3), 155.0 (CA2), 148.9 (CA6), 140.1 
(CA3/A4), 136.0 (CA5/B1), 135.8 (CA5/B1), 134.8 (CHCH2), 131.0 (CB5), 124.7 (CA3/A4), 119.9 
(CB6), 117.2 (CHCH2), 116.6 (CB4), 113.4 (CB2), 72.3 (CE3), 68.6 (CE2), 67.9 (CE1). 
19F NMR (376 MHz, aceton-d6) δ/ppm = -152.6 (s). 
MS (ESI): m/z = 1157.6 [Pd(42)2Cl]+ (calc. 1157.4). 
IR (ATR): ν∼/cm-1 = 3070m, 2924m, 2168m, 2037w, 1736w, 1582w, 1466m, 1373w, 1304m, 
1250m, 1211m, 1026s, 918m, 841m, 779m, 686m. 
Anal. calc. for C64H64B2F8N4O4Pd C 59.26, H 4.97, N 4.32; found C 60.03, H 5.15, N 4.36. 
 
5,5'-Bis(3-methoxyphenyl)-6-methyl-2,2'-bipyridine (77)  
 
 
5,5'-Bis(3-methoxyphenyl)-2,2'-bipyridine (34) (1.28 g, 3.47 mmol) was dissolved in 
anhydrous toluene (250 mL) and cooled to –78 °C. Methyl lithium (2.4 mL, 1.6M solution in 
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hexane, 3.82 mmol) was added drop wise to this solution. A slight colour change from 
colourless to orange was observed. The reaction mixture was allowed to warm to room 
temperature over night and the colour changed to intense blue/violet. To ensure complete 
conversion the solution was stirred again for 30 min at 100 °C (colour change to orange). 
Then the solution was cooled to room temperature and was extracted with H2O (200 mL). The 
water phase was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were 
dried over MgSO4, filtered and stirred in the presence of MnO2 (10 g) for 6h. Filtration and 
removal of solvents yielded colourless bipyridine 77 (1.09 g, 2.85mmol, 82%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.93 (d, J = 2.2 Hz, 1H, HA6), 8.54 (d, J = 8.2 Hz, 1H, 
HA3), 8.30 (d, J = 7.9 Hz, 1H, HC3), 8.02 (dd, J = 8.2, 2.3 Hz, 1H, HA4), 7.68 (d, J = 8.0 Hz, 
1H, HC4), 7.42 (t, J = 7.9 Hz, 1H, HB5), 7.38 (t, J = 7.8 Hz, 1H, HD5), 7.25 (d, J = 7.5 Hz, 1H, 
HB6), 7.20 – 7.18 (m, 1H, HB2), 6.99 – 6.91 (m, 4H, HB4+D2+D4+D6), 3.90 (s, 3H, HB, OMe), 3.86 
(s, 3H, HD, OMe), 2.63 (s, 3H, HC, Me). 
13C NMR (126 MHz, CDCl3) δ/ppm = 160.12 (CB3), 159.48 (CD3), 155.36 (CA2), 155.18 
(CC2), 154.08 (CC6), 147.67 (CA6), 141.33 (CD1), 139.17 (CB1), 138.01 (CC4), 136.81 (CC5), 
136.08 (CA5), 135.18 (CA4), 130.13 (CB5), 129.42 (CD5), 121.49 (CD6), 120.97 (CA3), 119.51 
(CB6), 118.28 (CC3), 114.82 (CD4), 113.37 (CB4), 112.85 (CD2), 112.81 (CB2), 55.34 (CB, OMe), 
55.29 (CD, OMe), 23.72 (CC, Me). 
MS (EI): m/z = 382.2 [M]+ (calc. 282.2). 
mp.: 143-144 °C. 
IR (ATR): ν∼/cm-1 = 3060w, 2993w, 2929w, 2832w, 1606m, 1578m, 1458s, 1439m, 1432m, 
1418m, 1295m, 1283s, 1209s, 1178m, 1167m, 1048m, 1035m, 1019m, 841s, 697s. 
Anal. calc. for C25H22N2O2 C 78.51 H 5.80 N 7.32; found C 78.34 H 5.98 N 7.13. 
 
5,5'-Bis(3-methoxyphenyl)-6,6'-dimethyl-2,2'-bipyridine (78) 
 
 
 
5,5'-Bis(3-methoxyphenyl)-6-methyl-2,2'-bipyridine (77) (102 mg, 267 µmol) was dissolved 
in anhydrous toluene (30 mL) and cooled to –20 °C. Methyl lithium (180 µL, 1.6M solution in 
hexane, 293 µmol) was added drop wise and an intense blue coloration appeared. The reaction 
mixture was stirred for 1h at this temperature, allowed to warm to room temperature and H2O 
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(5 mL) was added. The water phase was separated and extracted with CH2Cl2 (3 x 10 mL). 
The combined organic layers were treated with MnO2 (2 g) and stirred for 5 h at room 
temperature. Column chromatography (Al2O3, CH2Cl2) yielded colourless title compound 78 
(58.3 mg, 147 µmol 55%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.93 (d, J = 2.2 Hz, 1H, HA6), 8.54 (d, J = 8.2 Hz, 1H, 
HA3), 8.30 (d, J = 7.9 Hz, 1H, HC3), 8.02 (dd, J = 8.2, 2.3 Hz, 1H, HA4), 7.68 (d, J = 8.0 Hz, 
1H, HC4), 7.42 (t, J = 7.9 Hz, 1H, HB5), 7.38 (t, J = 7.8 Hz, 1H, HD5), 7.25 (d, J = 7.5 Hz, 1H, 
HB6), 7.20 – 7.18 (m, 1H, HB2), 6.99 – 6.91 (m, 4H, HB4+D2+D4+D6), 3.90 (s, 3H, HB, OMe), 3.86 
(s, 3H, HD, OMe), 2.63 (s, 3H, HC, Me). 
13C NMR (126 MHz, CDCl3) δ/ppm = 160.12 (CB3), 159.48 (CD3), 155.36 (CA2), 155.18 
(CC2), 154.08 (CC6), 147.67 (CA6), 141.33 (CD1), 139.17 (CB1), 138.01 (CC4), 136.81 (CC5), 
136.08 (CA5), 135.18 (CA4), 130.13 (CB5), 129.42 (CD5), 121.49 (CD6), 120.97 (CA3), 119.51 
(CB6), 118.28 (CC3), 114.82 (CD4), 113.37 (CB4), 112.85 (CD2), 112.81 (CB2), 55.34 (CB, OMe), 
55.29 (CD, OMe), 23.72 (CC, Me). 
MS (ESI): m/z = 397.4 [M+H]+ (calc. 397.2), 419.2 [M+Na]+ (calc. 419.2), 815.6 [2M+Na]+ 
(calc. 815.4). 
IR (ATR): ν∼/cm-1 = 3077w, 3052w, 2989m, 2959m, 2924m, 2832m, 1606m, 1575m, 1456m, 
1289m, 1209s, 1179m, 1049m, 1018m, 879w, 841s, 781s. 
Found C, 76.12; H, 6.15; N, 6.70; C26H24N2O2 · 0.75H2O requires C, 76.17; H, 6.27; N, 
6.83 %. 
 
Compound 79 
 
Compound 34 (1.92 g, 5.21 mmol) was dissolved in toluene (250 mL). Methyl lithium (3.9 
mL, 1.6 M solution in hexane, 6.25 mmol) was added dropwise at r. t. resulting in a 
blue/violet solution. Water (40 mL) was added and the organic phase was separated. The 
water phase was extracted with CH2Cl2 and the combined organic layers were dried over 
MgSO4, filtered and stirred in the presence of MnO2 (25 g) for 6h. After final filtration, spot 
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tlc showed the presence of two components. These were separated using column 
chromatography (Al2O3, CH2Cl2 → CH2Cl2 : MeOH (20:1)) and solvent removed from the 
fractions to yield 5 (first fraction, 668 mg, 1.75 mmol, 34%) and 7 (second fraction, 621 mg, 
814 µmol, 31%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.68 (d, J = 1.7 Hz, 2H, HA6), 7.72 (dd, J = 8.1, 2.2 Hz, 
2H, HA4), 7.53 (s, 2H, HE4), 7.52 (d, J = 8.1 Hz, 2H, HA3), 7.40 (t, J = 7.9 Hz, 2H, HB5), 7.31 
(t, J = 7.9 Hz, 2H, HF5), 7.17 (d, J = 7.7 Hz, 2H, HB6), 7.10 (s, 2H, HB2), 6.95 (dd, J = 8.2, 2.1 
Hz, 2H, HB4), 6.91 – 6.86 (m, 4H, HF4+F6), 6.81 (s, 2H, HF2), 3.87 (s, 6H, HB, OMe), 3.78 (s, 6H, 
HF, OMe), 2.63 (s, 6H, HMe). 
13C NMR (126 MHz, CDCl3) δ/ppm = 160.06 (CB3), 159.41 (CF3), 156.54 (CA2), 154.46 (CE6), 
153.30 (CE2), 147.20 (CA6), 140.55(CF1), 140.40 (CE4), 139.10(CB1), 136.14 (CE5), 134.85 
(CA5), 134.40 (CA4), 131.86 (CE3), 130.07 (CB5), 129.33 (CF5), 124.16 (CA3), 121.46 (CF6), 
119.47(CB6), 114.65 (CF2), 113.21 (CB4), 113.00 (CF4), 112.89 (CB2), 55.29 (CB, OMe), 55.19 
(CF, OMe), 23.31 (CMe). 
MS (ESI): m/z = 763.4 [M + H]+ (calc. 763.3). 
IR (ATR): ν∼/cm-1 = 3001w, 2932w, 2831 w, 1599s, 1578s, 1450m, 1424s, 1363w, 1285m, 
1211s, 1163m, 1037m, 1013m, 844m, 777s, 690s. 
Found C, 77.36; H, 5.70; N, 7.22; C50H42N4O4 · 0.75H2O requires C, 77.35; H, 5.65; N, 
7.22 %. 
 
[Cu(77)2](PF6) (80) 
 
 
To a solution of ligand 77 (32.0 mg, 83.7 µmol) in abs. CH2Cl2 (5 mL) [Cu(CH3CN)4](PF6) 
(15.7 mg, 42.0 µmol) dissolved in abs. CH3CN (5 mL) was added in N2-atmosphere. The red 
solution was stirred for 30 min at room temperature filtered over Al2O3 and the solvents were 
removed in vacuum. The copper(I) complex 80 (40.1 mg, 41.2 µmol, 98%) was analytically 
pure.  
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.91 (d, J = 1.7 Hz, 2H, HA6), 8.48 (d, J = 8.4 Hz, 2H 
HA3), 8.30 (d, J = 8.1 Hz, 2H, HC3), 8.24 (d, J = 7.1 Hz, 2H, HA4), 7.83 (d, J = 8.0 Hz, 2H, 
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HC4), 7.41 – 7.35 (m, 4H, HB5+D5), 7.25 (d, J = 7.8 Hz, 2H, HB6), 7.24 – 7.20 (m, 2H, HB2), 
7.01 – 6.91 (m, 8H, HB4+D2+D4+D6), 3.81 (s, 6H, HB, OMe), 3.80 (s, 6H, HD, OMe), 2.39 (s, 6H, 
HMe). 
13C NMR (126 MHz, CD3CN) δ/ppm = 161.39 (CB3), 160.74 (CD3), 156.25 (CC6), 153.74 (CA2), 
152.71 (CC2), 148.42 (CA6), 141.54 (CD1), 139.60 (CC4), 139.29 (CC5), 139.01 (CB1), 138.39 (CA5), 
136.66 (CA4), 131.41 (CB5), 130.75 (CD5), 122.44 (CA3), 122.31 (CD6), 120.36 (CB6), 119.86 (CC3), 
115.75 (CD2), 115.17 (CD4), 114.32 (CB4), 113.60 (CB2), 56.12 (CB, OMe), 56.08 (CD, OMe), 24.64 (CMe). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.1 (d, J = 705 Hz). 
IR (ATR): ν∼/cm-1 = 3062 w, 2954 w, 2922 m, 2850 w, 1599 m, 1581 m, 1470 m, 1447 m, 
1435 m, 1377 w, 1300 m, 1251 w, 1224 m, 1045 s, 1021 s, 837 s, 786 s, 690 m. 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 468 [6000], 319.0 [61000], 277.0 [50500]. 
Emission (CH2Cl2, λmax(nm), exc 350 nm) = 379. 
Found C, 61.39; H, 4.75; N, 5.54; C50H44CuN4O4PF6 requires C, 61.69; H, 4.56; N, 5.76 %. 
 
[Cu(80)2](PF6) (81) 
 
Copper(I) complex 81 was prepared analogue to procedure for 80 with ligand 78 (40.0 mg, 
101 µmol) and [Cu(CH3CN)4](PF6) (19 mg, 50.9 µmol). Filtration over Al2O3 yielded title 
compound 81 (48.1 mg, 48.0 µmol, 94%). 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.35 (d, J = 7.1 Hz, 4H, HC3), 7.98 (d, J = 7.3 Hz, 4H, 
HC4), 7.39 (t, J = 7.8 Hz, 4H, HD5), 7.03 – 6.94 (m, 12H, HD2+D4+D6), 3.80 (s, 12H, OMe), 2.32 
(s, 12H, Me). 
13C NMR (126 MHz, CD3CN) δ/ppm = 160.77 (CD3), 156.22 (CC6), 151.52 (CC2), 141.00 
(CD1), 140.32 (CC5), 140.10 (CC4), 130.85 (CD5), 122.35 (CD6), 120.70 (CC3), 115.83 (CD4), 
114.57 (CD2), 56.13 (COMe), 24.83 (CMe). 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.1 (d, J = 703 Hz). 
MS (ESI): m/z = 856.0 [M- PF6]+ (calc. 855.3) 
mp.: 240-243 °C. 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 467 [6100], 320.0 [61000], 277.0 [50600]. 
Emission (CH2Cl2, λmax(nm), exc 350 nm) = 383. 
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IR (ATR): ν∼/cm-1 = 3057w, 2972w, 2918w, 2842w, 1589m, 1448m, 1230w, 1223m, 1047w, 
1022m, 831s, 787m, 702m. 
Anal. calc. for C52H48CuF6N6O6P C 62.36, H 4.83, N 5.59; found C 62.96, H 4.95, N 5.58. 
 
5-Bromo-5'-(3-methoxyphenyl)-2,2'-bipyridine (82) 
 
 
3-Methoxyphenylboronic acid (33) (851 mg, 5.60 mmol) was added to 5,5'-dibromo-2,2'-
bipyridine (32) (1.90 g, 6.05 mmol) followed by toluene (200 mL), Na2CO3 (1.78 g, 
17.8 mmol) and water (50 mL). The biphasic mixture was then degassed for 20 min by 
bubbling nitrogen through the solution. [Pd(PPh3)4] (195 mg, 168 µmol) was added and the 
mixture was heated to reflux for 20 h. After cooling to room temperature, the phases were 
separated and the aqueous layer extracted with CH2Cl2 (3 × 50 mL). The organic extracts 
were combined and dried with MgSO4. After purification via chromatography (Al2O3, DCM) 
and (SiO2, CH2Cl2 : MeOH (100:1)) a colourless solid (820 mg, 2.40 mmol, 40%) could be 
isolated.  
 
1H NMR (500 MHz, CDCl3) δ/ppm = 8.89 (d, J = 1.9 Hz, 1H, HA6), 8.73 (d, J = 2.1 Hz, 1H, 
HA'6), 8.43 (d, J = 8.3 Hz, 1H, HA3), 8.35 (d, J = 8.5 Hz, 1H, HA'3), 8.00 (dd, J = 8.2, 2.3 Hz, 
1H, HA4), 7.94 (dd, J = 8.5, 2.3 Hz, 1H, HA'4), 7.41 (t, J = 7.9 Hz, 1H, HB5), 7.23 (d, J = 7.8 
Hz, 1H, HB6), 7.18 – 7.14 (m, 1H, HB2), 6.97 (dd, J = 8.2, 2.1 Hz, 1H, HB4), 3.88 (s, 3H, 
OMe). 
13C NMR (126 MHz, CDCl3) δ/ppm =160.1 (CB3), 154.3 (CA'2), 154.0 (CA2), 150.2 (CA'6), 
147.7 (CA6), 139.5 (CA'4), 138.9 (CB1), 136.6 (CA5), 135.3 (CA4), 130.2 (CB5), 122.3 (CA'3), 
121.1 (CA'5), 120.8 (CA3), 119.5 (CB6), 113.5 (CB4), 112.9 (CB2), 55.3 (OMe). 
MS (EI): m/z = 340.0 [M·+] (calc. 340.0). 
m.p.: 149-150 °C. 
IR (ATR): ν∼/cm-1 = 3080w, 3003w, 2952w, 2931w, 2834w, 1605m, 1575m, 1454s, 1433m, 
1360m, 1298m, 1283m, 1215m, 1170w, 1090m, 1052m, 1013s, 1003m, 928m, 833s, 816m, 
783m, 779m, 771m, 733m, 692w. 
Anal. calc. for C17H13BrN2O C 59.84, H 3.84, N 8.21; found C 59.75, H 3.80, N 8.16. 
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5'-(3-Methoxyphenyl)-2,2'-bipyridine-5-carbaldehyde (83) 
 
 
5-Bromo-5'-(3-methoxyphenyl)-2,2'-bipyridine (82) (760 mg, 2.23 mmol) was dissolved in 
abs. toluene (80 mL) and cooled to –78 °C. N-butyl lithium (1.46 mL, 1.6 M solution in 
hexane, 2.34 mmol) was added drop wise. The dark red solution was stirred for 30 min at this 
temperature before abs. DMF (3.44 ml) was added. The reaction mixture was gradually 
allowed to warm to room temperature and then poured to H2O (500 mL). The organic phase 
was separated and the water phase extracted with CH2Cl2 (3 x 50 mL). The combined organic 
layers were treated with MgSO4 and filtered. Column chromatography (Al2O3, CH2Cl2 : 
MeOH (0% → 2%)) yielded aldehyde 83 (190 mg, 654 µmol, 29%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 10.15 (s, 1H, CHO), 9.12 (d, J = 1.6 Hz, 1H, HA'6), 8.94 
(d, J = 1.9 Hz, 1H, HA6), 8.63 (d, J = 8.2 Hz, 1H, HA'3), 8.56 (d, J = 8.2 Hz, 1H, HA3), 8.28 
(dd, J = 8.2, 2.1 Hz, 1H, HA'4), 8.03 (dd, J = 8.2, 2.4 Hz, 1H, HA4), 7.42 (t, J = 7.5 Hz, 1H, 
HB5), 7.23 (d, J = 7.7 Hz, 1H, HB6), 7.18 – 7.16 (m, 1H, HB2), 6.97 (dd, J = 8.2, 2.1 Hz, 1H, 
HB4), 3.88 (s, 3H, OMe). 
13C NMR (126 MHz, CDCl3) δ/ppm = 190.53 (CCHO), 160.33 (CA'2), 160.16 (CB3), 153.53 
(CA2), 151.69 (CA'6), 147.94 (CA6), 138.61 (CB1), 137.37 (CA5), 136.85 (CA'4), 135.31 (CA4), 
130.97 (CA'5), 130.23 (CB5), 122.09 (CA3), 121.17 (CA'3), 119.53 (CB6), 113.70 (CB4), 112.93 
(CB2), 55.34 (COMe). 
IR (ATR): ν∼/cm-1 = 2952w, 2852w, 1696s, 1676s, 1590m, 1583m, 1572m, 1545m, 1465s, 
1359m, 1285m, 1210m, 1171w, 1114m, 1050m, 1010s, 994m, 838s, 772m, 740m, 695m. 
MS (EI): m/z = 290.1 [M]+ (calc. 290.1). 
m.p.: 151-154 °C. 
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Heteroditopic ligand 73 
 
 
5'-(3-Methoxyphenyl)-2,2'-bipyridine-5-carbaldehyde (83) (180 mg, 620 µmol), 1-(pyridin-2-
yl)ethanone (146 µl, 1.30 mmol), KOH (powder, 73.0 mg, 1.30 mmol) and NH3 (25%, 1.4 
mL) were stirred at 50 °C for 30 min in EtOH. The reaction mixture was stirred over night at 
room temperature and all volatiles were removed in vacuum. Column chromatography 
(Al2O3, CH2Cl2 : MeOH (0% → 1%)) yielded the heteroditopic ligand 73 (80.3 mg, 
163 µmol, 26%). 
 
1H NMR (500 MHz, CDCl3) δ/ppm = 9.22 (d, J = 1.5 Hz, 1H, HA6), 8.95 (d, J = 1.6 Hz, 1H, 
HB6), 8.81 (s, 2H, HT3'), 8.75 (d, J = 4.2 Hz, 2H, HT6+T6''), 8.69 (d, J = 7.9 Hz, 2H, HT3+T3''), 
8.59 (d, J = 8.4 Hz, 1H, HA3), 8.57 (d, J = 8.4 Hz, 1H, HB3), 8.34 (dd, J = 8.2, 2.1 Hz, 1H, 
HA4), 8.05 (dd, J = 8.2, 2.0 Hz, 1H, HB4), 7.90 (t, J = 7.7 Hz, 2H, HT4+T4''), 7.43 (t, J = 7.9 Hz, 
1H, HC5), 7.41 – 7.35 (m, 2H, HT5+T5''), 7.26 (d, J = 3.8 Hz, 2H, HC6), 7.19 (s, 1H, HC2), 7.01 – 
6.95 (m, 1H, HC4), 3.89 (s, 3H, OMe). 
13C NMR (126 MHz, CDCl3) δ/ppm = 160.16 (CC3), 156.23 (CT2'), 156.12 (CA2), 155.88 
(CT2+T2''), 154.51 (CB2), 149.17 (CT6+T6''), 147.90 (CT4'), 147.74 (CA6), 147.01 (CB6), 139.01  
(CB1), 136.99 (CT4+T4''), 136.61 (CB5), 135.58 (CA4), 135.35 (CB4), 133.96 (CA5), 130.19 (CC5), 
124.04 (CT5+T5''), 121.42 (CT3+T3''), 121.30 (CA3), 120.96 (CB3), 119.56 (CC6), 118.67 (CT3'), 
113.56 (CC4), 112.86 (CC2), 55.37 (OMe). 
MS (EI): m/z = 493.2 [M]+. 
m.p.: 221-225 °C (with partial decomposition). 
IR (ATR): ν∼/cm-1 = 3052w, 3000w, 2964w, 1603m, 1582m, 1576m, 1565m, 1558m, 1465s, 
1406m, 1358m, 1300m, 1234m, 1210m, 1179w, 1121m, 1035m, 1012s, 990m, 849m, 843m, 
836s, 788m, 780m, 741m, 731m, 697m, 651m. 
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Anal. calc. for C32H23N5O·1.75 H2O C 73.20, H 5.09, N 13.34; found C 73.10, H 5.11, 
N 13.41. 
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6.6 Experimental for Compounds in Chapter 5 
 
5,5'-Di(pyren-1-yl)-2,2'-bipyridine (84) 
 
 
Pyren-2-ylboronic acid (1.00 g, 4.06 mmol), 5,5'-dibromo-2,2'-bipyridine (32) (593 mg, 
1.89 mmol) and Na2CO3 (801 mg, 7.56 mmol) were dissolved in toluene (200 mL) and 
water (50 mL). The biphasic reaction mixture was degassed with N2 (30 min) prior to the 
addition of [Pd(PPh3)4] (219 mg, 189 µmol). The reaction mixture was stirred at reflux for 3 d 
under rigorous exclusion of light. An insoluble solid formed which was collected on a frit, 
washed with water (50 mL) and Et2O (50 mL) yielding title compound 84 (1.05 g,1.89 mmol, 
quant.).  
 
1H NMR (500 MHz, CD2Cl2/TFA (1:1)) δ/ppm = 9.43 (d, J = 1.8 Hz, 2H, HA6), 9.15 (dd, J = 
2.0, 8.2 Hz, 2H, HA4), 8.91 (d, J = 8.3 Hz, 2H, HA3), 8.46 (d, J = 7.9 Hz, 2H, HP), 8.39 (mc, 
4H, H2xP), 8.36 – 8.29 (m, 4H, H2xP), 8.26 – 8.13 (m, 8H, H4xP). 
13C NMR (126 MHz, CD2Cl2/TFA (1:1)) δ/ppm = 149.48, 146.92, 145.58, 142.36, 134.77, 
132.73, 132.05, 131.63, 130.96, 129.93, 128.65, 128.33, 128.26, 128.20, 128.17, 127.94, 
127.59, 126.69, 126.31, 125.64, 122.79. 
MS (EI): m/z = 556.2 [M+] (calc. 556.2), 278.1 [M2+] (calc. 278.1). 
UV-Vis (CH2Cl2, λmax(nm) [ε/ (cm-1 M-1)]) = 243 [93050], 280 [55100], 357 [55500]. 
Emission (CH2Cl2, λmax(nm), λexc = 355 nm) = 476. 
84H+: 
UV-Vis (CH2Cl2/TFA(1%), λmax(nm) [ε/(cm-1 M-1)]) = 276 [43300], 341 [46100], 432 
[14500]. 
Emission (CH2Cl2/TFA(1%), λmax(nm), λexc = 355 nm) = 609. 
Anal. calc. for C42H24N2·1.25H2O C 87.10, H 4.61, N 4.84; found C 87.08, H 4.38, N 4.76. 
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[Fe(84)3](BF4)2 (85) 
 
 
5,5'-Di(pyren-1-yl)-2,2'-bipyridine (84) (70.7 mg, 127 µmol) and iron(II) tetrafluoroborate 
hexahydrate (42.8 mg, 127 µmol) were suspended in MeCN (10 mL) and stirred in a 
microwave reactor (110 °C, 30 min). The solution was reduced to 2 mL and the compound 
was precipitated with H2O, filtered and washed with H2O (30 mL) and ether (30 mL). The 
resulting red iron(II) complex (50.9 mg, 26.7 µmol, 21%) is poorly soluble in MeCN and 
DMSO and unstable in DMSO (decolouration after 20 h). 
 
1H NMR (400 MHz, DMSO-d6) δ/ppm = 9.03 (d, J = 7.2 Hz, 6H), 8.37 (dd, J = 1.7, 8.1 Hz, 
6H), 8.27 (d, J = 5.3 Hz, 6H), 8.20 (d, J = 9.3 Hz, 6H), 8.10 (d, J = 9.1 Hz, 6H), 8.04 (sb, 6H), 
8.00 – 7.88 (m, 12H), 7.62 (s, 6H), 7.06 (sb, 6H), 6.06 (sb, 6H), 5.49 (sb, 6H). 
19F NMR (376 MHz, CD3CN) δ/ppm = -152.30 (s). 
MS (EI): m/z = 863.1 [M-2BF4]2+ (calc. 862.8). 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 240 [279 000], 276 [160 000], 313 [128 800], 
322 [130 000], 544 [8 140]. 
Emission (MeCN, λmax(nm), λexc = 355 nm) = 479. 
IR (ATR): ν∼/cm-1 = 3043w, 2922m, 2851w, 1593w, 1583w, 1470m, 1377w, 1238w, 1049s, 
1034s, 841s, 762m, 721m, 683m. 
Anal. calc. for C126H80B2F8FeN6 · 3 H2O C 77.47, H 4.02, N 4.30; found C 77.56, H 4.49, N 
3.66. 
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cis-[Ru(34)2Cl2] (89) 
MeO
Ru
N
N
OMe
N
N
MeOCl
Cl
MeO
 
89 
Commercial ruthenium trichloride trihydrate (267 mg, 1.02 mmol) and 5,5'-bis(3-methoxy-
phenyl)-2,2'-bipyridine (34) (760 mg, 2.06 mmol) were heated to reflux in DMF (100 mL) for 
4 h. The reaction mixture was reduced to 5 mL, cooled to room temperature, treated with 
acetone (100 mL) and kept at 4 °C over night. The precipitate was collected by suction 
filtration and washed with water (40 mL). The crude product was suspended in 500 mL of 
water–ethanol (1:1) and heated to reflux for 1 h, filtered from insoluble solid and treated 
carefully with 40 g of lithium chloride. Ethanol was removed in vacuo and the resulting water 
solution was cooled in an ice bath. Dark crystals formed. They were ground and dried in 
vacuo for 24 h. The dark powder (518 mg, 570 µmol, 44%) was spectroscopically pure. 
 
1H NMR (400 MHz, DMSO-d6) δ/ppm = 10.44 (s, 1H), 8.80 (s, 1H), 8.62 (s, 1H), 8.49 (s, 
1H), 8.07 (s, 1H), 7.80 (s, 1H), 7.56 (s, 1H), 7.44 (s, 2H), 7.28 (s, 1H), 7.14 (s, 1H), 6.93 (s, 
2H), 6.84 (s, 1H), 3.88 (s, 3H), 3.62 (s, 3H). 
MS (FAB): m/z = 908.1 [M] (calc. 908.1), 873.3 [M- Cl] (calc. 873.2), 838.2 [M- 2Cl] (calc. 
838.2). 
Anal. calc. for C48H40Cl2N4Ru · 3.5 H2O C 59.32, H 4.87, N 5.76; found C 59.33, H 4.52, N 
5.68. 
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[Ru(84)3](PF6)2 (86) 
 
5,5'-Di(pyren-1-yl)-2,2'-bipyridine (84) (127 mg, 228 µmol) and [Ru(DMSO)4Cl2] (37.1 mg, 
76.6 µmol) were suspended in 10 mL of ethylene glycol. The reaction mixture was stirred for 
2h at 250 °C in a microwave reactor. The orange mixture was added to 200 mL of an aqueous 
NH4PF6 solution (1.00 mmol). An orange precipitate formed which was filtered and washed 
with water (50 mL) and ether (50 mL) yielding the ruthenium complex 86 (131 mg, 63.6 
µmol, 83%) as an orange powder. 
 
1H NMR (500 MHz, DMSO-d6, 355 K) δ/ppm = 9.35 (d, J = 8.3 Hz, 6H, HA3), 8.51 (d, J = 
8.1 Hz, 6H, HA4), 8.38 (s, 6H, HA6), 8.31 (d, J = 7.6 Hz, 6H, HP6), 8.24 (d, J = 8.9 Hz, 6H, 
HP5), 8.14 (dd, J = 4.5, 8.1 Hz, 12H, HP3+P4), 7.99 (t, J = 7.6 Hz, 6H, HP7), 7.80 (d, J = 7.8 Hz, 
6H, HP2), 7.66 (d, J = 7.1 Hz, 6H, HP8), 7.22 (d, J = 9.1 Hz, 6H, HP10), 6.88 (d, J = 8.5 Hz, 6H, 
HP9). 
MS (ESI): m/z = 885.7 [M- 2 PF6]2+ (calc. 885.7). 
Emission (MeCN, λmax(nm)) = 476. 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 240 [129000], 276 [76100], 297 [69300], 323 
[66600], 379 [43300], 401 [43200]. 
Anal. calc. for C126H72F12N6P2Ru·H2O C 72.79, H 3.59, N 4.04; found C 72.70, H 3.66, N 
3.87. 
 
[Ru(84)(bpy)2](PF6)2 (87) 
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Complex 87 was synthesised according to procedure 67 with 5,5'-di(pyren-1-yl)-2,2'-
bipyridine (84) (94.2 mg, 169 µmol) and cis-[Ru(bpy)2Cl2] (82.0 mg, 169 µmol). Column 
chromatography (Al2O3, CH2Cl2 : MeOH (20:1)) yielded title compound 87 (201 mg, 
160 µmol, 94%) as an orange solid. 
 
1H NMR (500 MHz, CD3CN) δ/ppm = 8.82 (d, J = 8.3 Hz, 2H), 8.66 (d, J = 8.1 Hz, 2H), 8.50 
– 8.46 (m, 2H), 8.43 (dd, J = 8.3, 1.8 Hz, 2H), 8.38 – 8.33 (m, 4H), 8.32 (d, J = 8.0 Hz, 2H), 
8.25 – 8.19 (m, 4H), 8.19 – 8.12 (m, 8H), 7.98 (d, J = 7.9 Hz, 2H), 7.96 (d, J = 1.6 Hz, 2H), 
7.81 – 7.75 (m, 4H), 7.65 (d, J = 9.0 Hz, 2H), 7.63 – 7.57 (m, 2H), 7.20 (t, J = 6.6 Hz, 2H). 
13C NMR (126 MHz, CD3CN) δ/ppm = 158.07, 158.01, 156.55, 153.41, 153.27, 152.97, 
141.25, 140.30, 139.18, 138.72, 132.92, 132.36, 131.68, 131.62, 129.76, 129.64, 129.21, 
128.96, 128.90, 128.54, 128.31, 127.87, 127.26, 126.79, 126.20, 125.58, 125.49, 125.38, 
125.30, 125.19, 124.03. 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.09 (d, J = 706.4 Hz). 
MS (ESI): m/z = 485.2 [M- 2 PF6]2+ (calc. 485.1). 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 241 [134000], 288 [117000], 405 [47730]. 
Emission (MeCN, λmax(nm), λexc = 355 nm) = 495, 645. 
IR (ATR): ν∼/cm-1 =  3043w, 1601w, 1464w, 1447m, 1240m, 1161w, 831s, 762m, 729w. 
Anal. calc. for C62H40F12N6P2Ru·H2O C 58.27, H 3.31, N 6.58; found C 58.26, H 3.43, N 
6.52. 
 
[Ru(84)(34)2](PF6)2 (88) 
, 
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Complex 88 was synthesised according to procedure 67 with 5,5'-di(pyren-1-yl)-2,2'-
bipyridine (84) (64.1 mg, 115 µmol) and [Ru(bmpb)2Cl2] (89) (108 mg, 119 µmol). Colum 
chromatography (SiO2, CH2Cl2 → CH2Cl2: MeOH (50:1)) yielded title compound 88 (120 
mg, 71.2 µmol, 62%) as an orange solid. 
 
1H NMR (500 MHz, CD3CN) δ/ppm =  8.88 (d, J = 8.4 Hz, 2H, HA3), 8.75 (d, J = 8.5 Hz, 2H, 
HB3), 8.57 (d, J = 8.5 Hz, 2H, HD3), 8.50 (dd, J = 8.5 Hz, 1.7, 2H, HB4), 8.47 (dd, J = 8.3 Hz, 
1.7, 2H, HA4), 8.32 – 8.23 (m, 10H, HB6+A6+3xP), 8.18 (d, J = 9.0 Hz, 2H, HP), 8.14 – 8.09 (m, 
4H, H2xP), 8.06 (dd, J = 8.5, 1.8 Hz, 2H, HD4), 7.97 (d, J = 8.3 Hz, 4H, HD6+P), 7.90 (d, J = 9.2 
Hz, 2H, HP), 7.70 (d, J = 9.2 Hz, 2H, HP), 7.46 (t, J = 8.0 Hz, 2H, HC5), 7.21 – 7.18 (m, 2H, 
HC6), 7.17 (t, J = 6.7 Hz, 2H, HE5), 7.13 (s, 2H, HC2), 7.06 (dd, J = 8.3, 2.3 Hz, 2H, HC4), 6.86 
(dd, J = 8.3, 2.3 Hz, 2H, HE6), 6.76 (d, J = 7.8 Hz, 2H, HE4), 6.65 (s, 2H, HE2), 3.80 (s, 6H, 
HC-OMe), 3.55 (s, 6H, HE-OMe). 
13C NMR (126 MHz, CD3CN) δ/ppm = 161.51, 161.10, 156.84, 156.79, 156.47, 154.14, 
150.95, 150.43, 141.22, 140.73, 140.38, 140.22, 137.29, 137.09, 136.76, 136.55, 132.89, 
132.30, 131.82, 131.71, 131.54, 131.44, 129.72, 129.60, 129.26, 128.84, 128.26, 127.85, 
127.27, 126.81, 126.18, 125.71, 125.57, 125.52 (2x), 125.15, 123.91, 120.55, 120.11, 116.42, 
116.20, 113.58, 113.08, 56.36, 55.96. 
19F NMR (376 MHz, CD3CN) δ/ppm = -74.09 (d, J = 706.4 Hz). 
MS (ESI): m/z = 1539.5 [M- PF6]+ (calc. 1539.4) 697.3 [M- 2 PF6]2+ (calc. 697.2). 
UV-Vis (MeCN, λmax(nm) [ε/ (cm-1 M-1)]) = 241 [134700], 275 [91900], 321 [139100], 403 
[40200, shoulder]. 
Emission (MeCN, λmax(nm), λexc = 355 nm) = 464, 498, 638. 
IR (ATR): ν∼/cm-1 =  3047w, 2835w, 1597m, 1580m, 1466m, 1369m, 1300m, 1219m, 1175m, 
1022m, 825s, 777m, 685m. 
Anal. calc. for C90H64F12N6O4P2Ru·H2O C 63.49, H 3.91, N 6.94; found C 63.33, H 3.91, N 
4.52. 
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7 Appendix 
7.1 Crystal Structures from Chapter 2 
 
[Fe(34)3]2+ (452+) 
 
 
 
 
 
[Ru(31)]2+ (592+)   
 
 
 
Crystal Data 
Formula C112F12N11O18P2Ru 
Formula Weight 2178.29 
Crystal System Monoclinic 
Space group P21/n        (No. 14) 
a, b, c [Å] 22.8533(6)   17.8126(3)   28.7516(7) 
alpha, beta, gamma [deg] 90   99.5680(8)           90 
V [Å3] 11541.3(5) 
Z 4 
D(calc) [g/cm3] 1.254 
Mu(MoKa) [mm-1 ] 0.248 
F(000)   4300 
Crystal Size [mm] 0.12 x  0.25 x  0.44 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.7,  26.0 
Dataset   -28: 27 ; -14: 21 ; -32: 35 
Tot., Uniq. Data, R(int) 47722,  21737,  0.040 
Observed data [I > 2.0 sigma(I)] 11003 
Refinement 
Nref, Npar 11003,  625 
R, ωR2, S 0.3143, 0.4047, 3.53 
Max. and Av. Shift/Error 1.65, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -3.86, 9.61 
Crystal Data 
Formula C72H60FeN6O6, 3(C2H4Cl2), 2(F6P) 
Formula Weight 1747.95 
Crystal System Orthorhombic 
Space group Pbca    ba-c (No. 61) 
a, b, c [Å] 22.5632(1)   25.4589(2)   28.8665(2) 
alpha, beta, gamma [deg]  
V [Å3] 16581.91(19) 
Z 8 
D(calc) [g/cm3] 1.400 
Mu(MoKa) [mm-1 ] 0.495 
F(000)   7168 
Crystal Size [mm] 0.21 x  0.28 x  0.34 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.4,  27.9 
Dataset   -29: 29 ; -33: 29 ; -37: 36 
Tot., Uniq. Data, R(int) 113362,  19770,  0.049 
Observed data [I > 2.0 sigma(I)] 11198 
Refinement 
Nref, Npar 11198, 1081 
R, ωR2, S 0.0704, 0.0960, 1.05 
Max. and Av. Shift/Error 0.03, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.86, 1.53 
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[Ru(34)3]2+ (492+) 
 
 
 
 
34H+ 
 
 
 
 
 
 
 
Crystal Data 
Formula C72H60N6O6Ru, 2(F6P), 3(C2H4Cl2) 
Formula Weight 1793.18 
Crystal System Trigonal 
Space group P-3          (No.147) 
a, b, c [Å] 14.5348(1)   14.5348(1)   21.8419(2) 
alpha, beta, gamma [deg] 90           90          120 
V [Å3] 3996.13(5) 
Z 2 
D(calc) [g/cm3] 1.490 
Mu(MoKa) [mm-1 ] 0.521 
F(000)   1828 
Crystal Size [mm] 0.10 x  0.22 x  0.27 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.6,  27.9 
Dataset   -18: 16 ; -19: 19 ; -28: 28 
Tot., Uniq. Data, R(int) 31117,   6383,  0.050 
Observed data [I > 2.0 sigma(I)] 3852 
Refinement 
Nref, Npar 3852,  358 
R, ωR2, S 0.0525, 0.0792, 1.03 
Max. and Av. Shift/Error 0.03, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.72, 1.32 
Crystal Data 
Formula C24H20N2O2, F6P, H2O 
Formula Weight 531.41 
Crystal System Monoclinic 
Space group P21/a        (No. 14) 
a, b, c [Å] 13.0892(2)   10.5206(2)   18.0328(3) 
alpha, beta, gamma [deg] 90  109.5695(8)           90 
V [Å3] 2339.79(7) 
Z 4 
D(calc) [g/cm3] 1.509 
Mu(MoKa) [mm-1 ] 0.196 
F(000)   1092 
Crystal Size [mm] 0.08 x  0.13 x  0.25 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.3,  27.8 
Dataset   -17: 17 ; -13: 13 ; -23: 23 
Tot., Uniq. Data, R(int) 20955,   5546,  0.045 
Observed data [I > 2.0 sigma(I)] 3605 
Refinement 
Nref, Npar 3605,  325 
R, ωR2, S 0.0562, 0.0983, 1.13 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.28, 1.56 
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7.2 Crystal Structures from Chapter 3  
 
[Ru(34)(bpy)2]2+ (672+) 
 
 
 
[Ru(N^N)(bpy)2]2+ (642+) 
 
 
 
Crystal Data 
Formula C44H36N6O2Ru, 2(F6P), C2H3N 
Formula Weight 1112.85 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 12.449(3)    13.757(3)    14.219(3) 
alpha, beta, gamma [deg] 76.49(3)     74.54(3)     83.29(3) 
V [Å3] 2278.2(10) 
Z 2 
D(calc) [g/cm3] 1.622 
Mu(MoKa) [mm-1 ] 0.512 
F(000)   1124 
Crystal Size [mm] 0.07 x  0.25 x  0.30 
Data Collection 
Temperature (K) 446 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.5,  25.0 
Dataset   -14: 14 ; -16: 16 ; -16: 16 
Tot., Uniq. Data, R(int) 33505,   8048,  0.126 
Observed data [I > 2.0 sigma(I)] 7300 
Refinement 
Nref, Npar 8048,  669 
R, ωR2, S 0.0572, 0.1493, 1.10 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -1.86, 2.03 
Crystal Data 
Formula C58H62N6O8Ru, C58H62F12N6NaO8P2Ru, 3(F6P) 
Formula Weight 1446.13 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 15.154(3)    17.614(4)    26.892(5) 
alpha, beta, gamma [deg] 86.54(3)     82.28(3)     84.31(3) 
V [Å3] 7070(3) 
Z 4 
D(calc) [g/cm3] 1.359 
Mu(MoKa) [mm-1 ] 0.372 
F(000)   2952 
Crystal Size [mm] 0.16 x  0.28 x  0.45 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.4,  25.0 
Dataset   -18: 18 ; -20: 20 ; -32: 32 
Tot., Uniq. Data, R(int) 89634,  24992,  0.083 
Observed data [I > 2.0 sigma(I)] 21321 
Refinement 
Nref, Npar 24992, 1741 
R, ωR2, S 0.0658, 0.1755, 1.05 
Max. and Av. Shift/Error 0.04, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.90, 0.87 
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[Ru2(55)(bpy)4]4+ (652+) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crystal Data 
Formula C100H92N12O8Ru2, C2H4Cl2, 2.5(C4H8O2) 
Formula Weight 2691.12 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 14.1156(13)    20.075(2)    23.409(2) 
alpha, beta, gamma [deg] 77.354(5)    73.193(5)    85.179(5) 
V [Å3] 6194.5(10) 
Z 2 
D(calc) [g/cm3] 1.443 
Mu(MoKa) [mm-1 ] 0.437 
F(000)   2748 
Crystal Size [mm] 0.05 x  0.13 x  0.29 
Data Collection 
Temperature (K) 123 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.9,  33.7 
Dataset   -21: 21 ; -31: 31 ; -35: 36 
Tot., Uniq. Data, R(int) 386895,  48568,  0.050 
Observed data [I > 2.0 sigma(I)] 18510 
Refinement 
Nref, Npar 18510, 1825 
R, ωR2, S 0.0679, 0.1851, 1.04 
Max. and Av. Shift/Error 0.03, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.84, 1.70 
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7.3 Crystal Structures from Chapter 4  
 
[Pd(34)2]2+ (742+) 
 
 
 
 
Ligand 78 
 
 
 
 
Crystal Data 
Formula C48H40N4O4Pd, C24H20N2O2, 2(BF4) 
Formula Weight 1385.31 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 8.7623(2)   11.1136(2)   16.3282(3) 
alpha, beta, gamma [deg] 75.8896(11)  77.9053(12)  89.1174(12) 
V [Å3] 1506.78(5) 
Z 1 
D(calc) [g/cm3] 1.527 
Mu(MoKa) [mm-1 ] 0.396 
F(000)   710 
Crystal Size [mm] 0.05 x  0.25 x  0.34 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.9,  27.8 
Dataset   -11: 11 ; -14: 14 ; -21: 21 
Tot., Uniq. Data, R(int) 13865,   7175,  0.023 
Observed data [I > 2.0 sigma(I)] 5977 
Refinement 
Nref, Npar 5977,  430 
R, ωR2, S 0.0274, 0.0351, 1.11 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.65, 0.43 
Crystal Data 
Formula C26H24N2O2 
Formula Weight 396.49 
Crystal System Monoclinic 
Space group P21/c        (No. 14) 
a, b, c [Å] 10.0276(2)    8.1544(1)   12.9843(2) 
alpha, beta, gamma [deg] 90   111.960(1)           90 
V [Å3] 984.68(3) 
Z 2 
D(calc) [g/cm3] 1.337 
Mu(MoKa) [mm-1 ] 0.085 
F(000)   420 
Crystal Size [mm] 0.12 x  0.21 x  0.41 
Data Collection 
Temperature (K) 123 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.2,  35.5 
Dataset   -16: 16 ; -12: 11 ; -21: 20 
Tot., Uniq. Data, R(int) 25410,   4279,  0.036 
Observed data [I > 2.0 sigma(I)] 2689 
Refinement 
Nref, Npar 2689,  136 
R, ωR2, S 0.0512, 0.0608, 1.07 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.41, 0.50 
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[Cu(77)2]+ (80+) 
 
 
 
 
Compound 73 
 
 
 
 
 
 
 
 
Crystal Data 
Formula C50H44CuN4O4, F6P, 0.1(C2H4Cl2), 0.15(CH2Cl2) 
Formula Weight 996.07 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 10.3190(8)  15.0783(14)  16.6032(11) 
alpha, beta, gamma [deg] 90.627(7)    98.169(6)   106.230(7) 
V [Å3] 2451.7(4) 
Z 2 
D(calc) [g/cm3] 1.349 
Mu(MoKa) [mm-1 ] 0.575 
F(000)   1027 
Crystal Size [mm] 0.07 x  0.13 x  0.25 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.8,  35.1 
Dataset   -15: 16 ; -24: 24 ; -26: 26 
Tot., Uniq. Data, R(int) 74714,  21403,  0.140 
Observed data [I > 2.0 sigma(I)] 7665 
Refinement 
Nref, Npar 7665,  757 
R, ωR2, S 0.0958, 0.1300, 1.03 
Max. and Av. Shift/Error 0.03, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.74, 0.79 
Crystal Data 
Formula C32H23N5O 
Formula Weight 493.57 
Crystal System Monoclinic 
Space group P21/c        (No. 14) 
a, b, c [Å] 6.4613(2)   18.9013(5)   19.9753(6) 
alpha, beta, gamma [deg] 90    96.853(2)           90 
V [Å3] 2422.09(12) 
Z 4 
D(calc) [g/cm3] 1.354 
Mu(MoKa) [mm-1 ] 0.085 
F(000)   1032 
Crystal Size [mm] 0.03 x  0.05 x  0.23 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.2,  31.0 
Dataset   -9:  9 ; -27: 27 ; -28: 28 
Tot., Uniq. Data, R(int) 93608,   7731,  0.050 
Observed data [I > 2.0 sigma(I)] 4127 
Refinement 
Nref, Npar 4127,  343 
R, ωR2, S 0.0377, 0.0595, 1.13 
Max. and Av. Shift/Error  
Min. and Max. Resd. Dens. [e/Å3] -0.17, 0.37 
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7.4 Crystal Structures from Chapter 5  
 
 
Compound 84 
 
 
 
 
[Ru(84)3](PF6)2 (86) 
 
 
 
Crystal Data 
Formula C42H24N2 
Formula Weight 556.67 
Crystal System Monoclinic 
Space group P21/c        (No. 14) 
a, b, c [Å] 7.378(3)     6.923(3)   26.070(12 
alpha, beta, gamma [deg] 90     94.21(3)           90 
V [Å3] 1328.0(10) 
Z 2 
D(calc) [g/cm3] 1.392 
Mu(MoKa) [mm-1 ] 0.081 
F(000)   580 
Crystal Size [mm] 0.01 x  0.10 x  0.33 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 3.0,  28.6 
Dataset   -9:  9 ;  -9:  9 ; -34: 34 
Tot., Uniq. Data, R(int) 13452,   3235,  0.149 
Observed data [I > 2.0 sigma(I)] 1624 
Refinement 
Nref, Npar 1624,  200 
R, ωR2, S 0.1048, 0.1196, 1.10 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.50, 0.45 
Crystal Data 
Formula C126H72N6Ru, 2(F6P), C4O2, 2(O0.90), 0.2(O) 
Formula Weight 2172.95 
Crystal System Monoclinic 
Space group C2/c         (No. 15) 
a, b, c [Å] 31.036(6)    14.554(3)    30.004(6) 
alpha, beta, gamma [deg] 90    117.56(3)           90 
V [Å3] 12015(5) 
Z 4 
D(calc) [g/cm3] 1.201 
Mu(MoKa) [mm-1 ] 0.229 
F(000)   4432 
Crystal Size [mm] 0.06 x  0.10 x  0.35 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.4,  27.5 
Dataset   -40: 40 ; -18: 18 ; -38: 38 
Tot., Uniq. Data, R(int) 153371,  13745,  0.102 
Observed data [I > 2.0 sigma(I)] 12531 
Refinement 
Nref, Npar 13745,  834 
R, ωR2, S 0.0749, 0.2272, 1.19 
Max. and Av. Shift/Error 0.03, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.60, 0.79 
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[Ru(84)(bpy)2](PF6)2 (87) 
 
 
 
[Ru(84)(34)2](PF6)2 (88) 
 
 
 
 
 
Crystal Data 
Formula C62H40N6Ru, C4H8O2, 3(C3H7NO), 2(F6P) 
Formula Weight 1567.42 
Crystal System Triclinic 
Space group P-1          (No.  2) 
a, b, c [Å] 12.3207(4)   15.9054(5)   19.8308(5) 
alpha, beta, gamma [deg] 113.507(1)    96.569(2)    92.992(2) 
V [Å3] 3519.78(19) 
Z 2 
D(calc) [g/cm3] 1.479 
Mu(MoKa) [mm-1 ] 0.359 
F(000)   1608 
Crystal Size [mm] 0.04 x  0.09 x  0.39 
Data Collection 
Temperature (K) 173 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 2.1,  34.1 
Dataset   -19: 19 ; -24: 25 ; -30: 29 
Tot., Uniq. Data, R(int) 171563,  27495,  0.041 
Observed data [I > 2.0 sigma(I)] 17707 
Refinement 
Nref, Npar 17707,  937 
R, ωR2, S 0.0399, 0.0516, 1.07 
Max. and Av. Shift/Error 0.00, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -0.59, 0.98 
Crystal Data 
Formula 2(C90H64N6O4Ru), 2(C4H10O), 4(F6P), 10(C2H3N), C2H3N 
Formula Weight 3968.88 
Crystal System Monoclinic 
Space group P21/n        (No. 14) 
a, b, c [Å] 16.7663(9)  30.4322(17)  18.6382(11 
alpha, beta, gamma [deg] 90    97.028(3)           90 
V [Å3] 9438.4(9) 
Z 2 
D(calc) [g/cm3] 1.396 
Mu(MoKa) [mm-1 ] 0.285 
F(000)   4092 
Crystal Size [mm] 0.25 x  0.32 x  0.40 
Data Collection 
Temperature (K) 123 
Radiation [Å] MoKa      0.71073 
Theta Min-Max [deg] 1.7,  30.2 
Dataset   -23: 23 ; -42: 42 ; -26: 26 
Tot., Uniq. Data, R(int) 235317,  27749,  0.000 
Observed data [I > 2.0 sigma(I)] 22984 
Refinement 
Nref, Npar 19573, 1315 
R, ωR2, S 0.0627, 0.0853, 1.02 
Max. and Av. Shift/Error 0.04, 0.00 
Min. and Max. Resd. Dens. [e/Å3] -1.05, 1.78 
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7.5 Overview Crystal Structures  
Chapter 2 
 
   [Ru(31)]2+ (592+)  [Fe(34)3]2+ (452+) 
 
   [Ru(34)3]2+ (492+)   34H+ 
Chapter 3 
 
             [Ru(34)(bpy)2]2+ (672+)      [Ru(N^N)(bpy)2]2+ (642+) 
 
           [Ru2(55)(bpy)4]4+ (52-F12+) 
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Chapter 4 
 
   [Pd(34)2]2+ (742+)   Ligand 78 
 
   [Cu(77)2]+ (80+)        Compound 73 
Chapter 5 
 
   Compound 84   [Ru(84)3](PF6)2 (86) 
 
      [Ru(84)(bpy)2](PF6)2 (87)  [Ru(84)(34)2](PF6)2 (88) 
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